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Abstract 
Membrane proteins are vital to drug discovery, being targeted by some 60% of the 
currently marketed therapeutic medicines, with more than half of those targeting 
transmembrane receptors. Identification of transmembrane receptor targets of 
poorly characterised ligands can provide new starting points for drug innovation, 
provide valuable information about off-target effects, and enhance mechanistic 
understanding of molecular pathways. Whereas, over the years, various methods 
for target identification have been developed, due to unfavourable 
characteristics, such as hydrophobicity, low abundance and transient ligand-
interactions, identification of transmembrane proteins remains a challenge.  
Described herein is the design, synthesis and evaluation of four universal, 
trifunctional probes specifically developed to allow the covalent capture of 
transmembrane receptors in a process called ligand-based receptor capture (LRC). 
These probes contain three functional groups: (1) a ligand-coupling moiety; (2) a 
receptor-capturing moiety; (3) and an affinity tag. In an LRC experiment these 
probes would be coupled to the ligand of interest, after which the adduct would 
be added to cells believed to express the target receptor(s) to allow receptor-
capturing. After affinity purification, captured receptors would be identified using 
mass spectrometry.  
All four probes contained an N-hydroxysuccinimide (NHS)-ester to allow ligand-
coupling through free amines. For receptor capture, both a protected hydrazine 
moiety and the photoreactive groups benzophenone and diazirine were 
investigated. Protected hydrazine moieties will couple to aldehydes, present on 
sugar tails of glycosylated receptors after mild oxidation, whereas photoreactive 
groups will form covalent bonds with molecules in close proximity upon activation 
with UV-light. For affinity purification, probes either contained a biotin group, for 
purification using streptavidin, or an alkyne moiety, which would allow coupling 
to any reporter or affinity tag bearing an azide group using the copper-catalyzed 
azide-alkyne cycloaddition. 
The interactions between the two peptidic ligands, orexin A and substance P (SP), 
and their respective G-protein coupled receptors orexin 1 and neurokinin 1 (NK1), 
expressed in an inducible manner using the Flp-InTM T-RExTM system, were 
 IV 
employed as test systems. Initially, these systems were used to investigate 
individual steps in the LRC protocol, including ligand-coupling, potential 
interference of the probes on the ligand-receptor interaction, and ability of the 
probes to covalently couple to the receptor. Only for the probe containing an NHS-
ester, a diazirine moiety and a biotin group, could capture of the target receptor 
be demonstrated. This probe was then coupled to SP and used in a full LRC 
experiment to successfully identify NK1 as the only SP-binding receptor. This 
provides a proof of concept, demonstrating that this novel probe could be used as 
a general tool to help identify target receptors for a variety of ligands in the near 
future. 
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HEK293T Human embryonic kidney 293 cells transformed with large T-
antigen 
HEPES N-2-Hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
His Histidine 
HMBC Heteronuclear multiple bond correlation 
HOBT Hydroxybenzotriazole 
HPLC High-pressure liquid chromatography  
HRMS High resolution mass spectrometry 
HSQC Heteronuclear single quantum coherence 
HTRF A homogeneous time-resolved fluorescence 
ICL Intracellular loop 
IP1 Inositol monophosphate  
Kd Dissociation constant 
Ki Inhibitory constant  
LAMP-1 Lysosomal-associated membrane protein 1  
LB Luria-Bertani  
LC-MS Liquid chromatography mass spectrometry 
LC-MS/MS  Liquid chromatography tandem-mass spectrometry 
LIMP II Lysosome membrane protein 2 
LRC Ligand-based receptor capture 
MAPK Mitogen-activated protein kinase 
Me Methyl 
mRNA Messenger RNA 
MS Mass spectrometry  
MTBE Methyl tert-butyl ether 
MTX Methotrexate 
MWCO Molecular weight cut-off 
MYTH Membrane yeast two hybrid 
NHS N-Hydroxysuccinimide 
NK1 Neurokinin 1 receptor 
NK2 Neurokinin 2 receptor 
NK3 Neurokinin 3 receptor 
NKA Neurokinin A 
NKB Neurokinin B 
 XXVIII 
Nle Norleucine 
NMR Nuclear magnetic resonance 
NP40 Nonyl phenoxypolyethoxylethanol 40 
Nub N-terminal fragment of ubiquitin 
OX1 Orexin 1 receptor 
OX2 Orexin 2 receptor 
OXA Orexin A 16-33 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction  
PD Pull down 
PEG Poly ethyleneglycol 
PEI Polyethylenimine 
PPI Protein-protein interaction 
RF Retention factor  
RGS Regulators of G-protein signalling 
RIPA Radioimmunoprecipitation assay 
RNA Ribonucleic acid 
ROS Reactive oxygen species 
RT Room temperature 
RTK Receptor tyrosine kinase 
SDS Sodium dodecyl sulfate  
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM Standard error of the mean  
Ser Serine 
SP Acetyl-norleucine-substance P 
SPDP Succinimidyl 3-(2-pyridyldithio)propionate 
T/E Tris-EDT 
TAE Tris-acetate-EDTA  
TBS Tris-buffered saline  
TBTA Tris((1-benzyl-4-triazolyl)methyl)amine 
TCEP Tris(2-carboxyethyl)phosphine 
TEA Triethylamine  
TF Transcription factor 
TFA Trifluoroacetic acid 
TFAA Trifluoroacetic anhydride 
  XXIX 
THPTA Tris(benzyltriazolylmethyl)amine 
Thr Threonine 
TIC Total ion current 
TL Total lysate 
TLC Thin layer chromatography  
TM Transmembrane domain 
TOCSY Total correlation spectroscopy 
Tyr Tyrosine 
UDP Uridine diphosphate 
UV Ultraviolet 
VSV An 11-amino acid protein sequence (YTDIEMNRLGK) derived from 
vesicular stomatitis virus  
Wnt Wingless/integrated  
Y2H Yeast two-hybrid  
Y3H Yeast three-hybrid 
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1. Introduction  
1.1. A short history of the plasma membrane 
It is, nowadays, generally accepted that all living organisms are made up of cells, 
the smallest recognised unit of life. This, however, has not always been known. It 
was Robert Hooke who, in 1665, examined a piece of cork under a microscope and 
saw that this plant was made up of tiny pores he called ‘cells’, after the Latin 
word cella - small room (Figure 1-1; Hooke, 1665). Unbeknownst to himself, Hooke 
was actually looking at empty cell walls instead of cells. Nevertheless, the term 
stuck and 175 years later the cell theory, mostly attributed to Schleiden and 
Schwann, was postulated (Schleiden, 1838; Schwann, 1839). It was hypothesised 
that all living organisms were made up of cells and that these were the most basic 
units of life; a hypothesis that still stands today. 
 
Figure 1-1. Drawings of cork. Representative drawing of cork as seen through a microscope (top) 
and as seen by naked eye (bottom). Reprinted: Hook R. Micrographia, or Some Physiological 
Descriptions of Minute Bodies Made by Magnifying Glasses, 1665.  
Importantly, Schwann also hypothesised that cells were surrounded by a plasma 
membrane, even though these membranes might be invisible. He based this on 
the fact that he could see Brownian movement of cellular components within cells 
which stopped at a certain border (Schwann, 1839). For another century there was 
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much debate about the existence, nature and importance of the plasma 
membrane, however, by the early 20th century the consensus was reached that it 
existed (Lombard, 2014). It was then concluded that the plasma membrane was 
made up of lipids since lipid-soluble dyes entered cells more easily than water-
soluble dyes (Overton, 1900). Gorter and Grendel were the first to show that these 
lipids formed a bilayer; they extracted the lipids from a cell and created a 
monolayer with an area twice the size of the surface area of the cell (Gorter and 
Grendel, 1925). Although it later turned out that not all lipids had been extracted 
from the cell and that the cell size had been underestimated, the conclusion that 
membranes are lipid bilayers was correct and was an important breakthrough 
(Lombard, 2014). 
Around this time it had also become clear that membranes contained a certain 
amount of proteins and the paucimolecular model, which suggested that the lipid 
bilayer was flanked by an internal and an external layer of proteins, was 
postulated (Danielli and Davson, 1935). Although there were also other suggestions 
for the structure of the membrane, for decades the paucimolecular model was 
the most popular model (Lombard, 2014). Its position was strengthened when 
electron microscopy made it possible to visualise membranes as three-layered 
structures consisting of two dark bands, thought to be the proteins, enclosing a 
lighter band, thought to be the lipids (Robertson, 1960). Not much later, however, 
the first artificial lipid bilayers were created and electron microscopy revealed 
these had a similar three-layered structure, even though they lacked proteins (Hen 
et al., 1967). Furthermore, when the lipid bilayers of cellular membranes were 
separated and studied by electron microscopy bumps and cavities were visible on 
opposite sides of each other (Pinto da Silva and Branton, 1970). Slowly the general 
opinion began to change and a new model was postulated. This suggested that the 
membrane is a lipid bilayer with a hydrophobic interior framed by a hydrophilic 
exterior. Proteins can either interact with this bilayer or can be embedded in it. 
In this latter case, the hydrophobic parts of the proteins interact with the interior 
of the membrane (Singer and Nicolson, 1972). Although this is a simplistic view of 
the plasma membrane and membrane proteins, this model is still used today.  
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1.2. Membrane proteins  
Over the last 50 years membrane proteins, which are not only present in the 
plasma membrane, but also in membranes of intracellular compartments, have 
been the topic of many investigations. Membrane proteins are divided into two 
major classes, peripheral proteins and integral proteins (Figure 1-2). Peripheral 
proteins are loosely attached to the membrane or other membrane proteins 
through electrostatic interactions or hydrogen bonds; they can easily be removed 
from the membrane; and, like cellular proteins, they are water-soluble. Integral 
proteins are embedded in the membrane, often spanning it; they harbour 
hydrophobic regions which localise to the lipid-bilayer of membranes; and they 
are usually not functional outwith a membrane or membrane mimic (Hedin et al., 
2011). Integral proteins can either be endo- or exo-proteins, or transmembrane 
proteins (Figure 1-2). Endo- and exo-proteins do not cross the entire membrane 
but are located on the cytoplasmic or the extracellular side of the membrane, 
respectively. Transmembrane proteins span the full membrane and have 
additional regions both on the inside and the outside of the cell. Transmembrane 
proteins can cross the membrane once, however, it is more common that multiple 
transmembrane regions are present (Hedin et al., 2011; Stillwell, 2016).  
Sometimes a third class of membrane proteins is mentioned, lipid-anchored 
proteins (Figure 1-2). These proteins contain lipid tails which are inserted into the 
membrane and are thought to influence the localisation of these proteins within 
the membrane (Levental et al., 2010). Since the Van der Waals forces keeping 
these anchors in place are not very strong, usually lipid-anchored proteins also 
have integral regions or they exploit electrostatic and hydrophobic interactions to 
bind to the membrane (Stillwell, 2016).  
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Figure 1-2. Classes of membrane proteins. Peripheral membrane proteins are attached to other 
membrane proteins (1) or to the membrane (2) through electrostatic interactions or hydrogen bonds. 
Integral proteins are embedded within the membrane; transmembrane proteins (3) span the full 
membrane, while endo- and exoproteins localise to one side (4). Lipid-anchored proteins (5) utilise 
a lipid tail to anchor themselves to the membrane, however, these tails are usually found on proteins 
that can be classified as peripheral or integral as well.  
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1.3. Transmembrane proteins 
Transmembrane proteins are of the utmost importance for life as they can 
transport molecules and transmit signals between the intracellular and 
extracellular environment. It is estimated that 27% of the total protein encoding 
genes in humans are encoding for transmembrane proteins (Almén et al., 2009). 
1.3.1. Structure 
For single-transmembrane proteins the transmembrane region is formed by a 
series of hydrophobic amino acid residues present in the primary sequence of the 
protein. Whereas the side-chains of these amino acids are non-polar, the amide 
bond between the amino acids is polar. Hydrogen bonding between the amide 
bonds can reduce this polarity and, indeed, all transmembrane regions are known 
to form secondary structures (Figure 1-3). The most common structure, and the 
one always found in single-transmembrane proteins, is the α-helix (Heyden et al., 
2012). These helices are formed by roughly 20 hydrophobic residues. For multiple-
transmembrane proteins increased stability is gained from interactions between 
neighbouring helices; not only do these interactions allow for the presence of 
some hydrophilic, or even charged residues, they are also crucial for the final 
structure of the protein (De Marothy and Elofsson, 2015). α-Helical 
transmembrane proteins can also form dimers or higher order oligomers (Milligan, 
2009; Clarke and Gulbis, 2012; Maruyama, 2014). A small minority of multiple-
transmembrane proteins form so called β-barrels, consisting of β-sheets. A β-sheet 
crosses the membrane with an average of 11 amino acids and only every other side 
chain is hydrophobic (Tamm et al., 2004). Thus far, however, β-barrels have only 
been identified in bacterial, mitochondrial and chloroplastic outer membranes 
(Noinaj et al., 2017). 
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Figure 1-3. Structure of transmembrane proteins. Single-transmembrane proteins always form a 
single α-helix (1), while multiple-transmembrane proteins can either consist of a bundle of α-helices 
(2) or can form a β-barrel of β-sheets (3). 
1.3.2. Glycosylation 
Transmembrane proteins, like all proteins synthesised in the endoplasmic 
reticulum (ER), are usually glycosylated. Since the sugar residues are added in the 
lumen of the ER and the Golgi apparatus, transmembrane proteins are only 
glycosylated extracellularly. The oligosaccharides can be O-linked, via the 
hydroxyl group of serine or threonine residues, or they can be attached to the 
amide group of asparagine, resulting in N-linked glycosylation. The latter is the 
more common form, with 90% of all glycoproteins containing N-linked 
oligosaccharides (Alberts et al., 2008a).  
N-linked glycosylation starts as a co-translational process in the ER. Whilst the 
nascent protein is translated, oligosaccharyltransferase mediates the addition of 
a pre-assembled oligosaccharide, Glucose3Mannose9N-acetylglucosamine2, to 
asparagine residues within N-X-S/T motifs, where X is any amino acid but proline 
(Wang et al., 2015). The presence of these sugar groups alters the hydrophilicity 
of the protein and thereby directly affects its folding (Aebi, 2013). Moreover, the 
oligosaccharide plays an important function in the quality control of protein 
folding. ER-based glucosidases I and II rapidly cleave the terminal two glucose 
residues from the N-linked sugar tail (Figure 1-4, arrow 1). The monoglucosylated 
oligiosaccharide that remains forms the substrate for two lectins that act as 
chaperones, the ER-membrane bound calnexin (CNX) and its lumenal homolog 
calreticulin (CRT). Both CNX and CRT are conjugated to the thiol oxidoreductase 
ER resident protein 57 (ERp57) which generates transient disulphide bonds with 
the lectin-bound glycoproteins and thereby further assists in protein folding (Roth, 
2002; Wang et al., 2015). The glycoprotein is released from the lectins when its 
final glucose group is trimmed by glucoside II (Figure 1-4, arrow 2), however, if 
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the folding is not yet complete, UDP-glucose:glycoprotein glycosyltransferase will 
mediate reglucosylation and the glycoprotein will once again be bound by CNX or 
CRT (Figure 1-4, arrow 3). This process will be repeated until the protein is 
correctly folded. Only then, mannosidase I will further trim the glycan (Figure 1-4, 
arrow 4), resulting in a Mannose8N-acetylglucosamine2-tagged protein that will be 
transported to the Golgi apparatus (Figure 1-4, arrow 5) (Roth, 2002; Wang, 
Groenendyk and Michalak, 2015).  
 
Figure 1-4. The protein quality control system in the endoplasmic reticulum. Preassembled 
glucose3Mannose9N-acetylglucosamine2 is added to asparagine residues within the N-X-S/T motif of 
nascent proteins. The terminal glucose residues are immediately trimmed by glucosidases I and II 
(1). The monoglucosylated glycan then binds to calnexin (CLX) or calreticulin (CRT), conjugated to 
the thiol oxidoreductase ERp57, which functions as a chaperone. Glucosidase II will trim the final 
glucose residue leading to the disassociation of the protein from CLX/CRT (2). If the protein is not 
correctly folded UDP-glucose:glycoprotein glycosyltransferase will reglucosylate the protein and 
CLX/CRT will bind again (3). Once the protein is correctly folded mannosidase I will trim one more 
mannose residue off the glycan (4) and the protein will be transported to the Golgi apparatus (5).  
In the Golgi apparatus N-linked oligosaccharides are further modified by various 
glycosyltransferases and glycosidases to form more complex glycans. Sugar tails 
might be branched up to six times and other sugar moieties, including N-
acetylgalactosamine, galactose, glucosamine, fucose and sialic acid, can be added 
(Stanley, 2011). Furthermore, glycosyltransferases in the Golgi system also 
facilitate O-linked glycosylation. This process usually starts by the addition of N-
acetylgalactosamine to a serine or threonine residue, after which other sugars 
might be added (Van den Steen et al., 1998).  
Glycosylation of proteins has multiple purposes. To start with, glycans protect 
proteins from degradation by proteolytic enzymes. Moreover, the sugars tails are 
the substrate for various extracellular lectins, which, among others, are involved 
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in cell-growth, cell-cell adhesion and cell-cell recognition. Furthermore, 
oligosaccharides might affect protein-protein interactions (PPIs) as well as ligand-
binding (Lisowska and Jaskiewicz, 2012). 
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1.4. Transmembrane receptors 
As mentioned before, transmembrane proteins are a very important component 
of the plasma membrane as they form a passageway for molecules and signals to 
cross. Whereas single cellular organisms use most of their transmembrane proteins 
for transport, in multicellular organisms signal transduction is far more important. 
This is illustrated by the fact that transmembrane receptors count for only 5% of 
transmembrane proteins in E. coli compared to 23% in humans (Almén et al., 
2009).  
Transmembrane receptors bind to a wide range of endogenous ligands, including 
chemokines, cytokines, neurotransmitters, hormones, metabolites, ions and 
more, and are responsible for countless down-stream physiological processes. 
Their easy accessibility at the cell membrane, combined with the broad range of 
processes regulated by these receptors explains their key role in drug discovery; 
membrane proteins are targeted by 60% of the currently marketed drugs 
(Overington et al., 2006; Hauser et al., 2017; Santos et al., 2017). 
Most transmembrane receptors belong to one of the three major groups: ion-
channel coupled receptors, enzyme-coupled receptors or the G-protein coupled 
receptors (GPCRs). All these receptors have an extracellular ligand-binding 
domain, activation of which results in signal transduction, initiated through a 
conformational change in the transmembrane or intracellular region of the 
receptor (Uings and Farrow, 2000). The ligand-mediated activation of ion-channel 
coupled receptors and enzyme-coupled receptors will briefly discussed below. The 
focus, however, will be on the GPCRs, which count for 67% of all human 
transmembrane receptors and are the target of roughly 30% of the drugs on the 
market today (Almén et al., 2009; Santos et al., 2017).  
1.4.1. Ion-channel coupled receptors.  
Ion-channel coupled receptors are multimeric transmembrane proteins 
responsible for fast communication between cells within the nervous system and 
at the interface of nerves and muscles. The receptors are either tri-, tetra- or 
pentamers of similar, sometimes identical, subunits. Each subunit consists of a 
large extracellular domain, several transmembrane α-helices and a small 
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intracellular domain. The central pore that forms the actual ion-channel is created 
by one α-helix of each monomer, the charge and size of the amino acids on this 
helix determine the selectivity of the ion-channel (Tovar and Westbrook, 2012). 
These receptors are found at synapses; upon a change in electrical potential, 
neurotransmitters are released from presynaptic cells which then bind to the ion-
channel coupled receptors on postsynaptic cells. Binding of neurotransmitters to 
one or more subunits of the receptor triggers a conformational change leading to 
the opening of the ion-channel. These responses are extremely fast and short-
lived; individual channels are only open for tens of milliseconds. If the ligand is 
present for longer than that, the receptors enter a desensitised state in which the 
ligand is still bound, but the ion-channel is no longer open (Figure 1-5) (Plested 
2016).  
 
Figure 1-5. Activation and desensitisation of an ion-channel coupled receptor. The top row 
shows the extracellular and transmembrane regions of the zebrafish glycine receptor in three 
different states (resting, active and desensitised). The transmembrane helices that form the ion-
channel (M2) are highlighted. The bottom row shows the pore formed by the five M2 helices from the 
extracellular side in the same three states. The residues involved in closing the channel are depicted 
in spheres (9′-leucine in resting and active state, 2′-proline in desensitised state). In the resting state 
no ligand is bound and the ion channel is closed. In the active state ligand is bound and the ion 
channel is open. In the desensitised state ligand is bound, but the ion channel is closed. Reprinted 
by permission from Nature Pub. Group: Plested, A.J.R. Structural mechanisms of activation and 
desensitization in neurotransmitter-gated ion channels. Nature Structural & Molecular Biology, 23(6), 
pp.494–502, copyright 2016. 
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1.4.2. Enzyme-coupled receptors 
Of the three groups of transmembrane receptors, the enzyme coupled receptors 
are the most diverse and this group includes receptor tyrosine kinases (RTKs), 
tyrosine-kinase-associated receptors, receptor serine/threonine kinases, 
histidine-kinase-associated receptors, and receptor guanylyl cyclases. Contrary to 
the other two groups, subunits of these receptors usually only have a single α-
helical transmembrane domain. In general, inactive receptors exist as monomers 
on the plasma membrane and binding of a ligand to the extracellular domain 
induces dimerization. This dimerization brings the intracellular regions of the two 
subunits in close proximity to each other and activates the kinase or guanylyl 
cyclase regions on, or associated with, the receptors (Alberts et al., 2008b). 
Activation of kinase domains leads to trans-autophosphorylation of the subunits, 
creating recruitment sites for downstream signalling proteins, while dimerization 
of receptor guanylyl cyclases leads to the production of cyclic guanosine 
monophosphate (cGMP), a second messenger molecule (Lucas et al., 2000; 
Lemmon and Schlessinger, 2010). A few of these receptors already exist as 
oligomers in the absence of ligand. The insulin receptor, for example, forms a 
tetramer of two distinct subunits, linked together through disulphide-bridges 
(Hubbard, 2013). For such oligomeric receptors, binding of a ligand stabilises the 
interaction between the subunits leading to activation of the receptor. 
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1.5. G-protein coupled receptors 
As mentioned before, GPCRs are the largest class of human transmembrane 
receptors with roughly 5% of the protein encoding genes in humans encoding for 
800 distinct GPCRs (Fredriksson et al., 2003; Almén et al., 2009). While the GPCR 
superfamily is very diverse both with respect to the receptors’ ligands and their 
functions, members of this family share common structural features. The 
extracellular domain of GPCRs consists of the N-terminus and three flexible 
extracellular loops (ECL1-3); the transmembrane region contains seven α-helical 
transmembrane domains (TM1-7); and the intracellular domain consists of three 
intracellular loops (ICL1-3), an amphipathic helix (H8) and the C-terminus (Figure 
1-6). The extracellular regions and in some cases the TMs are responsible for ligand 
binding, upon which conformational changes in the TMs and the intracellular 
regions bind cytosolic signalling proteins thereby initiating signalling cascades 
(Venkatakrishnan et al., 2013).   
 
Figure 1-6. General structure of GPCRs. A GPCR consists of an N-terminus, three extracellular 
loops (ECL1-3), seven transmembrane α-helices (TM1-7), three intracellular loops (ICL1-3), an 
amphipathic helix (H8), and a C-terminus.  
1.5.1. Subfamilies  
Although GPCRs have general structural similarity, this superfamily can be 
phylogenetically divided into smaller subfamilies or clans. The first classification 
system divided the GPCRs into six classes or clans (A-F; Attwood & Findlay 1994; 
Kolakowski 1994), however, not all these classes are found in humans. Classes D 
and E, for example, contain fungal pheromone and cyclic adenosine 
monophosphate (cAMP) receptors, while subclass A1 contains invertebrate opsin 
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receptors. Another classification system, in which the mammalian GPCRs were 
first divided into five, and later six, major subfamilies, is nowadays more 
commonly used (Fredriksson et al., 2003; Nordström et al., 2011). The largest 
subfamily, by far, is the Rhodopsin family, which is still also referred to as class A 
receptors. In humans, this family contains approximately 690 receptors and has 
the most diverse ligands of all families. Most of the members of this group have 
short N-terminal domains and endogenous ligands usually bind to a cavity within 
the TM region. Therefore, compared to other families, TM regions within this 
family display a higher degree of variety (Fredriksson et al., 2003). All other 
families are significantly smaller and less diverse. The Secretin family (or class B1) 
contains 15 human receptors, all with medium length N-termini (~60-80 amino 
acids) that are the binding site for large peptidic ligands (Fredriksson et al., 2003). 
The 33 receptors in the Adhesion family (or class B2) have long, highly glycosylated 
N-termini (~200-2800 amino acids) which form rigid ‘stalks’ and are the binding 
site for large secreted glycoproteins and extracellular matrix proteins (Fredriksson 
et al., 2003; Paavola and Hall, 2012). The Glutamate family, which contains 22 
receptors, is characterised by long N-termini (~280-580 amino acids) that form 
two lobes surrounding a cavity that forms the ligand-binding pocket which closes 
upon ligand binding like a ‘Venus fly trap’ (Fredriksson et al., 2003). The Frizzled 
and Taste2 receptors were initially classed together as one family, however, 
recently the Taste2 receptors have been recognised as a distinct class (Fredriksson 
et al., 2003; Nordström et al., 2011). There are 11 human frizzled receptors, the 
N-termini of which (~200 amino acids) contain conserved cysteine residues that 
are likely to be involved in the binding of their ligands, Wingless/Integrated (Wnt) 
glycoproteins (Fredriksson et al., 2003). The final subfamily, the Taste2 receptors, 
contains 26 members which are involved in the tasting of bitterness. These 
receptors have short N-termini and are thought to bind to ligands through the 
extracellular loops, however, it is still unclear how these 26 receptors are able to 
recognise more than a thousand different bitter tastes (Fredriksson et al., 2003; 
Meyerhof et al., 2010).  
1.5.2. Signalling 
As for the other transmembrane receptors, binding of a ligand to the extracellular 
or transmembrane region of a GPCR induces conformational changes in both the 
transmembrane and the intracellular region of the receptor. Although this 
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suggests that a ligand can ‘switch on’ a receptor, it has become apparent that 
GPCRs are dynamic structures that are constantly transitioning between active 
and inactive conformations and binding of a ligand stabilises the active 
conformations (Latorraca et al., 2017). Although the exact activation mechanism 
is unique for each GPCR and GPCRs might even respond differently to different 
ligands, crystal structures, NMR data and molecular dynamics simulations do 
suggest that GPCRs of the Rhodopsin family have some generic features upon 
activation. Most importantly, once activated by a ligand, the intracellular part of 
TM6 rotates away from the transmembrane helix bundle, thereby creating an 
opening between TM3, TM5 and TM7 that serves as an intracellular binding pocket 
(Figure 1-7) (Venkatakrishnan et al., 2016; Latorraca et al., 2017).    
 
Figure 1-7. Conformational changes in rhodopsin-like GPCRs upon activation. Three 
rhodopsin-like GPCRs captured in their crystallographic inactive and active conformations reveal 
similar conformational changes upon activation. TM6 is highlighted. β2AR is the β2-adrenergic 
receptor, M2R is the M2 muscarinic acetylcholine receptor, and μOR is the μ-opioid receptor. 
Reprinted by permission from ACS Publications Support: Latorraca N.R., Venkatakrishnan A.J., Dror 
R.O. 2. GPCR Dynamics: Structures in Motion. Chem. Rev., 2017, 117 (1), pp 139–155. 
https://pubs.acs.org/doi/10.1021/acs.chemrev.6b00177 - further permissions related to the material 
excerpted should be directed to the ACS. 
1.5.2.1. G-proteins  
Thus, activation of GPCRs stabilises an active conformation with an intracellular 
binding pocket. This pocket binds to cytosolic effector proteins, which in turn 
regulate various intracellular signalling cascades. The first discovered and most 
researched class of these effector proteins, the associated guanine nucleotide-
binding proteins, or G proteins, are responsible for the name ‘G-protein coupled 
receptor’. In resting state G-proteins are heterotrimeric structures consisting of 
an α, β and γ subunit with guanosine diphosphate (GDP) bound to the Gα subunit 
(Figure 1-8, panel 1) (Lambright et al., 1996). Both the Gα and Gy subunits are 
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lipid-anchored to the plasma-membrane; these lipid tails are suggested to aid the 
localisation of the G-proteins in the vicinity of GPCRs (Vögler et al., 2008). Upon 
stabilisation of the active conformation of a GPCR, the Gα subunit binds to the 
intracellular region of the receptor, which then acts as a guanine exchange factor 
and catalyses the exchange of the Gα-bound GDP for guanosine-5'-triphosphate 
(GTP) (Figure 1-8, panel 2) (Dror et al., 2015). Binding of GTP triggers the 
disassociation of the Gα subunit from both the GPCR and the Gβγ dimer. Both the 
Gβγ dimer and the GTP-bound Gα subunit then independently modulate 
downstream effectors (Figure 1-8, panel 3) (Hilger et al., 2018). This activation is 
terminated when GTP is hydrolysed to GDP upon which the subunits reassemble 
to form an inactive trimer (Figure 1-8, panel 4). The Gα subunit has an intrinsic 
GTPase domain that is responsible for the hydrolysis of GTP. Although this domain 
will eventually hydrolyse GTP on its own, interaction of the  Gα subunit with 
various GTPase-activating proteins, including regulators of G-protein signalling 
(RGS), can increase the hydrolysis rate up to 2,000-fold (Oldham and Hamm, 
2006). One GPCR molecule can activate hundreds of G-proteins, thereby 
amplifying the initial signal (Lambright et al., 1996).  
 
Figure 1-8. G-protein mediated GPCR signalling. In resting state G-proteins are GDP-bound 
heterotrimers (1). Once a GPCR is activated by a ligand Gα binds to the GPCR which catalyses the 
exchange of GDP for GTP (2). Gα then dissociates from both the GPCR and the Gβγ dimer, and the 
Gβγ dimer and the GTP-bound Gα subunit independently modulate downstream effectors (3). This 
activation is terminated when GTP is hydrolysed to GDP upon which the subunits reassemble to 
form an inactive trimer (4). 
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Although the mechanism of G-protein activation is generic, the G-protein family 
contains multiple isoforms. In humans, there are 21 Gα subunits that share 35-95% 
sequence identity, 6 Gβ subunits that share 50–90% sequence identity and 12 Gγ 
subunits that share 30–80% sequence identity (Downes and Gautam, 1999). Usually 
the G-proteins are divided into 4 major classes, based upon the phylogenetics of 
the Gα subunits: Gαs Gαi/o Gαq/11 and Gα12/13. Each of these Gα subfamilies and 
the Gβγ dimer activate specific signalling pathways within the cells, these are 
depicted in Figure 1-9 (Thomsen et al., 2005).  
 
Figure 1-9. G-protein mediated signalling cascades. Upon activation of a G-protein the Gα 
subunits and the Gβγ dimer disassociate and activate specific downstream signalling cascades. 
Different Gα subtypes activate different downstream signalling cascades. cAMP is cyclic adenosine 
monophosphate, PKA is protein kinase A, PLC is phospholipase C, IP3 is inositol 1,4,5 trisphosphate, 
IP2 is inositol bisphosphate, IP1 is inositol monophosphate, DAG is diacylglycerol, PKC is protein 
kinase C, Rho is Ras homolog gene family, GEF is guanine nucleotide exchange factor, ROCK is 
Rho-associated protein kinase, and GRK is GPCR kinase.  
1.5.2.2. GPCR kinases and arrestins 
G-proteins are not the only effector proteins coupling to GPCRs; In mammals, 
there are seven closely related GPCR kinases (GRKs) that interact with activated 
GPCRs by phosphorylating various serine and threonine residues on their ICLs and 
C-tail (Figure 1-10, panel 1) (Komolov and Benovic, 2018). This phosphorylation 
leads to recruitment of a third class of GPCR effector proteins, arrestins (Figure 
1-10, panel 2). There are four different arrestins, numbered 1 to 4. Whereas 
arrestin 1 and 4 play a key role in regulation of rhodopsin signalling in rod 
photoreceptors cells, arrestin 2 and 3 (also called β-arrestin 1 and 2) are 
ubiquitously expressed throughout all cells types and are involved in the signalling 
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of most GPCRs (Tian et al., 2014). Binding of β-arrestin to a GPCR sterically hinders 
the binding of G-proteins and thus arrestin recruitment immediately results in 
termination of G-protein depend signalling. Moreover, binding of β-arrestin to a 
GPCR initiates clathrin-mediated endocytosis, which results in internalisation of 
the receptor (Figure 1-10, panel 3). Internalised receptors can either be recycled 
back to the plasma membrane, or they can be ubiquinated and degraded 
(Lefkowitz and Shenoy, 2005). More recently it has also been acknowledged that 
β-arrestin does not only terminate G-protein dependent signalling, but also 
activates signalling cascades on its own (Figure 1-10, panel 4). Mitogen-activated 
protein kinases (MAPKs), the serine/threonine kinase AKT, and the tyrosine kinase 
SRC are among the proteins activated by β-arrestin mediated GPCR signalling 
(Smith et al., 2018).  
 
Figure 1-10. GRK and β-arrestin mediated GPCR signalling. GRKs interact with activated GPCRs 
by phosphorylating serine and threonine residues (1). This leads to recruitment of β-arrestin (2), 
which terminates G-protein dependent signalling and initiates clathrin-mediated endocytosis, 
resulting in internalisation followed by recycling or degradation (3). β-Arrestin also activates signalling 
cascades (4). 
1.5.3. Functional assays   
As GPCRs are important targets in drug innovation much effort has been put into 
the development of high-throughput assays that allow the screening of large 
compound libraries. These assays are usually functional assays that measure levels 
of secondary messenger molecules affected by the activation of GPCRs. Although 
it goes beyond the scope of this thesis to discuss all GPCR-related functional 
assays, it is worth describing two of them: intracellular calcium ([Ca2+]i) assays 
and inositol monophosphate (IP1) accumulation assays, as these were used 
extensively while conducting the work described herein.  
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1.5.3.1. Intracellular calcium assays 
As depicted in Figure 1-9 activation of Gαq/11 results in the elevation of 
intracellular Ca2+. This elevation can be quantified using FURA-2 acetoxymethyl 
(AM) ester. When cells are incubated with FURA-2 AM, this molecule crosses the 
plasma membrane upon which esterases hydrolyse the AM esters yielding the 
fluorescent dye FURA-2 that is unable to cross the membrane again. Binding of 
Ca2+ to FURA-2 results in a change of its excitation wavelength from 380 nm to 340 
nm and the ratio between these two wavelengths is linear to the amount of Ca2+ 
(Scheme 1-1) (Grynkiewicz et al., 1985). 
 
Scheme 1-1. Hydrolysis and activation of FURA-2 AM.  
 
1.5.3.2. Inositol monophosphate accumulation assays 
Activation of Gαq/11 also results in the formation of inositol 1,4,5 trisphosphate 
(IP3), which rapidly hydrolyses to inositol bisphosphate (IP2) and then in IP1 (Figure 
1-9). Normally IP1 is degraded into inositol by inositol monophosphatase (IMPase), 
in IP1 accumulation assays, however, LiCl is added to cells to inhibit IMPase, 
resulting in the accumulation of IP1. IP1 is then quantified using a homogeneous 
time-resolved fluorescence (HTRF) kit. The accumulated intracellular IP1 
competes with the binding of an IP1-deravitive (HTRF acceptor) to an anti-IP1 
antibody (HTRF donor), thereby inhibiting the fluorescence resonance energy 
transfer (FRET) signal generated when the HTRF donor and acceptor are in close 
proximity (Figure 1-11) (Trinquet et al. 2011). 
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Figure 1-11. Inositol monophosphate accumulation assays. LiCl is added to cells to block the 
degradation of IP1 to inositol. After cell lysis an HTRF acceptor-coupled IP1-derivative and an HTRF 
donor-coupled IP1 antibody are added. The FRET signal is measured on a plate-reader. 
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1.6. Transmembrane receptors as drug targets   
Estimations on the total number of druggable proteins in humans range from 3051 
to 4497, corresponding to 15-22% of the protein encoding genes (Hopkins and 
Groom, 2002; Finan et al., 2017). In 2017, however, only 667 proteins were 
actually targeted by drugs (Santos et al., 2017). Although, as stated before, 
transmembrane receptors are specifically important drug targets, also in this 
category current drugs only act on a small portion of the proteins. For example, 
only 108 out of the 400 non-olfactory GPCRs are currently targeted by drugs 
(Hauser et al., 2017).  
As these numbers would suggest, major effort is being put into the development 
of new drugs and the identification of new drug targets. There are two main 
strategies used in drug discovery, the phenotype-based approach and the target-
based approach. Traditionally drugs were developed by the phenotypic approach, 
compounds were tested for their activity in cellular, tissue or animal models 
relevant to the disease of interest and active compounds were selected based on 
the observed effects. Over the last few decades the tactics changed and target-
based drug design became the norm. In this reversed approach the development 
of a new drug starts from a known target that has been selected based on genetic 
screens, biological observations, or is already an existing drug target. Once a 
target is identified and validated, compounds will be tested against this target 
after which initial hits will be optimised using rational design. Although target-
based drug design was initially believed to be superior, as drugs could be designed 
specifically for the protein they were targeting, the phenotypic approach has 
regained ground over the last few years. It has been realised that not targeting 
specific proteins had advantages for the discovery of new drug targets and indeed, 
even though target-based design yields more best-in-class drugs, phenotypic 
design yields more first-in-class drugs (Swinney, 2013). Moreover, compounds 
discovered through phenotypic screening are not restricted to one target and can 
be active on multiple proteins at once, a concept known as polypharmacology 
(Reddy and Zhang, 2013). A disadvantage of not targeting a specific protein, 
however, is that once an active compound is discovered its target protein is not 
immediately known and separate experiments will have to be performed to 
identify these target proteins. 
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1.7. Ligand-based identification assays 
Over the years various methods for target identification have been developed and 
the most important ones of those will be discussed below. It is important to realise 
that although these methods were introduced here in the light of drug discovery, 
drugs are just one type of ligand for which binding partners could be identified 
using such strategies. Examples of other ligands are proteins, to investigate PPIs, 
or pathogenic molecules to identify human receptors affected by them.  
The methods described below are divided into two major classes: gene-linked 
approaches and chemoproteomics. In gene-linked approaches the target proteins 
are physically linked to their gene sequence and proteins binding to the ligand of 
interest can thus be identified through sequencing. The cost to perform 
chemoproteomics is much higher as mass spectrometry (MS) is an expensive and 
time-consuming technique, nevertheless, although the scope of the gene-linked 
assays has expanded over the years, there are still major limitations and in 
practice chemoproteomics is more generally used (Ziegler et al., 2013). A few 
successful examples of ligand-based target identification have been listed in Table 
1-1, which can be found at the end of this section.   
1.7.1. Yeast hybrid systems 
Almost 30 years ago, the classic yeast two-hybrid (Y2H) system was developed 
(Fields and Song, 1989; Brückner et al., 2009). The main principle of Y2H assays 
is that a yeast transcription factor (TF) is split into two domains, the DNA-binding 
domain (DBD) and the transcriptional activation domain (AD) (Figure 1-14). Each 
of these domains will be fused to either a ligand of interest (bait) or potential 
interaction partner of this ligand (prey) and will be expressed in yeast cells. To 
identify an unknown binding partner for a given ligand cDNA libraries are used to 
construct prey libraries. Only when the bait binds to the prey, DBD and AD will be 
in close enough proximity to each other to activate the expression of a reporter 
gene (Figure 1-14). The reporter gene encodes a protein that provides a simple 
read out, for example the lacZ gene which encodes beta-galactosidase that can 
be detected with a colorimetric substrate. Cells that express the reporter gene 
can then be sequenced to reveal which protein they expressed. 
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Figure 1-12. Yeast two-hybrid assays. A transcription factor (TF) is split into a DNA-binding domain 
(DBD) and an activation domain (AD). The TF domains are fused with a ligand of interest (LOI) or a 
target protein (TP) to create the bait and the prey. When the bait and prey bind to each other, the 
DBD and AD are in in close enough proximity to activate expression of a reporter gene.  
In classic Y2H assays the ligand had to be a protein or a peptide and both the bait 
and the prey had to be able to enter the nucleus to allow transcription. Nowadays, 
however, numerous variants the system have been developed and made this 
method more widely applicable. To allow the investigation of membrane proteins, 
for example, the membrane yeast two hybrid (MYTH) system was developed 
(Figure 1-13) (Stagljar et al., 1998; Snider and Stagljar, 2016). Instead of a split 
TF, MYTH uses ubiquitin split into an N-terminal fragment (Nub) and a C-terminal 
fragment (Cub). The Cub moiety is fused with an artificial TF and the cytosolic 
terminus of a transmembrane or endoprotein (bait). The Nub protein is fused to a 
potential interaction partner (prey), which can be another membrane protein or 
a soluble protein or peptide. When the bait binds to the prey, Cub and Nub form 
pseudoubiquitin, which is a substrate for cellular deubiquitinating enzymes. This 
results in cleavage of the TF which can then enter the nucleus and direct 
expression of a reporter gene. 
 
Figure 1-13. Membrane yeast two-hybrid assays. The ligand of interest (LOI) and target protein 
(TP) are fused with the C-terminus and N-terminus of ubiquitin (Cub and Nub), respectively. Cub is 
also fused with a transcription factor (TF). When the bait and prey bind to each other, ubiquitin is 
formed, resulting in cleavage of the TF by deubiquitinating enzymes. The TF is then transported to 
the nucleus and activates expression of a reporter gene. 
The yeast three-hybrid (Y3H) system is another adaption to the classic Y2H system 
(Figure 1-14) (Licitra and Liu, 1996; Martin, 2012). These assays allow for the 
ligand to be a small molecule, or RNA-strand. As the name suggest, instead of two 
molecules that have to be combined, this system uses three: the hook, the bait 
and the fish. As before, the bait contains the ligand of interest. This ligand is 
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covalently linked to another ligand with a known protein partner, for example 
methotrexate (MTX), creating a dimeric compound. The hook consists of the 
known protein partner of the bait, for MTX this is dihydrofolate reductase (DHFR), 
fused to a DBD. The fish will be a potential interaction partner of the ligand of 
interest fused to an AD. MTX will bind to DHFR bringing the bait and the hook 
together, however, only when the bait binds to the fish will the TF be activated 
and the reporter gene expressed.  
 
Figure 1-14. Yeast three-hybrid assays. The DNA-binding domain (DBD) of a transcription factor 
(TF) is fused with dihydrofolate reductase (DHFR) to form the hook. Methotrexate (MTX) is linked to 
the ligand of interest (LOI) and this forms the bait. The fish is a target protein (TP) fused with the 
activation domain (AD) of the TF. When the bait binds to both the hook and the fish, the DBD and 
AD are close enough to each other to activate expression of a reporter gene. 
Yeast hybrid assays are simple assays that are cheap to perform and can be easily 
set up without the need for specialised equipment. Moreover, these assays are 
performed in vivo which helps avoid complications associated with cell lysis 
(Section 1.7.3). Nevertheless, there are clear disadvantages to this method. 
Firstly, proteins have to be expressed in yeast, which might lead to problems with 
expression levels, posttranslational modifications and cofactors. Furthermore, 
overexpression of prey proteins often leads to high numbers of false-positives. 
Moreover, notwithstanding the increase in the scope of the yeast assays, there are 
still many types of interactions that cannot be investigated (Snider et al., 2015). 
At the moment the Y3H assays can only be performed when the ligands can pass 
the cell membrane and when the proteins of interest are cytosolic proteins. 
Although the Y3H assay has successfully been merged with a ubiquitin split set-
up, in this case the Cub and Nub were both attached to cytosolic proteins 
(Dirnberger et al., 2006). Even if in the future Y3H was successfully combined with 
MYTH, ligands would still have to be present on the cytosolic site of the membrane 
protein, while, as discussed before, transmembrane receptors bind to 
extracellular ligands. 
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1.7.2. Phage display 
Another gene-linked approach is phage display. Phage display was first described 
in 1985 when Smith successfully fused peptides to a coat protein of a 
bacteriophage, a virus that replicates within bacteria (Smith, 1985). Peptidic 
phage libraries are still used today to discover high-binding peptidic ligands or to 
identify epitopes of known PPIs (Sundell and Ivarsson, 2014), however, phage 
display is nowadays also used to identify target proteins binding to ligands of 
interest (Omidfar and Daneshpour, 2015). To do so, phage libraries are created by 
fusing cDNA libraries to coat proteins of phages. These libraries are then added to 
plates that contain the immobilised ligand of interest on them. The unbound 
phages are washed away, after which the phages that did bind to the ligand are 
eluted, typically through lowering the pH or by using ultrasound (Lunder et al., 
2008). These latter phages are then multiplied in E. coli and sequenced (Figure 
1-15).  
 
Figure 1-15. Phage display. A library of phages displaying peptides or proteins of interest is 
generated and added to plates with the immobilised ligand of interest (LOI). Plates are then washed 
to remove the unbound phages, before the phages that did bind to the ligand are eluted. These 
phages are then used to infect E. coli so they can be multiplied.  
Initially there was limit to the length of the peptides and proteins that could be 
attached to the coat proteins of the phage, as too large proteins might interfere 
with the ability of the phage to infect E. coli and to assemble. To overcome this 
problem, phage vectors that require a helper phage for infection and assembly 
were designed (Omidfar and Daneshpour, 2015). 
Another improvement that was made to the phage display process is called 
biopanning, which is applied to prevent the identification of non-specifically 
bound proteins. Instead of sequencing the initial hits of a phage display, the eluted 
phages are multiplied in E. coli and again added to the ligand of interest. When 
this process is repeated three to five times, specifically binding phages are 
enriched and can then be identified (Omidfar and Daneshpour, 2015).   
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As for the yeast hybrid assays, phage display is a convenient and cheap technique 
that does not require specialised equipment, however, the expression of proteins 
in phages might also lead to problems with posttranslational modifications and co-
factors. Furthermore, as the phage libraries are initially expressed in E. coli, 
proteins that are toxic to E. coli or that will be degraded by these bacteria cannot 
be expressed on phages. Finally, while display of many cytosolic proteins has been 
successful, there are only a few membrane proteins that have been successfully 
displayed on phages (Vithayathil et al., 2011). 
1.7.3. Affinity pull down  
Although MS is an expensive technique, chemoproteomics is widely applied to for 
target identification. In contrast to the gene-based approaches, chemoproteomics 
does not require the generation of libraries, making it a less biased method. 
Classically targets are captured through affinity pull down which is then followed 
by MS (AP-MS). For these experiments the ligand of interest is linked to a solid 
support, usually agarose or magnetic beads, after which a protein extract is 
added, for example lysate of cells or tissue that is known to express the target 
protein(s). After an appropriate incubation time the beads are washed to remove 
non-specifically bound proteins. The specifically bound proteins can then be 
eluted either with free ligand or by heating the beads. Subsequently the released 
proteins are subjected to trypsin digest and liquid chromatography tandem-mass 
spectrometry (LC-MS/MS) analysis (Figure 1-16).  
 
Figure 1-16. Affinity pull down. A protein extract is added to the ligand of interest (LOI) which is 
immobilised on a solid support. Washes are performed to remove any unbound and non-specifically 
bound proteins and the target protein(s) are eluted, trypsinised and analysed by LC-MS/MS.   
The first step in AP-MS is the attachment of the ligand of interest to a solid 
support. How this is done depends on the nature of the ligand. For small molecules 
it is common practice that a linker is added to the ligand. This linker contains 
either an affinity tag or a functional moiety that can be used to attach the ligand 
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to the beads. The most common affinity tag is biotin, which binds to streptavidin 
with an extremely high affinity (Kd = 10−15 M), making it one of the strongest non-
covalent interactions known (Green, 1975). Examples of functional moieties used 
on linkers are amines and alcohols, which can be coupled to N-hydroxysuccinimide 
(NHS) or epoxy-activated beads, respectively. As it has been observed that 
hydrophilic linkers lead to less non-specifically binding background proteins, poly 
ethyleneglycol (PEG) is often used as a linker (Sato et al., 2010). Although small 
molecules that contain a functional moiety in their structure could be linked 
directly to functionalised beads, a linker is often still incorporated to create some 
distance between the resin and the ligand, thus avoiding steric hindrance (Ursu 
and Waldmann, 2015). When the ligand is a peptide or protein, it can be linked 
directly to beads through functionalised groups present in the ligand’s structure, 
however, especially for proteins this might lead to heterogenous attachment as 
multiple copies of the same moiety might be present. Therefore, it is more 
common to incorporate biotin into the structure of peptides and to create fusion 
proteins bearing an affinity tag, like the glutathione S-transferase (GST) tag, 
which binds to glutathione, or a polyhistidine hexapeptide (6xHis) tag, which binds 
to nickel (Lenz et al., 2011; Puckett, 2015; Vikis and Guan, 2015). It should be 
noted that coupling of a linker or affinity tag to a ligand could interfere with its 
binding to the target protein(s), therefore, it is important to test whether these 
ligand variants still display the same effect on cells or tissue as the original ligand 
did.  
Although ideally all non-specifically binding proteins would be washed away 
before elution of the specifically bound proteins, high background is a common 
problem in AP-MS experiments (Sato et al., 2010; Ziegler et al., 2013; Snider et 
al., 2015). To distinguish between the target protein(s) and the non-specifically 
bound proteins, control experiments have to be performed. The first control that 
can be performed is an AP-MS experiment in the absence of ligand (Sato et al., 
2010; Ziegler et al., 2013). This could be done as a ‘bead only’ experiment, in 
which only the solid phase is treated with the protein extract, however, it is also 
possible to attach the linker or the affinity tag used in the real AP-MS experiment 
to the beads. The best variant of this control would be the presence of a molecule 
very similar to the ligand but without any binding capacity. A scrambled version 
of a peptidic ligand, or an inactive mutant of a protein, for example. For small 
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molecule ligands, the inactive control should resemble the ligand closely in 
structure, hydrophobicity, size and charge. In theory an inactive enantiomer 
would be the best candidate, however, even if the original ligand is chiral, an 
enantiomer is not necessarily inactive. Another control method is to perform a 
second AP-MS in which an excess of the ligand of interest is added to the protein 
extract (Sato et al., 2010; Ziegler et al., 2013). The idea is that the free ligand 
will bind to the target protein(s), which will then be unable to bind to the 
immobilised ligand. All proteins that do still bind must, therefore, be non-specific. 
It has to be noted that even with these control experiments it is still important to 
keep the total level of background as low as possible, since high background in 
the samples complicates the identification of the target protein(s) by LC-MS/MS 
(Ziegler et al., 2013). 
AP-MS does have some important limitations. It is biased towards strong, long-
lived interactions, as such interactions will allow for harsher washes, thus reducing 
the amount of background. Moreover, it favours the identification of highly 
abundant targets, as there are higher chances for these targets to be captured by 
the ligand. Identification of weak or transient interactions, or of low abundance 
proteins is almost impossible with AP-MS. (Sato et al., 2010; Ziegler et al., 2013). 
Unfortunately, many transmembrane receptors do form weak or transient 
interactions with their ligands, and their abundancy is also generally lower (Savas 
et al., 2011; Vuckovic et al., 2013). Finally, to perform an AP-MS experiment 
lysates have to be prepared (Sato et al., 2010; Ziegler et al., 2013). This is again 
unfavourable for membrane receptors as their hydrophobicity and high number of 
post-translational modifications often results in aggregation and loss of ligand-
binding activity upon solubilisation (Savas et al., 2011; Vuckovic et al., 2013). 
1.7.4. Activity based probes 
When one searches for chemoproteomic methods, the terms activity based protein 
profiling (ABPP) and activity-based probe (ABP) will definitely show up. Originally 
an ABP was defined as a probe that contains two functional moieties: (1) an 
electrophilic small molecule warhead (the ligand) that can covalently be captured 
by nucleophiles present in the active site of a specific enzyme class, such as 
hydrolases, proteases, or kinases; and (2) an affinity tag, such as a biotin moiety, 
to isolate the captured receptors (Cravatt and Sorensen, 2000; Lenz et al., 2011). 
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It is important to realise that, nowadays, the terms ABP and ABPP are also used in 
the literature to describe trifunctional probes that covalently bind to the active 
site of the target protein(s) by means of a third moiety present on the probe, a 
photoreactive group. In this thesis such trifunctional probes are considered 
affinity based probes and will be discussed in Section 1.7.5. 
In a classic ABPP set up, an ABP is added to cell lysates, which will lead to the 
formation of a covalent bond between the ligand and the target protein(s). The 
affinity tag is used to isolate the receptor; washes are performed before the 
specifically bound proteins are eluted. Subsequently the isolated target protein(s) 
are subjected to trypsin digest and LC-MS/MS analysis (Figure 1-17).  
 
Figure 1-17. Activity based protein profiling. An ABP is added to a protein extract or to living cells, 
in the latter case cells are lysed after a sufficient incubation time. The ABP is isolated using affinity 
purification, for example with streptavidin. Washes are performed to remove any unbound and non-
specifically bound proteins and the target protein(s) are eluted, trypsinised and analysed by LC-
MS/MS. LOI is ligand of interest. 
As for AP-MS it is important to test whether the ABP retained the ligand’s function. 
Moreover, even though washes can be more stringent when compared to AP-MS, 
due to the formation of a covalent bond between the ligand and the target 
protein(s), control experiments should always be performed to determine which 
proteins are present due to non-specific background binding.  
ABPs usually target enzyme families instead of specific proteins, however, specific 
targets can be identified using a process called competitive ABPP (Cravatt et al., 
2008). For this method, lysates are treated with free ligand of interest before an 
ABP is added. The ABP should be targeting the enzyme class that the ligand is 
suspected to bind to. Since the ligand of interest is inhibiting the ABP from binding 
to the ligands target, comparison between enzymes captured by the ABP in ligand 
treated and untreated lysates will reveal the target for the ligand of interest 
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(Figure 1-18). This method has been successfully applied for both ligands that 
were irreversible and reversible inhibitors, however, for the latter the experiment 
should be performed under kinetic control to prevent the ABP from replacing the 
ligand (Cravatt et al., 2008).  
 
Figure 1-18. Competitive activity based protein profiling. An ABP is added to protein extracts or 
living cells in the absence (a) or presence (b) of the ligand of interest (LOI). Cells are lysed and the 
ABP is isolated using affinity purification, for example with streptavidin. Washes are performed to 
remove any unbound and non-specifically bound proteins and the target protein(s) are eluted, 
trypsinised and analysed by LC-MS/MS. Comparison between the captured proteins in the absence 
and presence of the LOI will reveal the LOI binding proteins.  
As has been discussed before, although some proteins might retain full 
functionality upon cell lysis, others might not. It was, therefore, a big 
improvement when ABPP probes were adapted to allow the capture of the target 
protein(s) in vivo. Due to the formation of a covalent bond between the ligand 
and the target protein(s) it is possible to utilise these probes on living cells and 
lyse the cells only after the covalent bond between the ligand and the target 
protein(s) has formed. As the enzyme classes targeted by ABPP are intracellular it 
was important that the probe could cross the membrane to enter the cell. To 
improve cell-permeability of the probes, the large reporter tags were replaced by 
alkyne or azide moieties that could, after cell lysis, be coupled to reporter tags 
using the copper-catalyzed azide-alkyne cycloaddition (CuAAc) (discussed in more 
detail in Section 3.2) (Cravatt et al., 2008; Lenz et al., 2011).  
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ABP is a valuable method, however, it can only be used for a small subset of 
ligands. Direct identification of targets with ABPs is restricted to small molecule 
ligands that form a covalent bond with the active site of their target (irreversible 
inhibitors). Moreover, usually these probes target whole families of enzymes 
instead of specific proteins. Although the competitive ABPP method does broaden 
the scope of ligands slightly, the targets of the ligands should still be targetable 
by existing ABPs. 
1.7.5. Affinity based probes  
Affinity-based probes (AfBPs), also referred to as photoaffinity probes, are far 
more versatile than ABPs. AfBPs are trifunctional compounds containing: (1) the 
ligand of interest, to bind to the target protein(s); (2) a photoreactive group to 
covalently capture the receptor, such as a benzophenone, diazerine or azide 
moiety (discussed in more detail in Section 4.1.1); and (3) an affinity tag to isolate 
the captured receptors, for example biotin (Hatanaka, 2015; Smith and Collins, 
2015; Murale et al., 2016). These probes are used with a similar protocol as ABPs, 
however, samples have to be irradiated with UV-light to initiate receptor capture 
by the photoreactive group (Figure 1-19). As these probes are not dependent on 
the ligand itself to form the covalent bond with the target protein(s), any ligand 
could in theory be used to create such probes. In practice, however, AfBPs are 
mostly based on small molecule or peptidic ligands. 
 
Figure 1-19. Affinity based protein profiling. An AfBP is added to protein extracts or living cells 
and the cells are irradiated with UV to activate capture of the target protein(s). Cells are lysed and 
the AfBP is isolated using affinity purification, for example with streptavidin. Washes are performed 
to remove any unbound and non-specifically bound proteins and the target protein(s) are eluted, 
trypsinised and analysed by LC-MS/MS. LOI is ligand of interest and PRG is photoreactive group. 
As for the chemoproteomics methods discussed above, whether incorporation of 
the ligand into an AfBP interferes with the ligand-target interaction has to be 
    Chapter 1. Introduction 31 
tested. Moreover, control experiments, to establish which proteins are present 
due to non-specific background binding, have to be performed.  
As for ABPs, AfBPs that contain an alkyne or azide moiety for subsequent CuAAC 
addition of an affinity tag have been created and successfully used to identify 
intracellular targets in living cells (Li et al., 2013). In theory it should, therefore, 
also be possible to identify transmembrane receptors using AfBPs. Binding of the 
ligand to the receptor could take place on living cells, circumventing the problems 
encountered upon solubilisation of transmembrane proteins. Moreover, the 
covalent bond that would form between the AfBP and the receptor would make 
this method more suitable for weaker and transient interactions than AP-MS. 
Nevertheless, in 2015, at the start of this project, literature on AfBPs targeting 
transmembrane receptors was very limited. There were some examples of AfBPs 
designed to target known ligand-transmembrane interactions, such as a probe 
based on CGP64213, a small molecule inhibitor of the γ-aminobutyric acid B-
receptor (Li et al., 2008), and AfBPs based on the kisspetins, the endogenous 
peptidic ligands of G-protein coupled receptor 54 (GPR54) (Misu et al., 2013) 
(Figure 1-20). These probes, however, were never used for proteomic 
experiments. 
 
Figure 1-20. Structures of CP64213, kisspetin 13 and the AfBPs based on them. 
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1.7.6. Identification of transmembrane receptors 
That transmembrane receptors are vital components of drug discovery has 
thoroughly been discussed above and identification of transmembrane receptor 
targets of poorly characterised ligands can provide new starting points for drug 
innovation, provide valuable information about off-target effects, and enhance 
mechanistic understanding of molecular pathways (Hopkins and Groom, 2002; 
Schirle and Jenkins, 2016). Whereas all ligand-based identification methods 
discussed in this section have successfully been used to identify proteins that bind 
to ligands of interest, these techniques have primarily been used for the 
identification of intracellular receptors.  
In 2015, to my knowledge, there was only one probe specifically designed for the 
identification of transmembrane receptors: Triceps (Figure 1-21) (Frei et al., 
2012). Although Triceps is a trifunctional probe, it is different from AfBPs in two 
important ways. Firstly, Triceps does not contain a photoreactive group to capture 
the target receptor, instead it uses a protected hydrazine that couples to 
aldehydes present on glycosylated receptors after mild oxidation. Secondly, no 
ligand is present in the structure of this probe, instead the probe contains an NHS-
ester that can in situ be attached to any ligand bearing a free amine, making 
triceps a universal probe to capture transmembrane receptors. More information 
about Triceps can be found in Section 3.1.  
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Figure 1-21. Structure of Triceps 
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 Table 1-1. Successful examples of ligand-based target identification. Structures of small molecules are given below their names. For chemoproteomic approaches 
the structure of the probe is also given with the affinity tag or functional group for bead-binding in orange and photoreactive groups in red. Arrows indicate the point of 
nucleophilic attack for ABPs. 
Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
RAD51D Intracellular protein 
involved in DNA repair 
and a known ovarian 
cancer susceptibility 
gene. 
E3 ubiquitin-
protein ligase 
RNF138 
RAD51D is ubiquitinated by 
RNF138, a process that is 
suggested to play an 
important role during the 
repair of interstrand DNA 
damage. 
Y2H (Yard et 
al., 2016) 
GLP1R GPCR involved in 
insulin secretion. 
Stress-associated 
endoplasmic 
reticulum protein 
(SERP)1 
SERP1 is thought to be 
involved in rescuing GLP1R’s 
function under ER stress. 
MYTH (Xiao et 
al., 2017) 
Atorvastatin 
 
 
 
Small molecule that is 
a competitive inhibitor 
of 3-hydroxy-3-
methylglutaryl-CoA 
reductase and is used 
to treat 
hypercholesterolemia.  
Retinal rod 
phosphodiesterase 
PDE6D 
PDE6D is an off-target of 
Atorvastatin. PDE6D interacts 
with various GTPases and it 
might have a broad role in cell 
signalling. Binding of 
Atorvastatin to PDE6D is 
suggested to affect this 
protein’s localisation within 
the cell.  
Y3H (Chidley 
et al., 
2011) 
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Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
Bisphenol A  
 
 
Small molecule that is 
a starting martial for 
the synthesis of 
plastics. 
Transforming 
acidic coiled-coil 
containing protein 
(TACC)3 
Bisphenol A is known to 
disrupt cell division both in 
vitro and in vivo. TACC3 is 
involved in the formation of 
the mitotic spindle apparatus 
and might thus be (partly) 
responsible for the disruption 
of cell division by this toxin.  
Phage 
display 
(Van 
Dorst et 
al., 2010) 
SARS-CoV ORF6  Protein of the severe 
acute respiratory 
syndrome coronavirus 
(SARS-CoV). 
Nuclear pore 
complex 
interacting protein 
family, member 
(NPIP)B3 
ORF6 inhibits type I interferon 
(IFN) signalling, binding of 
ORF6 to the C-terminus of 
NPIPB3, however, reduced this 
inhibition.  
Phage 
display 
(Huang et 
al., 2017) 
4-[5-(4- phenoxy-phenyl-2H-
pyrazol-3-yl]morpholine 
 
 
Probe: 
 
Small molecule that 
was identified in a 
high-through put 
phenotypic screen. It 
is toxic to 
Trypanosoma brucei 
(cause of sleeping 
disease). 
Adenosine kinase 
of Trypanosoma 
brucei rhodesiense 
(TbrAK) 
The ligand of interest turned 
out to activate TbrAK and this 
hyperactivation was toxic to 
the parasite.  
AP-MS (Kuettel 
et al., 
2009)  
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 Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
PP4C 
 
Probe: 
 
TEV-PP4C-CBD* 
 
Catalytic unit of the 
intracellular protein 
phosphatase 4 
PP4R3 (newly 
identified protein) 
PP4C forms a complex with 
the known protein PP4R2; and 
a novel protein PP4R3. PP4R3 
turned out to be conserved 
among species and depletion 
of its homolog in yeast 
resulted in hypersensitivity 
towards the DNA damage-
inducing drug cisplatin (an 
anti-cancer agent).  
AP-MS (Gingras 
et al., 
2005) 
TWS119 
 
 
Probe: 
 
Small molecule that 
was identified in a 
high-through put 
phenotypic screen. It 
induces neurogenesis 
in murine embryonic 
stem cells. 
Glycogen synthase 
kinase (GSK)3β 
It was revealed that TWS119 
inhibits GSK3β and that this 
kinase is involved in the 
induction of mammalian 
neurogenesis.   
AP-MS (Ding et 
al., 2003) 
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Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
WRR-086 
 
 
Probe: 
 
Small molecule that 
was identified in a 
high-through put 
phenotypic screen. It 
blocks Toxoplasma 
gondii (parasite that 
causes severe disease 
in immune-
compromised 
individuals) 
attachment and 
invasion of host cells. 
T. gondii DJ-1 
(TgDJ-1) 
WRP-086 acts by capturing a 
cysteine residue in the poorly 
characterised protein TgDJ-1. 
TgDJ-1 turned out to be 
critical for T. gondii. invasion  
ABP (Hall et 
al., 2011) 
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 Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
Wortmannin 
 
 
Probe: 
 
Small molecule that is 
a known covalent 
inhibitor of 
phosphoinositide 3-
kinases (PI3Ks). 
Polo-like kinases 
(PLK)1 
While studying the inhibition 
of PI3Ks it was revealed that 
wortmannin also inhibited 
PLK1 and that it was a 1,000 
fold more potent than the 
current inhibitors of PLK1.  
ABP (Liu et 
al., 2005) 
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Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
B-THP-T-1  
 
 
Probe:
 
Small molecule that 
was identified in a 
high-through put 
phenotypic screen. It 
effective against is 
toxic to Trypanosoma 
Brucei (cause of 
sleeping disease). 
F0F1-ATP synthase 
of Trypanosoma 
brucei 
The ligand turned out to 
inhibit ATP production in the 
parasites by binding to F0F1-
ATP synthase.  
AfBP (Tulloch 
et al., 
2017) 
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 Ligand 
(and probe where appropriate) 
Type of ligand Target identified Significance Method Ref. 
LW6 
 
 
Probe: 
 
Small molecule that 
was identified in a 
high-through put 
phenotypic screen. It 
reduces levels of 
hypoxia-inducible 
factor (HIF)-1. 
Malate 
dehydrogenase 
(MDH)2 
HIF-1 is responsible for poor 
prognosis in cancer therapy. 
This study revealed for the 
first time that MDH2 regulated 
HIF-1 accumulation.  
AfBP (Lee et 
al., 2013) 
* TEV = tobacco etch virus, CBD = calmodulin binding domain 
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1.8. Aim  
This project originally started out with the idea of (1) synthesising Triceps; (2) 
verifying its capability to identify transmembrane receptors starting from a ligand 
of interest using a known ligand-receptor couple; and (3) using Triceps to identify 
the transmembrane receptor that binds to the Bacteroides fragilis toxin (BFT). 
BFT is a toxin produced in the colon by Bacteroides fragilis that is known to bind 
a transmembrane receptor on epithelial cells and has been linked to the onset of 
colon cancer (Wu et al., 2009). Within weeks of starting the project, however, it 
was realised that the synthesis of Triceps was far from trivial and the development 
of a new universal probe to allow the capture of transmembrane receptors starting 
from ligands of interest became the new aim in this project.  
 Probe 1 (Figure 1-22), which closely resembled Triceps, was designed, 
synthesised and evaluated using a known ligand-receptor couple (Chapter 3). 
Working with probe 1 revealed that not only the synthesis of this probe was 
problematic, capturing transmembrane receptors using the protected hydrazine 
moiety did also turn out to be harder than initially expected. Therefore, probes 
2, 3 (Chapter 4) and 4 (Chapter 5), which combined the ligand-universality of 
Triceps with the capture mechanism found in AfBPs, were designed, synthesised 
and evaluated (Figure 1-22).  
 
Figure 1-22. Structures of probes 1-4. 
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2. Materials and methods  
2.1. Chemical synthesis  
2.1.1. General procedures 
All chemicals were commercially obtained and used without further purification, 
unless stated otherwise. Reactions involving air-sensitive reagents and dry 
solvents were performed in flame-dried glassware under nitrogen atmosphere. 
Reactions were monitored by thin layer chromatography (TLC), using plates with 
a UV fluorescent indicator (Merck 60 F254, 0.25 mM). Compounds were visualised 
either by UV absorption or by dipping in Molybdenum or a ninhydrin based stain, 
followed by heating. Column chromatography was performed using Merck silica 
gel 60 (35-70 μm) or with a Biotage Isolera One purification system and use of 
prepacked silica (ULTRA) Biotage SNAP cartridges. A Christ Alpha-2-4 lyophiliser 
equipped with a high vacuum pump was used for lyophilisation.  
NMR spectra were recorded using a Bruker Avance III 400 MHz spectrometer 
(400 MHz for 1H-NMR and 100 MHz for 13C-NMR) or Bruker Avance III UltraShield 
500 MHz spectrometer (500 MHz for 1H-NMR and 126 MHz for 13C-NMR) at ambient 
temperature. δH values are given in ppm, relative to an internal signal of Me4Si 
(0.00 ppm), the residual CHCl3 signal (7.26 ppm) or the residual H2O signal 
(4.79 ppm). δc values are given in ppm relative to the signal of Me4Si (0.00 ppm), 
the signal of CDCl3 (77.16), or the signal of (CD3)2SO (39.52). For 1H-NMR spectra 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, sept = 
septet, m = multiplet, br = broad, or a combination of these), coupling constants 
J (Hz) and assignments are also reported. For 13C-NMR spectra multiplicity and 
coupling constant are reported where appropriate.  
High resolution mass spectrometry (HRMS) was performed by the analytical service 
of the University of Glasgow, either on a Jeol MStation JMS-700 instrument using 
positive chemical ionisation or a positive ion impact, or on a Bruker micro TOFq 
High Resolution instrument using positive ion electrospray.  
Analytical high-pressure liquid chromatography (HPLC) was performed on the 
Prominence HPLC system (Shimadzu) with a UV-detector operating at 214 nm and 
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254 nm using either a Phenomenex gemini C18 column (110 Å, 5 μm, 250 x 4.6 mM) 
or a Dr Maisch Reprosil Gold C18 column (200 Å, 5 μm, 250 x 4.6 mM) at a flow 
rate of 1 mL/min using either a 40 min protocol (100% Buffer A for 2 min, a linear 
gradient of 0-100% Buffer B in buffer A for 28 min, 100% Buffer B for 2 min, 100-
0% Buffer B in buffer A for 3 min and 100% Buffer A for 5 min) or a 60 min protocol 
(100% Buffer A for 2 min, a linear gradient of 0-100% Buffer B in buffer A for 48 
min, 100% Buffer B for 2 min, 100-0% Buffer B in Buffer A for 3 min and 100% Buffer 
A for 5 min). Buffer A [H2O/MeCN 95:5 with 0.1% TFA]; Buffer B [MeCN/H2O 95:5 
with 0.1% TFA].  
Liquid chromatography mass spectrometry (LC-MS) was carried out with a Thermo 
Scientific LCQ Fleet quadrupole mass spectrometer and a Dionex Ultimate 3,000 
LC with use of a Dr. Maisch Reprosil Gold 120 C18 column (150 Å, 3 μm, 150 x 
4 mM). Buffers and protocols used were identical to those of analytical HPLC. 
2.1.2. Peptide synthesis 
All peptides were assembled by solid phase peptide synthesis on an automatic 
Tribute-UV peptide synthesiser (Protein Technologies) on a 0.25 mMol scale. 
Peptides names, sequences, synthesis procedure used, yields and MS data 
obtained can be found in Table 2-1. The UV traces from analytical HPLC can be 
found in Appendix 1.  
Table 2-1. Peptide synthesis yields and MS data. 
Name Sequence Procedure Yield MS data 
OXA NH2-LYELLHGAGNHAAGILTL-
CONH2 
1 16% Calcd for 
C85H136N24O23 
[M+2H]2+ 931.51 
found 931.83 
Ac-OXA Ac-LYELLHGAGNHAAGILTL-
CONH2 
2 8% Calcd for 
C87H138N24O24 
[M+2H]2+ 952.52 
found 952.83 
SP Ac-RPKPQQFFGLNle-CONH2 2 13% Calcd for 
C66H102N18O14 
[M+2H]2+ 686.40 
found 686.50 
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2.1.2.1. Procedure 1  
Peptides were synthesised on Rink Amide resin (0.24 mMol/g; Rapp Polymere 
GmbH, Tübingen, Germany). First, the resin was allowed to swell in DMF (3 x 
10 min). The Fmoc-group was then removed with piperidine/DMF (8 mL, 1:4, v/v), 
using the Tribute-UV peptide synthesiser RV_ top_UV_Xtend protocol, followed by 
washes with DMF (5 x 30 s). Next, the correct Fmoc-protected amino acid was 
preactivated for 2 min with HCTU (4 eq) and DIPEA (8 eq) in DMF, before it was 
added to the resin and shaken (20 min). The resin was washed with DMF (6 x 30 s), 
after which Fmoc-deprotection and coupling of the next amino acid took place as 
before. After the coupling of the last amino acid, one final Fmoc deprotection 
step took place. The resin was washed with DMF (5 x 30 s) and DCM (5 x 30 s). It 
was then dried under high vacuum and peptides were cleaved and deprotected in 
TFA/H2O/TIS (10 mL, 95:2.5:2.5, v/v/v; 1 h). To precipitate the peptide, the TFA 
mixture was added dropwise to an ice-cold solution of MTBE/hexanes (90 mL, 1:1, 
v/v). After centrifugation (2,000 x g, 5 min) the supernatant was discarded and 
the peptide was washed twice more with MTBE/hexanes. The peptide was then 
dissolved in tBuOH/H2O (15 mL, 1:1, v/v) and lyophilised to yield a crude peptide. 
This crude was further purified using the Agilent technologies 1260 Infinity LC 
System equipped with a Gemini C18 column (110 Å,10 μm, 250 x 20 mM) using a 
60 min linear gradient of 0-100% Buffer B in Buffer A at 12.5 mL/min (for buffers 
see Section 2.1.1). Auto-collection of fractions based on the UV measurements at 
214 nm was used. Fractions containing pure peptide, as assessed by analytical 
HPLC, were combined and lyophilised. 
2.1.2.2. Procedure 2  
Peptides were synthesised as described in Section 2.1.2.1, however, after the final 
Fmoc-deprotection step the resin was treated with Ac2O (250 μL, 2.3 mMol) and 
DIPEA (185 μL, 1 mMol) in DMF (10 mL) for 30 min. The resin was then washed with 
DMF (5 x 30 s) and DCM (5 x 30 s), dried under high vacuum and cleaved from the 
resin as described in Section 2.1.2.1.  
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2.1.3. Synthesis of probe 1 
2.1.3.1. Compound 15 
 
 
4,7,10-trioxa-1,13-tridecanedia-mine (1.0 mL, 4.4 mMol) was dissolved in DCM 
(9 mL) and a solution of di-tert-butyl dicarbonate (0.53 g, 2.4 mMol) in DCM 
(33 mL) was added dropwise over 5 h. The mixture was stirred overnight before it 
was washed with Na2CO3 (0.5 M, 50 mL, 3 x), dried over MgSO4 and concentrated 
under vacuum to yield the Boc-protected PEG-linker as a colourless oil (0.68 g, 
88%). 
Analytical data: 1H NMR (400 MHz, DMSO-d6) δ 6.77 (s, 1H), 3.53 – 3.48 (m, 4H), 
3.48 – 3.44 (m, 4H), 3.43 (t, J = 6.5 Hz, 2H), 3.38 (t, J = 6.3 Hz, 2H), 2.99 – 2.92 
(m, 2H), 2.57 (t, J = 6.8 Hz, 2H), 1.66 – 1.47 (m, 4H), 1.37 (s, 9H). 13C NMR 
(101 MHz, DMSO-d6) δ 155.5, 77.3, 69.8, 69.8, 69.5, 69.5, 68.5, 68.1, 38.8, 37.2, 
33.3, 29.7, 28.2 HRMS: calcd for C15H32N2O5 [M+H]+ 321.2384, found 321.2389. 
Analytical data corresponds to previously reported data (Liu et al., 2014).  
 
 
Biotin (289.1 mg, 1.18 mMol) and the Boc-protected PEG-linker (357 mg, 
1.12 mMol) were dissolved in DMF (25 mL). EDC (253 mg, 1.32 mMol) and 4-
dimethylaminopyridine (DMAP) (14.0 mg, 0.11 mMol) were added to this mixture, 
which was then stirred for 19 h before it was concentrated under vacuum. The 
crude product was purified by flash chromatography (DCM/MeOH, 10:0 → 9:1) 
yielding the Boc-protected PEG-biotin as a yellow oil (520 mg, 85%).  
Analytical data: 1H NMR (400 MHz, Chloroform-d) δ 6.55 (br s, 1H), 6.14 (br s, 
1H), 5.33 (br s, 1H), 5.03 (br s, 1H), 4.50 (dd, J = 7.8, 5.0 Hz, 1H), 4.31 (ddd, J = 
7.8, 4.6, 1.4 Hz, 1H), 3.67 – 3.50 (m, 12H), 3.37 – 3.32 (m, 2H), 3.25 – 3.10 (m, 
3H), 2.90 (dd, J = 12.8, 5.0 Hz, 1H), 2.74 (d, J = 12.8 Hz, 1H), 2.19 (t, J = 7.5 Hz, 
2H), 1.81 – 1.59 (m, 8H), 1.43 (s, 11H). 13C NMR (101 MHz, Chloroform-d) δ 173.3, 
164.1, 156.2, 79.0, 70.6, 70.6, 70.3, 70.1, 70.0, 69.6, 61.9, 60.3, 55.8, 40.6, 38.6, 
37.8, 36.2, 29.8, 29.1, 28.6, 28.4, 28.2, 25.8. HRMS: calcd for C25H46N4O7S [M+Na]+ 
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569.2979, found 569.2961. Analytical data corresponds to previously reported data 
(Kuan et al., 2013). 
 
 
The Boc-protected PEG-biotin (1.74 g, 3.18 mMol) was dissolved in DCM/TFA (2:1, 
v/v, 60 mL) and stirred for 3 h at RT until complete deprotection. The mixture 
was concentrated under vacuum and last traces of TFA were removed by co-
evaporations with toluene (3 x).  
The yellow oil that resulted was dissolved in MeOH (60 mL), and K2CO3 (~750 mg, 
5.4 mMol) was added until the pH was 8.5. When CuSO4·5H2O (7.5 mg, 30 μM) and 
1H-imidazole-1-sulfonyl azide·HCl (816.7 mg, 3.9 mMol) were added the pH 
dropped to 2.5 and more K2CO3 was added to bring the pH back up to 8.5. At this 
point the mixture turned green. During the reaction, the pH kept dropping and 
K2CO3 was added regularly to keep the pH between 8-9. The reaction was followed 
by TLC and stopped after 5 h. After concentration under vacuum the crude 
product was dissolved in MeOH, insoluble impurities were filtered off and the 
product was concentrated again before it was purified by flash chromatography 
(DCM/MeOH, 9:1) to yield compound 15 as a slightly yellow waxy solid (1.12 g, 
75% over 2 steps).  
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 4.49 (dd, J = 7.8, 4.9 Hz, 1H), 
4.30 (dd, J = 7.9, 4.4 Hz, 1H), 3.67 – 3.61 (m, 4H), 3.61 – 3.58 (m, 4H), 3.57 – 3.54 
(m, 2H), 3.54 – 3.50 (m, 2H), 3.39 (t, J = 6.7 Hz, 2H), 3.26 (t, J = 6.8 Hz, 2H), 3.23 
– 3.18 (m, 1H), 2.92 (dd, J = 12.7, 5.0 Hz, 1H), 2.70 (d, J = 12.7 Hz, 1H), 2.19 (t, 
J = 7.4 Hz, 2H), 1.87 – 1.53 (m, 8H), 1.44 (p, J = 7.7 Hz, 2H). 13C NMR (101 MHz, 
Methanol-d4) δ 175.9, 166.1, 71.6, 71.5, 71.3, 71.3, 70.0, 68.9, 63.4, 61.6, 57.0, 
49.5, 41.1, 37.8, 36.9, 30.4, 30.2, 29.8, 29.5, 26.9. HRMS: calcd C20H36N6O5S 
[M+Na]+ 495.2360, found 495.2352. Analytical data corresponds to previously 
reported data (Chambers et al., 2013).  
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2.1.3.2. Compound 17  
 
 
Fmoc-Lys(Boc)-OH (23.61 g, 50 mMol), Oxyma (10.48 g, 74 mMol) and 
propargylamine (3.4 mL, 53 mMol) were dissolved in DCM (1 L) and cooled on ice. 
EDC (18.87 g, 98 mMol) was added after which the, now unclear, mixture was 
stirred at RT for 40 min. The reaction mixture was washed with subsequently H2O 
(500 mL, 3 x), citric acid (1 M, 500 mL, 2 x), H2O (1 L), NaHCO3 (sat, 500 mL, 2 x) 
and H2O (1 L). The organic layer was dried over MgSO4 and concentrated under 
vacuum to yield a yellow solid (26.52 g, 95%). 
Analytical data: 1H NMR (400 MHz, Chloroform-d) δ 7.75 (dt, J = 7.6, 1.0 Hz, 2H), 
7.57 (d, J = 7.5 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.30 (td, J = 7.4, 1.2 Hz, 2H), 6.79 
(br s, 1H), 5.67 (br s, 1H), 4.68 (br s, 1H), 4.45 – 4.32 (m, 2H), 4.23 – 4.10 (m, 2H), 
4.06 – 3.92 (m, 2H), 3.13-3.06 (m, 2H), 2.13 (s, 1H), 1.94 – 1.21 (m, 15H). 13C NMR 
(101 MHz, Chloroform-d) δ 171.6, 156.5, 156.3, 143.9, 143.8, 141.4, 127.9, 127.2, 
125.2, 120.1, 79.3, 77.4, 71.9, 67.2, 54.7, 47.2, 40.0, 32.2, 29.7, 29.3, 28.6, 22.6. 
HRMS: calcd C29H35N3O5 [M+Na]+ 528.2469, found 528.2452. Analytical data 
corresponds to previously reported data (Hartwig and Hecht, 2010).  
2.1.3.3. Compound 18  
 
 
Over 45 min, a solution of Boc2O (12.02 g, 55 mMol) in THF (100 mL) was added to 
a solution of 6-aminocaproic acid (6.55 g, 50 mMol) in NaOH (0.5 M, 110 mL), 
which was cooled on ice. The suspension that resulted was stirred for 3 h at RT, 
after 1 h the mixture became clear. The reaction was quenched by addition of 
H2O (50 mL) after which the mixture was extracted with Et2O (100 mL, 3 x). The 
aqueous layer was basified by addition of KHSO4 (1 M, 100 mL) after which it was 
extracted with Et2O (200 mL, 4 x). These last organic layers were combined, dried 
over MgSO4 and concentrated under vacuum to yield Boc-protected caproic acid 
as a white solid (9.55 g, 83%).  
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Analytical data: 1H NMR (400 MHz, Chloroform-d) δ 5.79 (br s, 1H), 4.54 (br s, 
1H), 3.15 – 2.93 (m, 2H), 2.37 – 2.17 (m, 2H), 1.58 (p, J = 7.5 Hz, 2H), 1.49 – 1.22 
(m, 13H). 13C NMR (101 MHz, Chloroform-d) δ 177.9, 155.0, 78.2, 39.3, 32.9, 28.7, 
27.4, 25.2, 23.3. HRMS: calcd C11H21NO4 [M+Na]+ 254.1363, found 254.1365. 
Analytical data corresponds to previously reported data (Alam et al., 2000).  
 
 
Boc-protected caproic acid (9.27 g, 40.1 mMol) was dissolved in dry DCM (650 mL) 
together with NHS (4.64 g, 40.3 mMol). EDC (11.54 g, 60.2 mMol) was added and 
the mixture was stirred under N2. After 1 h the mixture became clear and after 
7 h the reaction was stopped. After washing with brine (150 mL, 3 x) the solution 
was dried over MgSO4 and concentrated under vacuum to yield the NHS-activated 
and Boc-protected variant of caproic acid as a white powder (13.2 g, quant).  
Analytical data: 1H NMR (400 MHz, Chloroform-d) δ 4.55 (br s, 1H), 3.14 – 2.91 (m, 
2H), 2.82 – 2.71 (m, 4H), 2.54 (t, J = 7.4 Hz, 2H), 1.70 (p, J = 7.4 Hz, 2H), 1.49 – 
1.30 (m, 13H). 13C NMR (101 MHz, Chloroform-d) δ 169.3, 168.6, 156.1, 79.2, 40.4, 
31.0, 29.7, 28.5, 26.0, 25.7, 24.4. HRMS: calcd C15H24N2O6 [M+Na]+ 351.1527, 
found 351.1519. Analytical data corresponds to previously reported data 
(Srinivasan and Huang, 2007). 
 
 
The NHS-activated and Boc-protected variant of caproic acid (12.9 g, 39.3 mMol) 
and 6-aminocaproic acid (5.16 g, 39.3 mMol) were dissolved in 350 mL dry DMF. 
DIPEA (16.5 mL, 117 mMol) was added and the mixture was stirred under N2 
atmosphere for 65 h. The mixture was washed with HCl (1M, 200 mL, 2 x), dried 
over MgSO4, filtered and concentrated under vacuum to yield 18 as a white solid 
(13.0 g, 96%).  
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 3.16 (t, J = 7.0 Hz, 2H), 3.02 
(t, J = 7.0 Hz, 2H), 2.29 (t, J = 7.4 Hz, 2H), 2.17 (t, J = 7.5 Hz, 2H), 1.68 – 1.55 
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(m, 4H), 1.54 – 1.27 (m, 17H). 13C NMR (101 MHz, Methanol-d4) δ 177.4, 176.0, 
158.5, 79.8, 41.2, 40.2, 37.0, 34.8, 30.7, 30.1, 28.8, 27.5, 27.4, 26.8, 25.7. HRMS: 
calcd C17H32N2O5 [M+Na]+ 367.2203, found 367.2194. Analytical data corresponds 
to previously reported data (Srinivasan and Huang, 2007). 
2.1.3.4. Compound 19  
 
 
Compound 17 (22.35 g, 44 mMol) was dissolved in DCM (150 mL) and TFA (50 mL) 
was added. The mixture was stirred for 25 min after which TLC indicated complete 
deprotection of the starting material. The solution was concentrated under 
vacuum and the last traces of TFA were removed by co-evaporations with toluene 
(3 x).  
The orange oil that resulted was suspended in DCM (250 mL) and after addition of 
DIPEA (8.5 mL, 50 mMol) the mixture became a solution. This solution was added 
to solution of compound 18 (13.8 g, 40 mMol), HBTU (18.3 g, 48 mMol) and DIPEA 
(8.5 mL, 50 mMol) in DCM (250 mL), which had already been stirring for 10 min at 
RT. In order to keep the pH around 8.5 more DIPEA (17 mL) had to be added to 
the mixture. The reaction was stopped after 70 min and the organic layer was 
washed with H2O (500 mL) and KHSO4 (1 M, 500 mL). These washes resulted in the 
formation of a gel in the organic layer, therefore, a little MeOH was added before 
the organic layer was dried over MgSO4. After concentration under vacuum, a 
brown solid was collected which was further purified by flash chromatography 
(DCM/MeOH, 20:0 → 19:1) yielding compound 19 as a white solid (18.05 g, 62% 
over 2 steps).  
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 7.90 (br s, 1H, NH), 7.78 (d, 
J = 7.5 Hz, 2H, 2 x Fmoc-CAR-H), 7.65 (t, J = 7.1 Hz, 2H, 2 x Fmoc-CAR-H), 7.38 (t, 
J = 7.4 Hz, 2H, 2 x Fmoc-CAR-H), 7.30 (td, J = 7.4, 1.2 Hz, 2H, 2 x Fmoc-CAR-H), 
6.53 (br s, 1H, NH), 4.47 – 4.27 (m, 2H, Fmoc-CH2), 4.20 (t, J = 6.8 Hz, 1H, Fmoc-
CH), 4.06 (dd, J = 9.0, 5.2 Hz, 1H, Lys-αCH), 4.02 – 3.86 (m, 2H, CH2C-CH), 3.21 – 
3.07 (m, 4H, Lys-εCH2 and caproic acid-εCH2), 3.07 – 2.93 (m, 2H, caproic acid-
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εCH2), 2.58 (t, J = 2.5 Hz, 1H, C-CH), 2.22 – 2.09 (m, 4H, 2 x caproic acid-αCH2), 
1.83 – 1.23 (m, 27H, 2 x caproic acid-β,γ,δCH2, Lys-β,γ,δCH2 and Boc-CH3). 13C NMR 
(101 MHz, Methanol-d4) δ 176.0, 174.5, 158.5, 158.4, 145.3, 145.1, 142.6, 128.8, 
128.2, 126.2, 120.9, 80.5, 79.8, 72.3, 67.9, 56.3, 48.4, 41.2, 40.2, 40.0, 37.0, 
37.0, 32.9, 30.6, 30.1, 30.0, 29.5, 28.8, 27.5, 27.4, 26.7, 26.7, 24.2. HSQC and 
COSY spectra are in accord with assignments given above. HRMS: calcd C41H57N5O7 
[M+Na]+ 754.4150, found 754.4119. 
2.1.3.5. Compound 20 
 
 
Piperidine (3.5 mL, 35 mMol) was added to a solution of compound 19 (5.23 g, 
7.1 mMol) in DMF (30 mL) and the mixture was stirred at RT. After 5 min, Et2O 
(600 mL) was added which led the formation of a white precipitate. After filtration 
the residue was dissolved in MeOH (100 mL) and concentrated under vacuum. The 
last traces of piperidine were removed by co-evaporations with toluene (3 x).  
The white solid that yielded (3.53 mg) was dissolved in DMF (30 mL) and succinic 
anhydride (832.3 mg, 8.3 mMol) and DIPEA (1.4 mL, 8.3 mMol) were added. The 
mixture was stirred for 10 min at RT after which it was concentrated under 
vacuum. The crude was purified by flash chromatography (DCM/MeOH/AcOH, 
9:1:0.1) to yield acid 20 as a white solid (4.05 g, 94% over 2 steps).  
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 4.29 (dd, J = 9.3, 4.9 Hz, 1H, 
Lys-αCH), 4.03 – 3.84 (m, 2H, CH2C-CH), 3.20 – 3.13 (m, 4H, Lys-εCH2 and caproic 
acid-εCH2), 3.02 (t, J = 7.0 Hz, 2H, caproic acid-εCH2), 2.66 – 2.43 (m, 5H, C-CH 
and CH2CH2COOH), 2.22 – 2.13 (m, 4H, 2 x caproic acid-αCH2), 1.89 – 1.75 (m, 1H, 
Lys-βCH2 (1H)), 1.70 – 1.26 (m, 26H, 2 x caproic acid-β,γ,δCH2, Lys-γ,δCH2, Lys-βCH2 
(1H) and Boc-CH). 13C NMR (101 MHz, Methanol-d4) δ 177.3, 176.0, 175.1, 174.2, 
158.5, 80.5, 79.8, 72.1, 54.6, 41.2, 40.2, 40.0, 37.0, 37.0, 32.5, 31.7, 30.8, 30.6, 
30.1, 30.0, 29.5, 28.8, 27.5, 27.4, 26.8, 26.7, 24.2. HSQC and COSY spectra are 
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in accord with assignments given above. HRMS: calcd C30H51N5O8 [M+Na]+ 
632.3630, found 632.3606. 
2.1.3.6. Compound 21 
 
 
Compound 20 (2.79 g, 4.5 mMol) and HBTU (2.09 g, 5.5 mMol) were dissolved in 
DMF (40 mL). When DIPEA (945 μL, 5.5 mMol) was added the solution turned red 
and when 6-aminocaproic acid (726 mg, 5.5 mMol) was added the mixture became 
unclear. After stirring for 1 h at RT the mixture became clear and after another 
4 h the reaction was stopped and concentrated under vacuum. Last traces of DMF 
were removed by co-evaporation with toluene (3 x). The crude oil that resulted 
was triturated with EtOAc (50 mL, 3 x) yielding 21 as a white solid (3.73 g, yield 
not determined) that was used for the synthesis of compound 23 (Section 2.1.3.8) 
without any further purification.  
Analytical data: No full characterisation of this intermediate was performed as it 
was not fully purified, however, the UV-trace of the LC-MS analysis is depicted in 
Appendix 2. HRMS: calcd C36H62N6O9 [M+Na]+ 745.4470, found 745.4437. 
2.1.3.7. Compound 22 
 
 
6-Chloronicotinic acid (6.52 g, 41.4 mMol) was dissolved in hydrazine hydrate 
(80%, 30 mL). The mixture was heated to 100 °C and stirred for 4 h before it was 
cooled down and concentrated under vacuum. The yellow solid that remained was 
dissolved in H2O and acidified to pH 5.4 with concentrated HCl. The precipitate 
that formed was filtered off and washed with ice-cold EtOH to yield the 
hydrochloric salt of 6-hydrazinonicotinic acid as a yellow powder (5.82 g, 74%).  
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Analytical data: 1H NMR (400 MHz, D2O/TEA, 95:5) δ 8.32 (dd, J = 2.3, 0.9 Hz, 
1H), 7.81 (dd, J = 8.8, 2.3 Hz, 1H), 6.56 (dd, J = 8.9, 0.8 Hz, 1H). 13C NMR 
(101 MHz, D2O/TEA, 95:5) δ 173.6, 162.0, 148.9, 139.1, 122.3, 106.3. MS: calcd 
C6H8N3O2 [M+H]+ 154.0611, found 154.0612. Analytical data corresponds to 
previously reported data (Abrams et al., 1990).  
 
 
The hydrochloric salt of 6-hydrazinonicotinic acid (2.03 g, 10.7 mMol) was 
dissolved in DMF (15 mL) and TEA (1.8 mL, 12.7 mMol) and Boc2O (2.78 g, 
12.7 mMol) were added. The suspension that resulted was heated to 50 °C and 
stirred overnight. The next day the mixture, which had become clear, was 
concentrated under vacuum and the crude product was purified by flash 
chromatography (EtOAc/AcOH, 99:1) to yield compound 22 as a yellow solid 
(2.70 g, quant). 
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 8.67 (dd, J = 2.3, 0.8 Hz, 1H), 
8.10 (dd, J = 8.8, 2.2 Hz, 1H), 6.70 (dd, J = 8.8, 0.8 Hz, 1H), 1.49 (s, 9H). 13C NMR 
(101 MHz, Methanol-d4) δ 168.7, 163.9, 158.3, 151.6, 140.4, 118.9, 106.8, 82.0, 
28.6. MS: calcd C11H15N3O4 [M+Na]+ 276.0955, found 276.0946. Analytical data 
corresponds to previously reported data (Abrams et al., 1990).  
2.1.3.8. Compound 23 
 
 
Intermediate 21 (1.50 g, ~1.8 mMol) was dissolved in DCM (20 mL) and cooled on 
ice before TFA (20 mL) was added. The mixture was stirred for 20 min on ice 
before it was concentrated under vacuum. The last traces of TFA were removed 
by co-evaporations with toluene (3 x). 
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The orange oil that resulted was dissolved in DMF (20 mL) and DIPEA was added 
until the solution became basic. This solution was added to a solution of compound 
22 (810.0 mg, 3.2 mMol), HBTU (1.02 g, 2.7 mMol) and DIPEA (460 μL, 2.7 mMol) 
in DMF (20 mL), which had already been stirring for 10 min at RT. After 1 h of 
stirring at RT the reaction was stopped and the mixture was concentrated under 
vacuum. The crude product was triturated with EtOAc (50 mL, 3 x) to yield 23 as 
a yellow solid (1.24 g, yield not determined) that was used for the synthesis of 
compound 25 (Section 2.1.3.9) without any further purification.  
Analytical data: No full characterisation of this intermediate was performed as it 
was not fully purified, however, the UV-trace of the LC-MS analysis is depicted in 
Appendix 3. HRMS: calcd C42H67N9O10 [M+Na]+ 880.4903, found 880.4907). 
2.1.3.9. Compound 25 
 
 
Intermediate 23 (0.96 g, ~ 1.4 mMol) was dissolved in dry DMF (30 mL) and NHS 
(167.2 mg, 1.5 mMol) and EDC (275.9 mg, 1.5 mMol) were added. The mixture was 
stirred at RT overnight after which it was concentrated under vacuum to yield a 
crude yellow solid of 1.51 g. 33% of this crude (501 mg, ~ 0.46 mMol) was further 
purified with reverse-phase chromatography on a Maisch C18 preperative column 
using a 60-minute linear gradient of 5-95% acetonitrile in H2O with 0.1% TFA and 
a flow rate of 12.5 mL/min. After lyophilisation compound 25 was obtained as a 
white fluffy powder (70.8 mg, 15% extrapolated yield over 4 steps).  
Analytical data: To prevent hydrolysis of this compound no full characterisation 
was performed, however, the UV-trace of the HPLC analysis is depicted in 
Appendix 4. MS: calcd C46H71N10O12 [M+H]+ 955.53, found 955.51. 
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2.1.3.10. Probe 1  
 
 
Compound 25 (70.3 mg, 74 μmol) was dissolved in TFA (10 mL) and stirred 
overnight. The next day the product was concentrated under vacuum and last 
traces of TFA were removed by co-evaporations with toluene (8 x) and with Et2O 
(1 x) to yield probe 1 as a yellow solid (74.3 mg, quantitative yield)  
Analytical data: To prevent hydrolysis of the probe no full characterisation was 
performed, however, the UV-trace of the HPLC analysis is depicted in Figure 3-2. 
MS: calcd C43H62F3N10O1 [M+H]+ 951.46, found 951.41. 
2.1.4. Synthesis of probe 2  
For long-term storage benzophenone containing products were protected from 
light. During, synthesis, however, no extra care was taken to avoid light and no 
activation of the benzophenone moiety was observed. 
2.1.4.1. Compound 32  
 
 
Piperidine (0.2 mL, 2 mMol) was added to a solution of compound 17 (126.7 g, 
250 μmol) in DMF (3 mL) and the mixture was stirred at RT. After 10 min the 
mixture was concentrated under vacuum and the piperidine was removed by co-
evaporations with toluene (3 x).  
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This crude mixture was suspended in DCM and added to a mixture of 4-
benzoylbenzoic acid (33.6 mg, 150 μmol), HBTU (56.7 mg, 150 μmol) and DIPEA 
(51 μL, 300 μmol) in DCM, which had been stirring for 10 min. The total mixture 
was stirred for 2 h at RT before it was washed with H2O (20 mL), KHSO4 (1M, 20 mL) 
and H2O (20 mL). The organic layer was dried over MgSO4, concentrated under 
vacuum and purified by flash chromatography (EtOAc/Hexane, 1:4 → 1:1) yielding 
compound 32 as a white solid (75.7 mg, quantitative yield over two steps). 
Analytical data: 1H NMR (500 MHz, Methanol-d4) δ 8.03 – 7.96 (m, 2H, 2 x CAR-H), 
7.86 – 7.80 (m, 2H, 2 x CAR-H), 7.81 – 7.75 (m, 2H, 2 x CAR-H), 7.70 – 7.61 (m, 1H, 
CAR-H), 7.58 – 7.50 (m, 2H, 2 x CAR-H), 4.56 (dd, J = 9.2, 5.6 Hz, 1H, Lys-αCH), 4.11 
– 3.88 (m, 2H, CH2C-CH), 3.05 (dt, J = 6.9, 3.3 Hz, 2H, Lys-εCH2), 2.59 (t, J = 
2.5 Hz, 1H, C-CH), 1.97 – 1.34 (m, 15H, Lys-β,γ,δCH2 and Boc-CH3). 13C NMR 
(126 MHz, Methanol-d4) δ 197.7, 174.1, 169.3, 158.6, 141.5, 138.8, 138.4, 134.2, 
131.1, 130.9, 129.7, 128.7, 80.5, 79.9, 72.3, 56.1, 41.1, 32.8, 30.6, 29.6, 28.8, 
24.4. HSQC and COSY spectra are in accord with assignments given above. HRMS: 
calcd C28H33N3O5 [M+Na]+ 514.2312, found 514.2290. 
2.1.4.2. Compound 34  
 
 
Compound 32 (30 mg, 61 μmol) was dissolved in DCM/TFA (1:1, v/v, 6 mL) and 
stirred for 10 min before it was concentrated under vacuum. The last traces of 
TFA were removed by co-evaporations with toluene (3 x).  
The yellow solid that yielded was dissolved in DMF (3 mL) and succinic anhydride 
(7.4 mg, 73 μmol) and DIPEA (25 μL, 73 μmol) were added. The mixture was stirred 
for 25 min at RT after which it was concentrated under vacuum. The crude was 
dissolved in DCM (10 mL) and extracted with NaHCO3 (sat, 10 mL). The aqueous 
layer was acidified with HCl (1M, until pH = 1) after which the product was 
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extracted with DCM (10 mL, 3 x). The organic layer was washed with brine 
(20 mL), dried over MgSO4 and concentrated under vacuum to yield a yellow oil, 
which was purified by flash chromatography (DCM/MeOH/AcOH, 19:1:0.2) to yield 
compound 34 as a white solid (15.2 mg, 51% over 2 steps).  
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 8.01 (d, J = 7.0 Hz, 2H, 2 x CAR-
H), 7.87 – 7.74 (m, 4H, 4 x CAR-H), 7.71 – 7.62 (m, 1H, CAR-H), 7.61 – 7.44 (m, 2H, 
2 x CAR-H), 4.54 (dd, J = 9.0, 5.4 Hz, 1H, Lys-αCH), 4.12 – 3.85 (m, 2H, CH2C-CH), 
3.22 – 3.14 (m, 2H, Lys-εCH2), 2.67 – 2.50 (m, 3H, C-CH and CH2CH2COOH), 2.43 
(t, J = 6.3 Hz, 2H, CH2CH2COOH), 1.96 – 1.73 (m, 2H, Lys-βCH2), 1.64 – 1.37 (m, 
4H, Lys-γCH2 and Lys-δCH2). 13C NMR (101 MHz, Methanol-d4) δ 197.7, 176.4, 174.6, 
174.1, 169.4, 141.5, 138.8, 138.4, 134.2, 131.1, 130.9, 129.7, 128.8, 80.5, 72.3, 
55.4, 40.0, 32.7, 31.7, 30.4, 30.0, 29.6, 24.4. HSQC and COSY spectra are in 
accord with assignments given above. HRMS: calcd C27H29N3O6 [M+Na]+ 514.1949, 
found 514.1930. 
2.1.5. Synthesis of probe 3 
For long-term storage diazirine containing products were protected from light. 
During, synthesis, however, no extra care was taken to avoid light and no 
activation of the diazirine moiety was observed 
2.1.5.1. Compound 33  
 
 
Compound 17 (748.4 mg, 1.5 mMol) was dissolved in Piperidine/DMF (1:15 (v/v) 
25 mL) and the mixture was stirred at RT. After 10 min the mixture was 
concentrated under vacuum and the piperidine was removed by co-evaporations 
with toluene (3 x).  
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This crude mixture was dissolved in DCM (10 mL) and 3-(4-(3-(trifluoromethyl)-3H-
diazirin-3-yl)phenyl)propanoic acid (304.0 mg, 1.2 mMol) (synthesised by Dominik 
Herkt as described before by Geurink et al. 2010), HBTU (448.1 mg, 1.2 mMol) and 
DIPEA (790 μL, 4.6 mMol) were added. The total mixture was stirred for 2 h at RT 
before it was washed with H2O (50 mL), KHSO4 (1M, 50 mL) and H2O (50 mL). The 
organic layer was dried over MgSO4, concentrated under vacuum and purified by 
flash chromatography (DCM/MeOH 20:0→19:1) yielding compound 33 as a white 
solid (555.9 mg, 91%). 
Analytical data: 1H NMR (400 MHz, Chloroform-d) δ 7.26 (br s, 1H, NH), 7.20 (d, J 
= 8.4 Hz, 2H, 2 x CAR-H), 7.09 (d, J = 8.0 Hz, 2H, 2 x CAR-H), 6.73 (d, J = 8.0 Hz, 
1H, NH), 4.79 (t, J = 6.0 Hz, 1H, NH), 4.52 (td, J = 7.8, 5.8 Hz, 1H, Lys-αCH), 4.06 
– 3.85 (m, 2H, CH2C-CH), 3.15 – 2.99 (m, 2H, Lys-εCH2), 2.94 (td, J = 7.6, 4.4 Hz, 
2H, CH2CH2CAR), 2.52 (t, J = 7.7 Hz, 2H, CH2CH2CAR), 2.20 (t, J = 2.5 Hz, 1H, C-
CH), 1.92 – 1.19 (m, 15H, Lys-β,γ,δCH2 and Boc-CH3). 13C NMR (101 MHz, 
Chloroform-d) δ 172.0, 171.6, 156.2, 142.5, 128.8, 127.1, 126.7, 122.16 (q, J = 
274.7 Hz, CF3), 79.3, 77.3, 71.6, 52.7, 40.0, 37.4, 32.1, 31.1, 29.6, 29.1, 28.5 
28.33 (q, J = 40.4 Hz, CN2-CF3), 22.5. HSQC and COSY spectra are in accord with 
assignments given above. HRMS: calcd C25H32F3N5O4 [M+Na]+ 546.2299, found 
546.2284 
2.1.5.2. Compound 35  
 
 
Compound 33 (554.2 mg, 1.1 mMol) was dissolved in DCM/TFA (1:1 (v/v) 60 mL) 
and stirred for 10 min before it was concentrated under vacuum. The last traces 
of TFA were removed by co-evaporations with toluene (3 x).  
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The yellow solid that yielded was dissolved in DMF (50 mL) and succinic anhydride 
(128.4 mg, 1.3 mMol) and DIPEA (880 μL, 5.1 mMol) were added. The mixture was 
stirred for 45 min at RT after which it was concentrated under vacuum. The 
remaining solid was dissolved in DCM (100 mL) and extracted with NaHCO3 (sat, 
150 mL, 2 x). The aqueous layers were acidified with concentrated HCl and 
extracted with EtOAc (100 mL, 3 x). The organic layers were combined, dried over 
MgSO4, concentrated under vacuum and purified by flash chromatography 
(DCM/MeOH/AcOH, 19:1:0.2) to yield compound 35 as a white solid (417.9 mg, 
75% over 2 steps). 
Analytical data: 1H NMR (400 MHz, Methanol-d4) δ 7.32 (d, J = 8.4 Hz, 2H, 2 x CAR-
H), 7.16 (d, J = 8.0 Hz, 2H, 2 x CAR-H), 4.25 (dd, J = 8.7, 5.4 Hz, 1H, Lys-αCH), 4.05 
– 3.79 (m, 2H, CH2C-CH), 3.19 – 3.08 (m, 2H, Lys-εCH2), 2.94 (t, J = 7.7 Hz, 2H, 
CH2CH2CAR), 2.66 – 2.50 (m, 5H, CH2CH2CAR and CH2CH2COOH), 2.45 (t, J = 6.9 Hz, 
2H, CH2CH2COOH), 1.83 – 1.20 (m, 6H, Lys-β,γ,δCH2). 13C NMR (101 MHz, Methanol-
d4) δ 176.4, 174.8, 174.5, 174.0, 144.7, 130.3, 127.8, 127.7, 126.4 (q, J = 
274.0 Hz, CF3), 80.5, 72.3, 54.5, 40.0, 38.0, 32.7, 32.3, 31.7, 30.5, 29.9, 29.6 (q, 
J = 39.7 Hz, CN2-CF3), 29.5, 24.0. HSQC and COSY spectra are in accord with 
assignments given above. HRMS: calcd C24H28F3N5O5 [M+Na]+ 546.1935, found 
546.1916.  
2.1.5.3. Probe 3  
 
Compound 35 (78.4 mg, 150 μmol) was dissolved in 20 mL dry DMF, and NHS 
(20.7 mg, 180 μmol) and EDC (58.2 mg 304 μmol) were added. The mixture was 
stirred under N2 atmosphere for 2.5 h, after which it was concentrated under 
vacuum. The crude yellow oil was triturated with ice-cold H2O (1 mL, 3 x) to yield 
probe 3 as a white solid (52.8 mg, 57%). 
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Analytical data: To prevent hydrolysis of the probe no full characterisation was 
performed, however, the UV-trace of the LC-MS analysis is depicted in Figure 4-2. 
HRMS: calcd C28H31F3N6O7 [M+Na]+ 643.2099, found 643.2077.  
2.1.6. Synthesis of probe 4 
For long-term storage diazirine containing products were protected from light. 
During, synthesis, however, no extra care was taken to avoid light and no 
activation of the diazirine moiety was observed 
2.1.6.1. Compound 42  
 
 
Compound 35 (58.1 mg, 111 μmol) and compound 15 (65.1 mg, 138 μmol) were 
dissolved in MeOH (3 mL). Next, aqueous CuSO4 (10 mM, 2.8 mL) and aqueous 
NaAsc (30 mg/mL, 335 μL) were added. The mixture was stirred under N2 
atmosphere for 2 h before it was concentrated under vacuum. The crude product 
was purified by flash chromatography (DCM/MeOH/AcOH, 19:1:0.2→16:4:0.2) to 
yield the biotinylated product 42 as a white solid (70.9 mg, 65%).  
Analytical data: 1H NMR (500 MHz, DMSO-d6) δ 8.44 (br s, 1H, NH), 8.16 (br s, 1H, 
NH), 7.90 – 7.83 (m, 2H, NH and triazole-CH), 7.76 (t, J = 5.7 Hz, 1H, NH), 7.35 
(d, J = 8.0 Hz, 2H, 2 x CAR-H), 7.17 (d, J = 7.9 Hz, 2H, 2 x CAR-H), 6.44 (s, 1H, NH), 
6.37 (s, 1H, NH), 4.37 (t, J = 7.0 Hz, 2H, PEG-CH2Ntriazole), 4.33 – 4.24 (m, 3H, 
NHCH2Ctriazole and Biotin-SCH2CH), 4.24 – 4.14 (m, 1H, Lys- αCH), 4.13 (ddd, J = 7.3, 
4.5, 1.8 Hz, 1H, Biotin-SCHCH), 3.54 – 3.34 (m, 12H, 2 x PEG-OCH2CH2O and 2 x 
PEG-CH2CH2CH2O, overlapping with water signal), 3.13 – 3.02 (m, 3H, Biotin-SCH 
and PEG-CH2NH), 3.00 – 2.92 (m, 2H, Lys-εCH2), 2.88 – 2.78 (m, 3H, , Biotin-SCH2 
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(1H) and CH2CH2CAR ), 2.58 (d, J = 12.4 Hz, 1H, Biotin-SCH2 (1H)), 2.50 – 2.40 (m, 
2H, CH2CH2CAR), 2.26 (s, 4H, CH2CH2COOH), 2.09 – 1.96 (m, 4H, PEG-CH2CH2Ntriazole 
and Biotin αCH), 1.81 – 1.09 (m, 14H, Lys-β,γ,δCH2, Biotin-β,γ,δCH2  and PEG-
CH2CH2NH). 13C NMR (126 MHz, DMSO-d6) δ 171.9, 171.2, 162.7, 144.8, 144.0, 
129.3, 126.3, 125.1, 122.8, 122.0 (d, J = 275.5 Hz, CF3), 69.8, 69.7, 69.6, 69.5, 
68.1, 66.9, 61.1, 59.2, 55.4, 46.5, 40.0, 38.2, 36.2, 35.7, 35.2, 34.3, 31.6, 30.6, 
30.0, 29.4, 28.7, 28.2, 28.0, 28.0 (d, J = 39.8 Hz, CN2-CF3), 25.3, 22.7. HSQC, 
HMBC, COSY and TOCSY spectra are in accord with assignments given above. 
HRMS: calcd C44H64F3N11O10S [M+Na]+ 1018.4403, found 1018.4394.  
2.1.6.2. Probe 4 
 
 
Compound 42 (27.5 mg, 27.6 μmol) was dissolved in 3 mL dry DMF, and NHS 
(33.5 mg, 291 μmol) and EDC (55.3 mg 288 μmol) were added. The mixture was 
stirred under N2 atmosphere for 2.5 h, after which it was concentrated under 
vacuum. The crude yellow oil was triturated with ice-cold H2O (1 mL, 3 x) to yield 
a white solid (13.45 mg, 45%).  
Analytical data: To prevent hydrolysis of the probe no full characterisation was 
performed, however, the UV-trace of the LC-MS analysis is depicted in Figure 5-2. 
HRMS: calcd C48H67F3N12O12S [M+Na]+ 1115.4566, found 1115.4607. 
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2.2. Biological assays  
2.2.1. General procedures 
General chemicals and the materials for cell culture were purchased from Sigma-
Aldrich or Thermo Fisher Scientific. Oligonucleotides were produced at Eurofins. 
The cDNA encoding NK1 (TACR100000) was from the cDNA Resource Center. The 
pEGFP-N1 plasmid harbouring A206K eGFP was a gift from Dr. K. Herrick-Davis 
(Albany, NY, USA). Flp-InTM T-RExTM VSV-OX1-eYFP cells were previously generated 
in this lab (Ellis et al., 2006). When buffers were supplemented with proteosome 
inhibitors, cOmpleteTM EDTA-free Protease Inhibitor Cocktail (Roche) was used. 
Peptides and probes were synthesised as described above (Section 2.1). UV-
activation at 365 nm was performed using a high intensity UV-lamp (SB-100p/FB; 
Spectroline) 
2.2.2. Buffers and solutions  
- Ambic buffer: 50 mM NH4HCO3, pH 8 
- Assay buffer: 50 mM HEPES, 3 mM MnCl2, pH 7.4 
- Capture buffer: 120 mM NaCl, 2.5 mM KCl, 10 mM Na2HPO4, 3 mM KH2PO4, 
pH 6.5 
- Coomassie staining solution: 0.5% (w/v) Coomassie Brilliant Blue R-250, 
50% (v/v) MeOH and 10% (v/v) AcOH. 
- Coomassie destaining solution: 40% (v/v) EtOH and 10% (v/v) AcOH 
- Detergent buffer: 150 mM NaCl, 1% (v/v) glycerol, 1% (v/v) Triton X 100, 
50 mM NH4HCO3  
- DNA loading buffer (5X): 15% (w/v) Ficoll®, 1% (v/v) sat. bromophenol 
blue, 1% (v/v) sat. orange g, 0.125% (v/v) sat. xylene cyanol FF  
- Fixing solution: 50% (v/v) MeOH, 7%  (v/v) AcOH 
- HEPES Microscopy buffer: 130 mM NaCl, 5 mM KCl, 20 mM HEPES, 10 mM 
glucose, 1 mM MgCl2, 1 mM CaCl2, pH 7.4 
- Hank’s balanced salt solution (HBSS): 137 mM NaCl, 5.3 mM KCl, 0.34 mM 
Na2HPO4, 0.44 mM KH2PO4, 4 mM NaHCO3, 1.26 mM CaCl2, 0.5 mM MgCl2, 
0.4 mM MgSO4, pH 7.2  
- IP-One stimulation buffer: 10 mM HEPES, 1 mM CaCl2 , 0.5 mM MgCl2 , 
4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose and 50 mM LiCl, pH 7.4 
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- Luria-Bertani (LB) agar: 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 
7.5 g/L agar, pH 7  
- Luria-Bertani (LB) broth: 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 
pH 7  
- Laemmli buffer (5X): 250 mM Tris-HCl, 50% (v/v) glycerol, 250 mM DTT, 
400 mM SDS, 0.01% bromophenol blue, pH 6.8.  
- Phosphate-buffered saline (PBS): 120 mM NaCl, 2.5 mM KCl, 10 mM 
Na2HPO4, 3 mM KH2PO4, pH 7.4.  
- Running buffer:  50 mM MOPS, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 
7.7 
- Radioimmunoprecipitation assay (RIPA) buffer: 50 mM HEPES (pH 7.4), 
150 mM NaCl, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate, 0.1% 
(w/v) SDS, 10 mM NaF, 5 mM EDTA, 10 mM Na2HPO4, 5% (v/v) ethylene 
glycol, pH 7.3, supplemented with proteasome inhibitors 
- SOC medium: 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose 
- Transfer buffer: 25 mM Tris-base, 192 mM glycine, 20 % (v/v) MeOH  
- Tris-acetate-EDTA (TAE) buffer: 40 mM Tris, 1 mM EDTA (pH 8.0), 20 mM 
acetic acid  
- Tris-buffered saline (TBS) buffer: 50 mM Tris-Base, 150 mM NaCl, pH 7.5  
- Tris-EDTA (T/E) buffer: 10 mM Tris-HCl, 1 mM EDTA, pH 7.0  
 
2.2.3. Molecular biology and cloning  
2.2.3.1. Chemical transformation  
2.2.3.1.1. DH5α ™ competent cells 
DH5α ™ competent cells (Invitrogen) were thawed on ice and 50 μL was 
transferred to a precooled 10 mL polystyrene tube, after which 200 ng plasmid 
DNA was added. The cells were incubated for 30 min on ice before a heat shock 
was applied by heating them to 42 °C for 45 s. After a 2 min incubation on ice, 
950 μL prewarmed SOC medium was added and the cells were shaken at 37 °C for 
1 h. An aliquot of 100 μL was then plated onto LBagar, containing 100 μg/mL 
ampicillin. The plate was incubated at 37 °C overnight. The next day the 
transformed colonies were selected and cultured overnight at 37 °C in 5 mL LB 
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broth containing 100 μg/mL ampicillin while shaking. These cultures were either 
used for DNA miniprep (Section 2.2.3.2.1) or DNA quantities were further 
amplified by transferring the cultures into 100 mL LB broth containing 100 μg/mL 
ampicillin and incubating them overnight at 37 °C while shaking.      
2.2.3.1.2. XL10-Gold ultracompetent cells 
XL10-gold ultracompetent cells (Agilent) were thawed on ice and 4 μL 
β-mercoptoethanol was added to 100 µL of cells. The cells were incubated on ice 
for 10 min, while they were swirled every 2 min. Next, 2 μL ligation mixture 
(Section 2.2.3.10) was added. The cells were incubated for 30 min on ice before 
a heat shock was applied by heating them to 42 °C for 30 s. After a 2 min 
incubation on ice, 900 μL prewarmed LB broth was added and the cells were 
shaken at 37 °C for 1 h. An aliquot of 100 μL was then plated onto LBagar, 
containing either 100 μg/mL ampicillin (pcDNA5/FRT/TO plasmid) or 25 µg/mL 
kanamycin (pEGFP-N1-plasmid). The plate was incubated at 37 °C overnight. The 
next day the transformed colonies were selected and cultured overnight at 37 °C 
in 5 mL LB broth containing either 100 μg/mL ampicillin or 25 μg/mL kanamycin 
while shaking. These cultures were either used for DNA miniprep (Section 
2.2.3.2.1) or DNA quantities were further amplified by transferring the cultures 
into 100 mL LB broth containing either 100 μg/mL ampicillin or 25 μg/mL 
kanamycin and incubating them overnight at 37 °C while shaking. 
2.2.3.2. Purification of plasmid DNA 
2.2.3.2.1. Miniprep purification 
Microgram quantities of plasmid DNA were purified using the Wizard® Plus SV 
Minipreps DNA Purification System (Promega) as per the manufacturer’s 
instructions. Briefly, 3 mL overnight bacterial culture (Section 2.2.3.1) was 
pelleted by centrifuging at 10,000 x g for 5 min. Pellets were resuspended in 
resuspension solution, lysis solution was added and lysates were incubated with 
alkaline phosphatase for 5 min at RT. Neutralisation solution was then added and 
the samples were centrifuged at 14,000 x g for 5 min. The cleared lysate was 
decanted into a spin column which was then centrifuged at 14,000 x g for 1 min 
to allow the DNA to bind the column. The column was washed thrice with wash 
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solution before the DNA was eluted into a sterile microcentrifuge tube with 30-
100 μL nuclease-free water.  
2.2.3.2.2. Maxiprep purification  
Milligram quantities of plasmid DNA were purified using the QIAGEN® Plasmid Maxi 
Kit (Quiagen) as per the manufacturer’s instructions. Briefly, 400 mL overnight 
bacterial culture (Section 2.2.3.1) was pelleted by centrifuging at 3,000 x g for 
30 min at 4 °C. The pellets were frozen at -20 °C for 1 h before they were 
resuspended in prechilled resuspension buffer. To lyse the cells, lysis buffer was 
added and samples were incubated for 5 min at RT. Neutralisation buffer was then 
added and after a 20 min incubation on ice, the samples were centrifuged at 3,000 
x g for 30 min at 4 °C. The lysate supernatant was applied to a pre-equilibrated 
QIAGEN-tip 100 column and passed through the column by gravity flow to allow 
the DNA to bind the column. The column was washed twice with wash buffer, after 
which elution buffer was applied. The DNA was precipitated via the addition of 
isopropanol and collected through centrifugation 3,000 x g for 30 min at 4 °C. The 
DNA was desalted by washing with 70% ethanol and airdried before it was dissolved 
in 1 mL nuclease-free water. 
2.2.3.2.3. Determination of DNA concentration 
To determine the concentration of plasmid DNA samples were diluted 50 times 
and the absorbance at 260 nm was measured using a spectrophotometer. The 
purity of the DNA was evaluated using the A260/A280 ratio; for maxipreps a ratio 
>1.5 was considered pure, for minipreps a ratio >1.8 was considered pure.  
2.2.3.3. Polymerase chain reaction 
Restriction sites and epitope tags were added to DNA fragments via the 
polymerase chain reaction (PCR). Reaction mixtures (50 μL) were placed in a 
thermal cycler. Primers were ordered at Eurofins Genomics.  
Reaction mixture components:  
- 1X green GoTaq® Buffer (Promega) 
- 0.2 mM deoxyadenosine triphosphate (Promega) 
- 0.2 mM deoxythymidine triphosphate (Promega) 
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- 0.2 mM deoxycytidine triphosphate (Promega) 
- 0.2 mM deoxyguanosine triphosphate (Promega) 
- 0.5 μM forward primer  
- 0.5 μM reverse primer 
- 100 ng template DNA 
- 1.25 units GoTaq® DNA Polymerase (Promega) 
Thermal cycler conditions:   
1. Preheating 95 °C 2 min  
2. Denaturing 95 °C 30 s  
3. Annealing 55 °C 30 s  
4. Extension 72 °C 90 s  
5. Repeat steps 2–4 (29 x)  
6. Final extension 72 °C 5 min  
7. Hold 4 °C ∞  
Samples were purified via agarose gel electrophoresis (Section 2.2.3.4) followed 
by gel extraction (Section 2.2.3.5).  
2.2.3.4. Agarose gel electrophoresis 
DNA was resolved using agarose gel electrophoresis to either purify fragments, to 
verify results of digestions and annealing reactions, or to roughly determine DNA 
concentrations. To prepare the gels, 0.8% (w/v) agarose (Flowgen, Biosciences) 
and 1X SYBR® Safe DNA stain (Life Technologies) were dissolved in TAE buffer. 
The mixture was poured into a gel tray, cooled until the gel set and then 
submerged in TAE buffer. Samples were mixed with 5X DNA loading buffer (apart 
from PCR samples in Green GoTaq® buffer) and loaded onto the gel (5-25 μL per 
well). To determine size and concentration of the DNA in the samples, 
HyperLadder™ 1kb (5-15 μl; bioline) was also loaded onto the gel. Gels ran at 125 
V for 20 min and bands were then visualised using the Gel Doc 2000 (Biorad). 
2.2.3.5. Gel extraction   
DNA, which was resolved on agarose gels, was extracted from the gels using the 
QIAquick Gel Extraction Kit as per the manufacturer’s instructions (Quiagen). 
Briefly, bands were visualised using the E-Gel® Safe Imager™ Transilluminator 
(Invitrogen) and cut out using a razor blade. The gel was solubilised by adding 
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three gel volumes of solubilisation buffer and heating to 50 °C for 10 min. Next, 
one gel volume of isopropanol was added and the mixture was added to a spin 
column, which was then centrifuged at 14,000 x g for 1 min. The column was 
washed twice with wash solution before the DNA was eluted with 100 μL nuclease-
free water. 
2.2.3.6. Restriction endonuclease digestion  
Vectors and PCR products were digested using restriction enzymes to create sticky 
or blunt ends. Reaction mixtures (50 μL), containing one or two restriction 
enzymes, were incubated overnight at 37 °C.  
Reaction mixture components:  
- 1X buffer (Table 2-2)  
- 5-20 μg vector DNA, 20 μL PCR product, or 30 μL blunted DNA product  
- 10-40 units restriction enzyme (Table 2-2)  
Table 2-2. Restriction enzymes used. 
Enzyme Supplier  Units/50 μL Buffer used Double 
digest with 
BamHI Roche  15  SuRE/Cut Buffer B  XhoI 
XhoI Roche  15  SuRE/Cut Buffer B  BamHI 
NotI- High 
Fidelity (HF) 
® 
New England 
Biolabs 
40 CutSmart® Buffer EcoRC-HF® 
or 
AgeI-HF® 
EcoRC-HF®  
 
New England 
Biolabs 
40 CutSmart® Buffer NotI-HF® 
AgeI-HF® New England 
Biolabs 
40 CutSmart® Buffer NotI-HF® 
AscI New England 
Biolabs   
10 CutSmart® Buffer - 
NheI Fermentas 20 FastDigest Buffer - 
 
DNA fragments digested with NheI were subjected to DNA blunting (Section 
2.2.3.7). All other digestion products were purified via agarose gel electrophoresis 
(Section 2.2.3.4) followed by gel extraction (Section 2.2.3.5) and ligation (Section 
2.2.3.10).  
2.2.3.7. DNA blunting 
Sticky ended DNA fragments were subjected to a blunting protocol to create blunt 
ends. After overnight incubation, the 50 μL restriction digestion mixture (Section 
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2.2.3.6) was supplemented with 100 μM dNTPs (25 μM each, Promega) and 5 units 
T4 DNA polymerase (New England Biolabs). The mixture was incubated for 15 min 
at 12 °C. Next, 0.5 M EDTA was added to a final concentration of 10 mM and the 
reaction was heated to 72 °C for 20 min. The DNA was then purified via DNA 
purification (Section 2.2.3.8). 
2.2.3.8. DNA purification 
Blunting products were purified using the QIAquick® PCR Purification Kit (QIAGEN) 
as per the manufacturer’s instructions. Briefly, the blunted DNA was diluted in 
five volumes of binding buffer and the mixture was added to a spin column, which 
was then centrifuged at 14,000 x g for 1 min The column was washed once with 
wash solution before the DNA was eluted with 30 μL nuclease-free water. Blunted 
DNA was then subjected to further restriction endonuclease digestion (Section 
2.2.3.6).  
2.2.3.9. DNA annealing  
To anneal primers together and create a sticky-ended DNA fragment, a forward 
and reversed primer were annealed together. Reaction mixtures (50 μL) were 
incubated at 100 °C for 5 min before being left to cool overnight.  
Reaction mixture components: 
- 1X MULTI-CORE™ Buffer (Promega) 
- 20 μM forward primer 
- 20 μM reverser primer  
The resulting fragment was used for ligation (Section 2.2.3.10) without any 
purification.  
2.2.3.10. DNA ligation  
To insert DNA fragments into vectors, sticky ended and/or blunt ended DNA was 
ligated. The exact amount of DNA used in these reactions was not quantified, but 
a rough idea of DNA concentrations was obtained via agarose gel electrophoresis 
(Section 2.2.3.4). Reaction mixtures (10 μL) were incubated overnight at 16 °C.  
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Reaction mixture components:  
- 1X T4 DNA Ligase Reaction Buffer (New England Biolabs) 
- ~50 ng vector DNA  
- ~0.5-10 ng insert DNA 
- 400 units T4 DNA Ligase (New England Biolabs) 
Mixtures were kept on ice until used for transformation into XL10-Gold competent 
bacteria (Section 2.2.3.1.2). 
2.2.3.11. Generation of HA-NK1-eGFP in pcDNA5/FRT/TO 
A human NK1 construct in pcDNA3.1+ was used as PCR template. Primers were 
designed to introduce an HA-epitope on the N-terminus of the NK1 construct. 
Moreover, XhoI and BamHI restriction sites were introduced at the 5’ and 3’ 
termini respectively. Apart from these features, the forward primer contains a 
Kozak sequence and a start codon. The primers used are given below with non-
coding DNA in black, restriction sites underlined, the Kozak sequence in italic, the 
start codon in green, HA-encoding codons in blue, and parts of the NK1 sequence 
in red. 
Primers: 
5’ ACGTACGTACGTCTCGAGGCCACCATGTACCCCTATGACGTGCCCGATTACGCGGATAA
CGTCCTCCCGGTGGACTCAGACCTCTCC 3’  
5’ ACGTACGTACGTTGGATCCCGGGAGAGCACATTGGAGGAGAAGCTGAAGC 3’  
 
 
Next, the resulting DNA fragment was subcloned in between the XhoI and BamHI 
sites of the pEGFP-N1-plasmid (Clontech) harbouring eGFP A206K, a variant of 
enhanced green fluorescent protein (eGFP) that is less prone to dimerisation (von 
Stetten et al., 2012), resulting in a HA-NK1-eGFP construct. The HA-NK1-eGFP 
construct was excised from pEGFP-N1 with NheI and NotI. The NheI end was 
blunted and the fragment was subcloned into pcDNA5/FRT/TO (Invitrogen) 
between EcoRV and NotI. This plasmid was used in the Flp-InTM T-RExTM system to 
create cells inducibly expressing HA-NK1-eGFP. (Section 2.2.4.2)  
2.2.3.12. Generation of HA-NK1-6xHis in pcDNA5/FRT/TO 
Using NotI and AgeI, eGFP was excised from the HA-NK1-eGFP construct in 
pcDNA5/FRT/TO. Next, DNA encoding a 6xHis-tag, created by annealing the two 
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primers, was subcloned into the same site, thereby creating a HA-NK1-6xHis 
construct. This plasmid was used in the Flp-InTM T-RExTM system to create cells 
inducibly expressing HA-NK1-6xHis (Section 2.2.4.2). The primers used are given 
below with non-coding DNA in black, restriction sites underlined, the stop codon 
in orange and the 6xHis-tag-encoding codons in blue. 
Primers: 
5’ CCGGTCCACCATCACCATCACCATTAGGGCGCGCCGC 3’  
    3’ AGGTGGTAGTGGTAGTGGTAATCCCGCGCGGCGCCGG 5’ 
 
2.2.3.13. DNA sequencing 
Sequences of all DNA constructs were verified via DNA sequencing, performed by 
DNA Sequencing & Services (MRC I PPU, College of Life Sciences, University of 
Dundee, Scotland, www.dnaseq.co.uk) using Applied Biosystems Big-Dye Ver 3.1 
chemistry on an Applied Biosystems model 3730 automated capillary DNA 
sequencer. Chromas software and EMBOSS Matcher 
(http://www.ebi.ac.uk/Tools/psa/emboss_matcher/) were used interpret the 
sequenced results. 
2.2.4. Mammalian cell culture 
2.2.4.1. Maintenance of mammalian cell lines 
All cells were maintained in a humidified 5% CO2 atmosphere at 37 °C and 
subcultured every three days.  
2.2.4.1.1. HEK293T cells 
Human embryonic kidney 293 cells transformed with large T-antigen (HEK293T 
cells) were maintained in complete Dulbecco’s modification of Eagle’s medium 
(DMEM) with 4500 mg/L glucose and sodium bicarbonate, without L-glutamine and 
sodium pyruvate, supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 
units/mL penicillin, and 100 μg/mL streptomycin.  
    
 
Chapter 2. Materials and methods 71 
2.2.4.1.2. Parental Flp-InTM T-RExTM 293 cells  
Parental Flp-InTM T-RExTM 293 cells (Life Technologies) cells were maintained in 
complete DMEM with 4500 mg/L glucose and sodium bicarbonate, without sodium 
pyruvate, supplemented with 10% (v/v) FBS, 100 units/mL penicillin, 100 μg/mL 
streptomycin, and 5 μg/mL blasticidin.  
2.2.4.1.3. Transfected Flp-InTM T-RExTM 293 cells 
Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP, HA-NK1-eGFP, or HA-NK1-
6xHis were maintained in complete DMEM with 4500 mg/L glucose and sodium 
bicarbonate, without sodium pyruvate, supplemented with 10% (v/v) FBS, 100 
units/mL penicillin, 100 μg/mL streptomycin, 200 μg/mL hygromycin, and 
5 μg/mL blasticidin.  
2.2.4.1.4. Subculturing 
 Confluent cells were washed with PBS before they were detached via a 5 min 
incubation with trypsin-EDTA. Trypsin was deactivated by addition of prewarmed 
DMEM and 1/10th of the total mixture was transferred to a sterile flask containing 
prewarmed DMEM. 
2.2.4.1.5. Cryopreservation 
For long-time storage cells were frozen in liquid nitrogen. A confluent T75 flask 
with cells was washed with PBS before cells were detached via a 5 min incubation 
with trypsin-EDTA. Trypsin was deactivated by addition of DMEM and the mixture 
was centrifuged at 300 x g for 5 min. The pellet of cells was resuspended in 3 mL 
FBS with 10% (v/v) DMSO and divided into two vials. Vials were wrapped in cotton 
wool and frozen at -80 °C to ensure slow freezing. Once frozen, cells were 
transferred to liquid nitrogen. To revive cells, vials were thawed at 37 °C and cells 
were diluted with 10 mL prewarmed DMEM. Cells were collected via centrifugation 
at 300 x g for 5 min, resuspended in 10 mL prewarmed DMEM and transferred to a 
sterile T75 flask.  
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2.2.4.2. Stable transfection of cell lines 
The Flp-InTM T-RExTM system was used for stable transfection of cells as described 
before (Ward et al., 2011). Briefly, parental Flp-InTM T-RExTM 293 cells contain a 
FRT site that, under control of Flp recombinase, can recombine with the FRT site 
on the pcDNA5/FRT/TO vector thereby introducing the DNA of interest and 
hygromycin resistance to the cells. Parental Flp-InTM T-RExTM 293 cells were grown 
to 70% confluency in a 10 cm2 tissue culture dish. First, 7.2 μg POG44 FLp 
recombinase vector and 0.8 μg pcDNA5/FRT/TO vector containing the gene of 
interest were diluted in 250 μL NaCl (150 mM), then 30 μg polyethylenimine (PEI) 
(Polysciences) diluted in 250 μL NaCl (150 mM) was added. The mixture was 
vortexed and incubated for 10 min at RT before it was added dropwise to the cells. 
After 24 h the medium was refreshed and 24 h later cells were subcultured 1:10 
and 1:30. To initiate selection, after another 24 h the medium was replaced with 
medium containing 200 μg/mL hygromycin. After 10-14 days of selection, resistant 
colonies formed, these were pooled together and tested for doxycycline (Dox) 
inducible expression of the protein of interest by immunoblotting (Section 2.2.8)  
and, if possible, by epifluorescence quantification and visualisation (Section 
2.2.6). 
2.2.5. Lysate preparation  
2.2.5.1. Whole-cell lysates (RIPA) 
All subsequent steps were performed on ice or at 4 °C. Cells were passed through 
a 25 gauge needle (6 x) to enhance disruption and homogenisation. The cells were 
rotated for 45 min at before they were centrifuged at 21,000 x g for 10 min to get 
rid of any cell debris. If lysates were not used directly, they were stored at -20 °C 
until use.  
2.2.5.2.  Whole-cell lysates (Rapigest SF) 
All subsequent steps were performed on ice or at 4 °C. To enhance disruption and 
homogenisation, the cells were passed through a 25 gauge needle (10 x). The cells 
were rotated for 45 min before they were centrifuged at 21,000 x g for 10 min to 
remove cell debris. If lysates were not used directly, they were stored at -20 °C 
until use.  
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2.2.5.3. Membrane preparation 
All subsequent steps were performed on ice or at 4 °C. Cells were harvested and 
pelleted by centrifugation 3200 x g for 5 min. Pellets were frozen at -20 °C for at 
least 1 h. Cells were thawed and resuspended in PBS buffer supplemented with 
proteasome inhibitors. Next they were passed through a 25 gauge needle (10 x), 
homogenised on ice using a glass on Teflon homogeniser (50 x), and again passed 
through a needle (10 x). To remove cell debris the mixture was centrifuged at 200 
x g for 5 min, after which the supernatant was centrifuged at 50,000 x g for 
30 min. The pellets were resuspended in PBS buffer supplemented with protease 
inhibitors. If membranes were not used directly, they were stored at -80 °C until 
use.  
2.2.5.4. Solubilisation of membrane preparation  
To solubilise membrane preparations 1% (v/v) NP40 was added to the membrane 
prep and the sample was rotated for 1 h at 4 °C. The mixture was then centrifuged 
at 21,000 x g for 10 min at 4 °C to remove any non-solubilised material. 
2.2.5.5. Protein concentration determination  
A bicinchoninic assay (BCA) was used to determine protein concentrations in whole 
cell lysates and membrane preparations. To create a standard curve, 0.2–2 mg/mL 
bovine serum albumin (BSA) solutions were used. First, 10 μL of sample or standard 
was added to a clear 96-well plate. Next, 4% (w/v) CuSO4·5H2O and Proteoquant 
BCA Reagent A (Expedeon) were mixed (1:49) and 200 μL was added to each well. 
After a 20-40 min incubation at 37 °C, the absorbance at 562 nm was read on a 
POLARStar Omega 67 plate reader (BMG Labtech). The concentrations of the 
samples were then interpolated from the standard curve. 
2.2.6. Assessing receptor expression 
2.2.6.1. Dox titration – Immunoblotting 
Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP, HA-NK1-eGFP or HA-NK1-
6xHis were grown in poly-D-lysine coated 6-well plates and incubated with various 
concentrations of Dox overnight. Cells were washed twice with PBS before 200 µL 
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RIPA buffer was added and lysates were prepared (Section 2.2.5.1). These were 
subjected to SDS-PAGE and immunoblotting (Section 2.2.8).  
2.2.6.2. Dox titration - Epifluorescence quantification  
Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP or HA-NK1-eGFP were cultured 
on black clear bottom 96-well plates coated with poly-D-lysine. After induction 
with various concentration of Dox the plates were incubated overnight. The next 
day the cells were washed with HBSS twice before they were incubated for 20 min 
at 37 °C with 10 μg/mL Hoechst nuclear stain to enable cell number 
determination. After two more washes with HBSS, fluorescence was measured 
with a CLARIOstar microplate reader (BMG Labtech). To quantify the Hoechst 
stained nuclei an excitation wavelength of 355/20 nm and an emission wavelength 
of 455/30 nm were used. eYFP was quantified using excitation and emission 
wavelengths of 497/15 nm and 540/20 nm, respectively, while for eGFP 470/15 
nm and 515/20 nm were used.  
2.2.6.3. Epifluorescence microscopy imaging of live cells  
Flp-InTM T-RExTM 293 cells harbouring VSV-G-OX1-eYFP or HA-NK1-eGFP were 
seeded on poly-D-lysine coated coverslips and incubated for 8 h before they were 
induced with 100 ng/mL Dox. After incubation overnight, the cells were washed 
with HEPES microscopy buffer (6 x) before they were put into the microscope 
chamber containing HEPES microscopy buffer. VSV-OX1-eYFP was imaged using an 
inverted Nikon Eclipse TE2000-E microscope equipped with an X40 oil-immersion 
Fluor lens with a numerical aperture of 1.3. A computer-controlled Optoscan 
monochromator (Cairn Research) attached to an ultra-highpoint intensity 102-
watt Mercury Optosource lamp was used to generate the excitation wavelength, 
which was set at 500 nm to excite eYFP. Imaging of HA-NK1-eGFP was carried out 
using a Zeiss 880 laser scanning confocal microscope (invert configuration), 
equipped with a 63x oil immersion Plan Apochromat objective lens with a 
numerical aperture of 1.4. HA-NK1-eGFP was excited at 488 nm using the Zeiss 
Zen Black software.  
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2.2.7. Functional assays  
2.2.7.1. Intracellular calcium assays 
Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP were cultured on black clear 
bottom 96-well plates coated with poly-D-lysine. After induction of the 
appropriate wells with 100 ng/mL Dox, plates were incubated overnight. Next, 
the medium was removed from the wells and replaced with 50 μL medium 
containing 3 μM Fura-2-AM. Plates were incubated at 37 °C for 45 min, in the dark, 
after which wells were washed twice with HEPES microscopy buffer and filled with 
100 μL buffer (for competition experiments 5 μM SB408124 was added to the cells 
at this stage). Cells were incubated for another 45 min at 37 °C in the dark. The 
FLEX-station II (Molecular Devices) was used to add 100 µL of 2X ligand solutions 
in HEPES microscopy buffer to the wells and to test the effect of the ligands by 
measuring the excitation of free and calcium bound Fura-2 at 340 and 380 nm, 
respectively. The 340/380 ratio was determined for each well. 
2.2.7.2. Inositol monophosphate accumulation assays  
A HTRF assay (HTRF IP-One Tb kit, Cisbio Bioassays) was used to measure 
accumulated IP1. Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP or HA-NK1-
6xHis were grown in T75 tissue culture flasks and induced with 100 ng/mL Dox, 
after which they were incubated overnight. Uninduced cells, grown in a similar 
fashion, were used as negative control. Cells were harvested using Versene, after 
which they were resuspended in IP-One stimulation buffer. Cells were added to 
white, solid-bottom, 384-well plates with appropriate ligand concentrations 
present in these wells and incubated at 37 ° C for 2 h. To create a standard curve, 
11-11,000 nM IP1 solutions were added to the plate. After addition of d2-IP1 in 
lysis buffer (3 μl/well) and anti-IP1 Lumi4-Tb cryptate in lysis buffer (3 μl/well), 
the plate was incubated for 1-24 h at RT. Using a PHERAstar FS plate reader (BMG-
Labtech), the ratio of 665 nm/620 nm fluorescence was measured. The IP1 
concentrations of the samples were then interpolated from the standard curve.  
2.2.7.3. Data analysis  
Using GraphPad Prism version 5.00 for Windows, the data for individual 
experiments were fitted against a three-parameter sigmoidal curve according to the 
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equation below (Response = Y and [Ligand] = X). To pool data from multiple 
experiments data points were normalised assuming that the Bottom was 0% and the 
Top was 100%. The pooled data points were then again fitted against a three-
parameter sigmoidal curve.  
𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 = 𝐵𝑜𝑡𝑡𝑜𝑚 +
𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚
1 + 10𝐿𝑜𝑔𝐸𝐶50−[𝐿𝑖𝑔𝑎𝑛𝑑]
 
2.2.8. SDS-PAGE and immunoblotting  
2.2.8.1. SDS-PAGE  
Proteins were separated using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Samples were mixed with 5X laemmli buffer and 
heated at 65 °C for 5 min. If samples contained Cu2+, the heating step was 
replaced by a 5 min incubation at RT. BOLT® 4–12% Bis-Tris Plus Gels (Life 
Technologies) or NuPAGE® Novex® 4–12% Bis-Tris Gels (Life Technologies) were 
submerged in MOPS SDS running buffer (Life Technologies), samples were loaded 
into the wells and the gels were ran at 200 V for 45–60 min.  
2.2.8.2. Immunoblotting  
Antibodies used for immunoblotting can be found in Table 2-3. Proteins on a SDS-
PAGE gel were transferred to nitrocellulose membranes using a wet transfer 
system. Transfer took place in transfer buffer at 30 V for 60 min. These were then 
blocked for 45 min at RT in PBS blocking buffer (LI-COR) and subsequently 
incubated with primary antibody diluted in PBS blocking buffer with 0.2% (v/v) 
Tween-20 either for 3 h at RT or overnight at 4 °C. The membranes were rinsed 
once and washed 4 x 5 min with PBS containing 0.1% (v/v) Tween-20. This was 
followed by addition IRDye® fluorescently labelled secondary antibody and/or 
IRDye® fluorescently labelled Streptavidin diluted in PBS blocking buffer with 0.2% 
(v/v) Tween-20. After incubation for 1 h at RT in the dark, the membranes were 
rinsed once and washed 4 x 5 min with PBS containing 0.1% (v/v) Tween-20, 
followed by a double rinse with PBS. A Odyssey Scanner (LI-COR) was used to image 
the membranes.  
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Table 2-3. Antibodies used for immunoblotting.  
Antibody Species Supplier Dilution 
Primary     
Anti-GFP  Sheep Produced in house 1:10,000 
Anti-6xHis (ab9108) Rabbit Abcam  1:4,000 
Anti-tubulin (ab7291) Mouse Abcam 1:4,000 
Secondary     
IRDye 800CW anti-goat  Donkey  Li-COR 1:10,000 
IRDye 800CW anti-rabbit Donkey Li-COR 1:10,000 
IRDye 680RD anti-mouse Goat Li-COR 1:10,000 
IRDye 800CW anti-mouse Goat Li-COR 1:10,000 
IRDye 680LT Streptavidin - Li-COR 1:10,000 
 
2.2.9. Evaluation of probe 1 
2.2.9.1. Ligand coupling  
OXA, Ac-OXA, BSA or Gly were dissolved in HEPES (pH 8.2) at 1 mg/mL. A stock 
solution of probe 1 in DMSO (100 mM) was added to a final concentration of 0.6 mM 
or 3.0 mM. The mixtures were shaken for 1 h at RT to create ligand-probe-1 
mixtures and used immediately for receptor capture (Section 2.2.9.3) or 
intracellular calcium assays (Section 2.2.7.1).  
2.2.9.2. Optimisation of the click reaction  
BSA-probe-1 (Section 2.2.9.1) was incubated for 1 h with biotin-PEG-azide (15; 
1 mM), TBTA (100 μM), CuSO4 (100 μM) and TCEP or sodium ascorbate (NaAsc) (1, 
5 or 10 mM). Samples were subjected to SDS-PAGE and immunoblotting as 
described in Section 2.2.8.  
2.2.9.3. Oxidation of cells and receptor capture  
Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP were grown in T75 tissue 
culture flasks and induced with 100 ng/mL Dox, after which they were incubated 
overnight. Uninduced cells, grown in a similar fashion, were used as negative 
control. All subsequent steps were performed on ice or at 4 °C. Two confluent 
flasks of cells were harvested with PBS by centrifuging at 300 x g for 5 min. The 
pellet of cells was resuspended in 49 mL capture buffer and 1 mL NaIO4 solution 
was added to a final concentration of 1.5 mM. The suspension was incubated for 
15 min in the dark under constant agitation. Cells were centrifuged at 300 x g for 
5 min and washed with capture buffer before being resuspended in 20 mL capture 
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buffer and split into two portions of 10 mL. Next, 100 μg OXA coupled to probe 1 
or Gly coupled to probe 1 (Section 2.2.9.1), was added to the oxidised cells and 
the mixtures were incubated for 90 min under constant agitation. Cells were 
centrifuged at 300 x g for 5 min and 800 µL Ambic buffer was added followed by 
the addition of 90 µL 1% (w/v) Rapigest SF solution (Waters) in Ambic buffer and 
lysates were prepared (Section 2.2.5.2).  
2.2.9.4. Biotin click  
Lysates of the receptor capture reaction (Section 2.2.9.3) were incubated with 
100 units benzonase nuclease (Novagen) for 30 min at RT. Protein concentrations 
were determined (Section 2.2.5.5) and, if these were higher than 1 mg/mL, 
lysates were diluted. Then click reagents were added - biotin-PEG-azide (15; 
1 mM), TBTA (100 μM), CuSO4 (100 μM) and TCEP (1 mM), followed by 90 min of 
incubation at RT. The mixtures were transferred to a 10 kDa MWCO centrifuge 
tube and click reagents were removed via consecutive addition of 0.2% (w/v) SDS 
in Ambic buffer and concentration (3 x). After the final concentration to ~100 μL, 
protein concentrations were determined and equalised. These lysates were then 
subjected to VSV (Section 2.2.9.5) or eYFP (Section 2.2.9.6) immunoprecipitation.   
2.2.9.5. VSV immunoprecipitation   
7.5 μL Agarose conjugated anti-VSV tag antibody (ab21487, Abcam) was 
prewashed thrice with Ambic buffer before 100 μL lysate of OXA-probe-1 treated 
cells (1 mg/mL) was added. After overnight incubation at 4 °C under constant 
rotation, the beads were collected via centrifugation at 1700 x g for 1 min at 4 °C 
and the supernatant was kept as flow-through (FT). The beads were washed 4 
times with 0.2% (w/v) SDS in Ambic buffer, 40 μL 1X Laemmli buffer was added. 
The mixture was heated to 65 °C for 10 min, centrifuged at 1700 x g for 2 min and 
supernatant was collected as pull-down (PD). Collected FT and PD fractions were 
subjected to SDS-PAGE and immunoblotting as described in Section 2.2.8 except 
that no extra Laemmli buffer was added to the PD fractions.  
2.2.9.6. eYFP immunoprecipitation   
25 μL GFP-trap (Chromotek) slurry was prewashed thrice with the appropriate 
buffer. Next, 120 μL lysate of OXA-probe-1 treated cells (1 mg/mL) was added. 
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After 1 h incubation at 4 °C under constant rotation, the beads were collected via 
centrifugation at 2,000 x g for 2 min at 4 °C and the supernatant was kept as FT. 
The beads were washed three times with Ambic buffer before 50 μL 2X Laemmli 
buffer was added and the mixture was heated at 65 °C for 10 min, centrifuged at 
1700 x g for 2 min and supernatant was collected as PD. Collected FT and PD 
fractions were subjected to SDS-PAGE and immunoblotting as described in Section 
2.2.8 except that no extra Laemmli buffer was added to the PD fractions. 
2.2.10. Evaluation of probes 2 and 3 
2.2.10.1. UV-activation 
The free acid variant of probes 2 and 3 (compounds 34 and 35) were dissolved in 
MeOH (1 mg/mL) and 750 μL was placed in a 12-well plate and exposed to light of 
365 nm for 15 min. Samples were analysed by LC-MS.  
2.2.10.2. Ligand coupling 
SP (1.48 mg/mL), Gly (1 mg/mL) or BSA (1 mg/mL) were dissolved in 25 mM PBS 
(pH 8.2) A stock solution of probe 3 in DMSO (50 mM) was added to a final 
concentration of 5 mM. To redissolve any formed precipitate, mixtures were 
diluted 1:1 with DMSO, creating ligand-probe-3 mixtures at a final concentration 
of 0.5 mM in 55% DMSO. To keep the amount of probe, probe by-products and 
DMSO between SP-probe-3 and Gly-probe-3 equal, in all experiments the volume 
of Gly-probe-3 used was always identical to the volume of SP-probe-3 used. Both 
mixtures were stored at -20ºC and went through numerous freeze-thaw cycles over 
the span of a year without any obvious loss of activity. 
2.2.10.3. Optimisation of the click reaction  
2.2.10.3.1. The effect of buffers on the click reaction 
BSA-probe-3 (Section 2.2.10.2) was either used directly, after buffer exchange 
took place by addition of RIPA buffer in a 10 kDa MWCO centrifuge, or upon 
addition to membrane preparations of Flp-InTM T-RExTM 293 cells (Section 2.2.5.3; 
10X dilution). These samples were incubated with click reagents for 1 h at RT - 
biotin-PEG-azide (15; 1 mM), TBTA (100 μM), CuSO4 (100 μM) and TCEP (1 mM). 
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Samples were subjected to SDS-PAGE and immunoblotting as described in Section 
2.2.8.  
2.2.10.3.2. The stability of the NK1 receptors during the click reaction 
Membrane preparations of Flp-InTM T-RExTM 293 cells harbouring HA-NK1-6xHis or 
HA-NK1-eGFP (Section 2.2.5.3) or membrane preparations of cells subjected to 
receptor capture with SP-probe-3 (Section 2.2.10.4) were incubated with click 
reagents for 1 h, overnight or for 24 h - biotin-PEG-azide (15; 1 mM), TBTA (0 or 
100 μM) or THPTA (0, 2 or 5 mM), CuSO4 (0-1 mM), and TCEP (0 or 1 mM) or NaAsc 
(0, 1 or 2 mM). Samples were subjected to SDS-PAGE and immunoblotting (Section 
2.2.8), or reactions took place in a sealed black 96-well plate (50 µL/well) and 
the fluorescence of eGFP was quantified over time using a PHERAstar FS plate 
reader (BMG-Labtech) using 470/15 nm and 515/20 nm as the excitation and 
emission wavelengths, respectively.  
2.2.10.4. Receptor capture via UV-activation 
Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP or HA-NK1-6xHis were cultured 
on 6-well plates coated with poly-D-lysine. After induction with Dox (100 ng/mL) 
plates were incubated overnight. The next day the cells were washed twice with 
HBSS (37 °C) before SP-probe-3 (1 µM) or Gly-probe-3 in HBSS (1 mL) 
supplemented with 0.1% BSA was added to the wells. Cells were incubated at 37 °C 
for 10 min before they were placed on ice and exposed to light of 365 nm for 
15 min. Cells were washed twice with ice-cold PBS before membrane preparations 
were made in a final volume of 100 µL PBS per well (Section 2.2.5.3). Often cells 
of three identically treated wells would be combined to create larger volumes.  
2.2.10.5. Biotin click 
Membrane preparations of cells subjected to receptor capture with SP-probe-3 
(Section 2.2.10.4) were incubated with click reagents for 1 h, - biotin-PEG-azide 
(15; 1 mM), THPTA (2 mM), CuSO4 (0.5 mM), and TCEP (0 or 1 mM) or NaAsc (0, 1 
or 2 mM). Samples were subjected to SDS-PAGE and immunoblotting (Section 
2.2.8).  
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2.2.10.6. Click to beads  
Membrane preparations of cell subjected to receptor capture with SP-probe-3 
(Section 2.2.10.4) were diluted to 1 mg/mL and 85 µL was added to 25 µL azide-
Dde-agrose beads (Jena Bioscience) that had been prewashed thrice with PBS 
supplemented with proteasome inhibtors. Next click reagents were added - CuSO4 
(1 mM), TBTA (1.5 mM) and NaAsc (5 mM). Reactions were incubated for 1 h 
before the FT was taken off and the beads were washed thrice with PBS with 
protease inhibitors. Proteins were released from the beads by incubating for 2 h 
at RT with 100 µL Tris buffer (200 mM, pH 8.5) supplemented with 0.05% (w/v) 
SDS. Beads were washed twice more with PBS with protease inhibitors before 100 
µL 1X Laemmli buffer was added and the samples were heated to 65 °C for 10 min. 
Fractions collected were subjected to SDS-PAGE and immunoblotting as described 
in Section 2.2.8.  
2.2.11. Evaluation of probe 4 
2.2.11.1. UV-activation 
The free acid variant of probe 4 (compound 42) was dissolved in MeOH (1 mg/mL) 
as treated as described in Section 2.2.10.1. 
2.2.11.2. Ligand coupling  
SP (1.48 mg/mL) or Gly (1 mg/mL) were dissolved in 25 mM PBS (pH 8.2) A stock 
solution of probe 4 in DMSO (50 mM) was added to a final concentration of 2.5 mM. 
To redissolve any formed precipitate, mixtures were diluted 1:1 with DMSO, 
creating ligand-probe-4 mixtures at a final concentration of 0.5 mM in 52.5% 
DMSO. To keep the amount of probe, probe by-products and DMSO between SP-
probe-4 and Gly-probe-4 equal, in all experiments the volume of Gly-probe-4 used 
was always identical to the volume of SP-probe-4 used. Both mixtures were stored 
at -20ºC and went through numerous freeze-thaw cycles over the span of a year 
without any obvious loss of activity. 
2.2.11.3. Live cell imaging assays 
Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP were grown on poly-D-lysine 
coated coverslips and induced with 100 ng/mL Dox and serum starved overnight. 
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Uninduced cells, grown in a similar fashion, were used as negative control. All 
subsequent steps, apart from the actual imaging, were performed on ice or at 
4 °C and HBSS was used for all washes and dilutions. Cells were washed three 
times, incubated with SP-probe-4 (1 μM) or Gly-probe-4 for 1 h in the dark and 
washed a further three times. The cells were placed on ice and exposed to light 
of 365 nm for 15 min.  For competition experiments, SP (10 μM) was added and 
cells were incubated for 3 h in the dark, followed by three more washes. Cells 
were washed three times and incubated with DyLight™ 594-conjugated 
streptavidin (15 μg/mL; Vectorlabs) for 30 min at RT in the dark. After three final 
washes, cells were imaged.  
A Zeiss 880 laser scanning confocal microscope, (invert configuration), equipped 
with a 63x oil immersion Plan Apochromat objective lens, (numerical aperture = 
1.4), was used to acquire high resolution, 12 bit depth channel images, (image 
size = 512 x 512). Using the single track multiple channel capability of the Zeiss 
Zen Black software, (version 2.3), HA-NK1-eGFP and DyLight™ 594 labelled ligand 
were excited simultaneously at 488 and 561 nm respectively. Well separated 
spectral emission detection windows, (495 – 555 nm for eGFP and 600-700 nm for 
DyLight™ 594), were set up to ensure that the emission signals elicited from each 
fluorophore were recorded without any bleed through or time delay issues. The 
pinhole diameter was set to 1 Airy unit and frame averaging was set to 4 to 
minimise noise and optimise signal collection. Bright field transmission images 
were simultaneously detected along with the fluorescence images using the 
dedicated transmitted light detector.  
Each recorded channel image was exported into Metamorph, (version 7.8.13, 
Molecular Devices), and a green or red look up table was assigned to the eGFP and 
DyLight™ 594 channel images respectively. The total background level of 
autofluorescence, was subtracted (using a black coloured region adjacent to 
fluorescing cell) from every matrix pixel used to form each 512 x 512 channel 
image. 
To quantify the co-localisation between HA-NK1-eGFP and DyLight™ 594, green-
red pixel intensity scatterplots were generated for each image. Pearson 
correlation coefficient values were generated from the generated scatter plots 
that described the degree by which eGFP and DyLight™ 594 fluorescence at each 
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homologous pixel varied from a perfect positive correlation slope value of 1.0. 
This was done for 4 representative images for each experimental group. 
Significant statistical difference, between the experimental groups was 
determined using ANOVA with Tukey’s multiple comparison test.  
2.2.11.4. Receptor capture via UV-activation  
2.2.11.4.1. Protocol 1 - Full lysates in RIPA buffer 
Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP were grown in T75 tissue 
culture flasks and induced with 100 ng/mL Dox, after which they were incubated 
overnight. A T75 flask of cells was harvested with ice-cold HBSS by centrifuging at 
300 x g for 5 min at 4 °C. All subsequent steps were performed on ice or at 4 °C. 
The pellet was resuspended in HBSS (1.5 mL) supplemented with SP-probe-4 (1 
µM) or Gly-probe-4. Cells were incubated for 1 h under constant agitation. Cells 
were then moved to a well in a 6-well plate and exposed to UV-light of 365 nm for 
15 min. Cells were transferred back to a 15 mL falcon, centrifuged for at 3220 x g 
for 5 min, washed twice with PBS and then lysed using 1 mL RIPA buffer (Section 
2.2.5.1). Lysates were either subjected directly to SDS-PAGE and immunoblotting 
(Section 2.2.8), used for the full ligand-based receptor capture (LRC) experiment 
(Section 2.2.11.5.1), or HA-NK1-eGFP was first purified using GFP-trap 
(Chromotek). In the latter case, 750 µL lysate was added to 25 µL GFP-trap that 
had been prewashed with RIPA buffer, this was then incubated for 2 h. The FT was 
then taken off and the beads were washed thrice with 500 µL RIPA buffer before 
100 µL 2X Laemmli buffer was added and the beads were heated for 5 min at 
65 °C.  
2.2.11.4.2. Variations to protocol 1 
Small variations were made to protocol 1 for different experiments. Firstly, in 
certain experiments 10 µM SP-probe-4 was used. Secondly, 1 or 2 washes with 
HBSS were performed before UV-activation. This was done by spinning down the 
cells at 300 x g for 5 min at 4 °C. A third variation was that membranes 
preparations in 200 µL PBS (Section 2.2.5.3) were prepared instead of lysates in 
RIPA. Finally, in one experiment SP-probe-3 was used, membranes were prepared 
and these were incubated with click reagents (0.5 mM CuSO4, 2 mM THPTA, 2 mM 
NaAsc and 100 µM biotin-PEG-azide) for 1 h at RT. These membranes were then 
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spun again at 50,000 x g for 30 min at 4 °C, resuspended in 250 µL PBS 
supplemented with proteasome inhibitors and solubilised as described in Section 
2.2.5.4.  
2.2.11.4.3. Protocol 2 - Membrane preparations in PBS 
Flp-InTM T-RExTM 293 cells harbouring HA-NK1-6xHis were grown in a 10 cm dish 
and induced with 100 ng/mL Dox overnight. If needed for a negative control, 
uninduced cells were grown in a similar fashion. Cells were harvested using 
Versene. All subsequent steps were performed on ice or at 4 °C. Cells were 
resuspended in HBSS (600 µL) supplemented with SP-probe-4 (1 µM) or Gly-probe-
4. Cells were incubated for 1 h in the dark and under constant agitation. Cells 
were spun down at 300 x g for 3 min and washed twice with HBSS, before they 
were then resuspended in HBSS (600 µL), transferred to a 12-well plate and 
exposed to light of 365 nm for 15 min. Cells were transferred back to a 15 mL 
Falcon tube, centrifuged at 3200 x g for 5 min and washed twice with PBS before 
membrane preparations were prepared (Section 2.2.5.3) and solubilised (Section 
2.2.5.4), giving a final volume of 150 µL membrane preparation. These membranes 
were either subjected to SDS-PAGE and immunoblotting (Section 2.2.8) or used 
for the full LRC experiment (Section 2.2.11.5.2).  
2.2.11.5. Full ligand-based receptor capture experiment 
2.2.11.5.1. Protocol 1 - Full lysates in RIPA buffer 
For the first full LRC experiment, receptor capture took place according to 
protocol 1 (Section 2.2.11.4.1) with the exception that 2 washes with HBSS were 
performed before UV-activation took place. Moreover, the experiment was done 
a larger scale: 5 confluent T150 flasks were used per sample, buffer quantities 
were multiplied by 10, and UV-activation was performed in a 10 cm dish. Once 
lysates were made in RIPA buffer these were added to Pierce™ Streptavidin 
Agarose beads (250 µL; Thermo Fisher Scientific). The beads were incubated for 
1 h at 4 °C, before they were washed with RIPA buffer (4 x). Beads were frozen 
at -80 °C until they were analysed by LC-MS/MS (Section 2.2.11.5.3). 
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2.2.11.5.2. Protocol 2 – Membrane preparations 
For the second full LRC experiment, receptor capture took place receptor capture 
took place according to protocol 2 (Section 2.2.11.4.3) with the exception that 5 
confluent T150 flasks were used, buffer quantities were multiplied by 10, and UV-
activation was performed in a 10 cm dish. All subsequent steps were performed 
on ice or at 4 °C and all buffers were supplemented proteasome inhibitors. The 
membranes were added to Pierce™ Streptavidin Agarose beads (250 µL; Thermo 
Fisher Scientific) and the total volume was made up to 3 mL using PBS 
supplemented with 1% (v/v) NP40. The beads were incubated overnight, before 
they were washed with RIPA buffer (4 x), with PBS supplemented with 880 mM 
NaCl (4 x), and with PBS (4 x). Beads were frozen at -80 °C until they were 
analysed by LC-MS/MS (Section 2.2.11.5.3). For each condition three biological 
repeats were performed. 
2.2.11.5.3. LC-MS/MS analysis 
Proteomics was carried out by the University of Leicester Proteomics Facility 
(PNACL, University of Leicester). The streptavidin-conjugated beads were re-
suspended by gentle mixing and transferred to a 30,000 MWCO (Vivacon 500; 
Satorius). Excess liquid was removed by spinning at 14,000 x g for 15 min. The 
beads were then resuspended a total of 2 times in 200 µL of freshly prepared 8 M 
Urea in 0.1 M Tris/HCL pH 8.5 and spun at 14,000 x g for 15 min, discarding the 
flow through solution. Reduction was carried out by addition of 100 µL 5 mM 
dithiothreitol solution for 30 min at 60 °C. After cooling, samples were incubated 
with addition of 100 µL of 50 mM iodoacetamide solution for 30 min at RT in the 
dark. After incubation, solutions were removed by spinning at 14,000 x g for 
15 min. Beads were then resuspended a total of two times in 100 µL of 8 M urea 
in 0.1 M Tris/HCL pH 8.5 and spun at 14,000 x g for 15 min, discarding the flow 
through solution. Beads were then resuspended twice in 100 µL of 50 mM 
triethylammonium bicarbonate and spun at 14,000 x g for 15 min, discarding the 
flow through solution. Just prior to use, lyophilised trypsin was re-suspended in 
Ambic buffer and 5 µg was added to each sample. Digestion took place overnight 
at 37 °C in a humidified chamber. Filter units were transferred to a clean 
collection tube and samples were spun down for 10 min at 14,000 x g. A further 
40 µL of Ambic buffer was added to beads and samples spun again for 10 min at 
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14,000 x g. The samples were concentrated to approximately 20 µL volume in a 
SpeedVac centrifuge and digests were then acidified with formic acid (final 
concentration 0.1%). LC-MS/MS was carried out using an RSLCnano HPLC system 
(Dionex) and an LTQ-Orbitrap-Velos mass spectrometer (Thermo Fisher Scientific). 
Samples were loaded at high flow rate onto a reverse-phase trap column (0.3 mM 
i.d. x 1 mM), containing 5 μm C18 300 Å Acclaim PepMap media (Dionex) 
maintained at a temperature of 37 °C. The loading buffer was 0.1% formic acid / 
0.05% trifluoroacetic acid / 2% acetonitrile. Peptides were eluted from the trap 
column at a flow rate of 0.3 µL/min and through a reverse-phase capillary column 
(75 μm i.d. x 250 mM) containing Symmetry C18 100 Å media (Waters) that was 
manufactured in-house using a high pressure packing device (Proxeon Biosystems). 
The output from the column was sprayed directly into the nanospray ion source of 
the LTQ-Orbitrap-Velos mass spectrometer. The LTQ-Orbitrap-Velos mass 
spectrometer was set to acquire a 1 microscan FTMS scan event at 60,000 
resolution over the m/z range 300-2,000 Da in positive ion mode. The maximum 
injection time for MS was 500 ms and the AGC target setting was 1e6. Accurate 
calibration of the FTMS scan was achieved using a background ion lock mass for 
C6H10O14S3 (401.922718 Da). Subsequently up to 10 data dependent HCD MS/MS 
were triggered from the FTMS scan. The isolation width was 2.0 Da, normalised 
collision energy 42.5. Dynamic exclusion was enabled. The maximum injection 
time for MS/MS was 250 ms and the AGC target setting was 5e4. The .raw data file 
obtained from each LC-MS/MS acquisition was processed using Proteome 
Discoverer (version 1.4; Thermo Fisher Scientific), searching each file in turn using 
Mascot (version 2.2.04, Matrix Science Ltd; Perkins et al., 1999) against the human 
reference proteome downloaded from UniProtKB (Proteome ID: UP000005640; 
UniProt Consortium, 2010). The peptide tolerance was set to 5 ppm and the MS/MS 
tolerance was set to 0.05 Da. Fixed modifications were set as carbamidomethyl 
(C) with variable modification of oxidation (M) and phosphorylation (S), (T) and 
(Y). Trypsin was selected as the enzyme and up to 3 missed cleavages were 
allowed. A decoy database search was performed. The output from Proteome 
Discoverer was further processed using Scaffold Q+S (version 4.0.5, Proteome 
Software; Searle, 2010). Upon import, the data was searched using X!Tandem (The 
Global Proteome Machine Organization; Craig and Beavis, 2004). PeptideProphet 
(Keller et al., 2002) and ProteinProphet (Institute for Systems Biology; Nesvizhskii 
et al., 2003) probability thresholds of 95% were calculated from the decoy 
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searches and Scaffold was used to calculate an improved 95% peptide and protein 
probability threshold on the data from the two different search algorithms. 
Protein identifications were accepted if they contained at least 3 identified 
peptides.  
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3. A clickable, hydrazone forming probe  
3.1. Introduction 
In chemoproteomics the combination of affinity chromatography and mass-
spectrometry (MS) has led to the successful identification of various intracellular 
ligand-receptor interactions (Lenz et al., 2011). Unfortunately, transmembrane 
receptors harbour some unfavourable characteristics which hamper the use of a 
similar approach. Not only are they highly hydrophobic, they also have a high 
number of posttranslational modifications which, upon solubilisation, results in 
aggregation and loss of ligand-binding activity. Moreover, these receptors are 
often of low abundance and their interactions with ligands are regularly transient 
in nature, which makes the maintenance of ligand-receptor interactions 
throughout experiments extremely difficult (Wright, 2009; Helbig et al., 2010; 
Savas et al., 2011; Vuckovic et al., 2013).  
In 2012 Frei et al. described a ligand-based receptor capture (LRC) method, to 
identify transmembrane receptors binding to known ligands using the molecular 
probe Triceps (5; Figure 3-1) (Frei et al., 2012). Not only could this probe be used 
on living cells, leaving receptors in their natural environment, it also bound 
covalently to both the ligand and the receptor, which enabled identification of 
weak and transient interactions. The probe was specific for glycosylated receptors 
as the covalent bond between the probe and the receptor was formed through 
aldehydes present on glycosylated receptors after mild oxidation. Since most cell 
surface receptors are glycosylated, Triceps was presented as a universal probe for 
membrane receptors (Frei et al., 2012).  
Triceps consists of three functional groups, an NHS-ester for ligand binding; a 
trifluoroacetyl protected hydrazine for receptor binding; and a biotin moiety for 
affinity purification (Figure 3-1). Scheme 3-1 depicts the use of Triceps in an LRC 
experiment. In short, following the coupling of Triceps to a ligand of interest, the 
ligand-probe adduct is added to mildly oxidised cells resulting in the formation of 
a hydrazone bond between the probe’s hydrazine and aldehydes present on the 
oxidised, glycosylated membrane receptors. The specific binding of the ligand of 
interest to its receptor will ensure that a significant amount of Triceps molecules 
binds to this receptor. After cell lysis and trypsin digestion, streptavidin beads are 
  Chapter 3. A clickable, hydrazone forming probe 90 
used to pull down the probe and any glycosylated peptides attached to it. These 
peptides are then released from the beads with PNGase F, an enzyme that cleaves 
N-linked glycans from proteins and peptides, after which they are analysed with 
LC-MS/MS. A negative control experiment, using Triceps that has been coupled to 
another ligand or quenched with glycine, is performed in parallel to distinguish 
between unspecific background binding and specific binding to the ligand’s 
receptor (Frei et al., 2012, 2013). 
 
Figure 3-1. Structure of Triceps 
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Scheme 3-1. Ligand-based receptor capture using Triceps. Triceps is first coupled to the ligand 
of interest (top of scheme) or a control ligand (bottom of scheme), after which the adduct is added to 
cells potentially expressing a target receptor, which have been treated with mild oxidative conditions. 
The ligand should then bind to its receptor and the probe will form covalent bonds with oxidised 
membrane proteins. Subsequently, cells are lysed, proteins are digested, and Triceps is isolated 
using biotin-streptavidin affinity purification. After enzymatic release by PNGase F, peptides are 
analysed using mass spectrometry. Comparison between the proteins identified for ligand-treated 
and glycine-treated treated cells should reveal the ligand-binding receptor. This scheme was based 
on Figure 2 in Frei et al. 2012. 
3.1.1. Aim  
Although Triceps has successfully been used to identify transmembrane receptors 
in a non-biased manner via LC-MS/MS, its synthesis is far from trivial. Therefore, 
a similar probe, adapted to improve both synthesis and specificity, was designed 
and synthesised. The known interaction between the orexin receptor 1 (OX1) and 
its peptidic ligand orexin A was employed as test system to investigate individual 
steps in the LRC protocol, including ligand-coupling, interference of the probe on 
the ligand-receptor interaction, and ability of the probe to covalently couple to 
the receptor.  
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3.2. Design of probe 1 
As mentioned above, this project did not start out with the intention of designing 
a new probe; the initial idea was to repeat the synthesis of Triceps. It was soon 
realised, however, that the original synthesis route of Triceps could use some 
optimisation and these considerations, discussed in more detail below, led to the 
design of a new trifunctional probe, probe 1 (Figure 3-2). Two of the three 
functional groups contained in this probe, the NHS-ester for ligand coupling and 
the protected hydrazine for receptor capture, are identical to Triceps. The biotin 
moiety, however, present in Triceps, is replaced with an alkyne group.  
 
Figure 3-2. Structure of probe 1.  
 
The synthesis of Triceps as described by Frei et al. started with the coupling of 
biotin-PEG-amine (7) to a protected lysine (6), resulting in a reaction scheme in 
which all intermediates contained a biotin moiety (Scheme 3-2) (Frei et al., 2012). 
The presence of this biotin group, known to be poorly soluble in organic solvents, 
resulted in the need to use mixtures containing H2O as an eluent for all flash 
chromatography purification steps and eluents used by Frei et al. contained CHCl3, 
DCM, MeOH and H2O (Frei et al., 2012). Unfortunately, these solvents do not 
neatly dissolve in each other and, when similar eluents were created, in our hands 
this resulted in the formation of emulsions, thus hindering separation. 
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Scheme 3-2. Triceps synthesis route. Reagents and conditions: (a) DIPEA, HBTU, DMF, 78%. (b) 
1. TFA, DCM; 2. 2,5-dioxo-pyrrolidin-1-yl 6-(6-((tert-butoxycarbonyl)amino)hexanamido)hexanoate, 
TEA, MeOH, 84%. (c) piperidine, DMF, 67%. (d) Succinic anhydride, DIPEA, DMF, 61%. (e) 1. 6-
aminocaproic acid, DIPEA, HBTU, DMF; 2 TFA, DCM, 61%. (f) 6-(2-(tert-
butoxycarbonyl)hydrazinyl)nicotinic acid, DIPEA, HBTU, DMF, 68%. (g) 1. TFA; 2. TFAA, 90%. (h) 
NHS, EDC, DMF, 62%.  
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In order to overcome these solubility problems of the intermediates, it was 
decided to incorporate the biotin moiety into the probe in a later stage of the 
synthesis. It was realised that biotin, which is needed for affinity purification, did 
not have any function during the ligand nor receptor coupling and it is not unlikely 
that the biotin-group might, due to steric hindrance, have a negative effect on 
these two binding steps. With these arguments in mind a strategy that allowed 
the coupling of biotin to the probe after its binding to both the ligand and the 
receptor was developed. 
In practice, coupling biotin to the probe after this has been bound to both a ligand 
and a receptor meant that this coupling would take place in a biomolecule rich 
environment. To avoid undesired side-reactions it was important that the coupling 
of biotin to the probe was biorthogonal. CuAAC is a well-known and very effective 
bioorthogonal coupling strategy, mostly referred to as a click reaction (Scheme 
3-3) (Meyer et al., 2016). Not only are the azide and alkyne moieties, used to 
make a covalent bond, both absent in native biomolecules, the reaction between 
these two handles is also very selective. Furthermore, this reaction can take place 
over a wide range of temperatures and pH values, and is compatible with various 
solvents, including aqueous buffers (Hein et al., 2008). As discussed in Section 
1.7, using a click reaction to couple biotin to chemoproteomic probes has been 
widely used before when targeting cytosolic receptors, as replacing the biotin 
moiety with an azide or alkyne handle aids cell entry of such probes (Lenz et al., 
2011; Smith and Collins, 2015). 
 
Scheme 3-3. Copper-catalyzed azide-alkyne cycloaddition.  
 
Combining the idea of coupling biotin to the probe using click chemistry with the 
original structure of Triceps led to the design of the alkyne containing probe 1, 
which, once clicked to the literature compound biotin-PEG-azide (15) (Chambers 
et al., 2013), would lead to compound 16, which was very similar to Triceps 
(Scheme 3-4). The click reaction would be performed after cell lysis, to prevent 
toxic effects from the copper on the cells, but before trypsin digestion, to allow 
size dependent separation of the excess of click reagents and the desired 
biotinylated proteins (Scheme 3-5).
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Scheme 3-4. Click reaction between probe 1 and biotin-PEG-azide.  
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Scheme 3-5. Ligand-based receptor capture using probe 1. Probe 1 is first coupled to the ligand of interest (top of scheme) or a control ligand (glycine - bottom of 
scheme), after which the adduct is added to cells potentially expressing a target receptor, which have been treated with mild oxidative conditions. The ligand should then 
bind to its receptor and the probe will form covalent bonds with oxidised membrane proteins. Subsequently, cells are lysed, biotin-PEG-azide is clicked to probe 1 and 
the proteins are digested, and the probe is isolated using biotin-streptavidin affinity purification. After enzymatic release by PNGase F, peptides are analysed using mass 
spectrometry. Comparison between the proteins identified for ligand-treated and glycine-treated cells should reveal the ligand-binding receptor. 
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3.3. Synthesis of probe 1 
3.3.1. Coupling propargylamine 
 
 
Consistent with the synthesis of Triceps, the synthesis of probe 1 started with 
Fmoc-N-ε-Boc-Lysine (6). This protected lysine was coupled to propargylamine in 
a similar way as described before (Hartwig and Hecht, 2010), however, instead of 
using hydroxybenzotriazole (HOBT) as an additive, which has been reclassified by 
the United Nations as a desensitised explosive (Wehrstedt et al., 2005), the less 
explosive and equally efficient Oxyma was used (Subirós-Funosas et al., 2009). 
The structure of Oxyma and the mechanism of this coupling are depicted in 
Scheme 3-6. This coupling worked excellently and gave alkyne 17 with a 95% yield. 
 
Scheme 3-6. Mechanism for amide coupling using Oxyma in an EDC-mediated coupling 
reaction.  
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3.3.2. Coupling di-aminocaproic acid 
 
 
Similar to the synthesis of Triceps, after addition of the affinity tag, or in the case 
of Probe 1, the alkyne handle, the Boc-group was removed using standard 
conditions followed by the coupling of Boc-protected diaminocaproic acid (18 -  
synthesised as described before by Srinivasan & Huang 2007). Compound 19 was 
purified by flash chromatography using 0-5% MeOH in DCM as eluent, and this 
resulted in the reasonable yield of 62%.  
3.3.3. Coupling succinic anhydride  
 
 
Again, in line with the Triceps synthesis, the next step was Fmoc removal and 
coupling of succinic anhydride. Compound 20 was also purified using MeOH and 
DCM, this time in the presence of 1% AcOH to keep the carboxylic acid moiety 
protonated, and gave a 94% yield.  
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3.3.4. Coupling aminocaproic acid  
 
 
The next step was the coupling of aminocaproic acid. Unfortunately, after this 
coupling, purification of the intermediates became more problematic. Whereas 
the carboxylic acid 21 ran well on TLC, with a retention factor (RF) of 0.35 
(DCM/MeOH/AcOH, 9:1:0.1), it did not behave the same once brought onto a silica 
column. The product stuck to the column and it could only be recovered upon 
flushing the column with pure MeOH, leading to the presence of several impurities. 
Therefore, it was decided to perform a quick work up on the product by triturating 
it with EtOAc, before it was carried forward to the next reaction without any 
further purification. 
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3.3.5. Coupling hydrazine containing moiety  
 
 
The synthesis proceeded with Boc-deprotection of compound 21 followed by 
coupling of Boc-protected 6-hydrazinonicotinic acid (22 - synthesised as described 
before by Abrams et al. 1990). The product of this reaction, 23, again ran fairly 
well on TLC, with an RF of 0.19 (DCM/MeOH/AcOH, 9:1:0.1), but could not be 
recovered from a silica column without using pure MeOH. Therefore, the product 
was again triturated with EtOAc and carried forward to the next reaction without 
any further purification. 
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3.3.6. Trifluoroacetyl protection hydrazine (I) 
 
 
To replace the Boc-protecting group on the hydrazine moiety with a 
trifluoroacetyl-protecting group, Frei et al described a two-step process in which 
the compound was first deprotected using TFA, after which TFAA was used to 
protect it again (Frei et al., 2012). The same two steps were performed on 23 and 
the reaction was monitored with LC-MS, which revealed complete conversion to 
24. In our hands, however, following this procedure, it was impossible to obtain 
24 in a pure form, as both purification over a Sephadex LH-20 column, as 
described by Frei et al, and purification over a silica column resulted in hydrolysis 
of 24, yielding the free hydrazine. 
A solution to this problem was found in a paper by Surfraz et al. (2007). Surfraz 
and coworkers were incorporating Boc-protected 6-hydrazinonicotinyl moieties 
into peptides using solid phase peptide synthesis but realised that cleavage of 
these peptides from the resin using TFA resulted in the, for them undesired, 
formation of trifluoroacetyl protected hydrazines. A similar approach was then 
attempted, and stirring 23 in TFA overnight did indeed result in its complete 
conversion to compound 24. Moreover, all side-products from this reaction were 
volatile and there was no need to further purify the product after concentration 
under vacuum.  
While this new method of creating the trifluoroactyl-protected hydrazine did 
eliminate the problem of deprotection during the work up, compound 24 remained 
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very unstable. Therefore, it was impossible to synthesise and purify the final 
product, probe 1, without deprotection of the hydrazine group. To get around this 
problem it was decided to incorporate the NHS-ester into the molecule before 
deprotecting the Boc-hydrazine. 
3.3.7. NHS-esterification 
 
 
Instead of deprotecting compound 23 it was now activated with an NHS-ester in 
the presence of EDC. Initially, it was tried to purify the product from this reaction, 
25, using flash chromatography, however, the MeOH needed to get the product 
off the column led to transesterification of the NHS-ester yielding an Me-ester. 
Instead, 25 was purified using preparative HPLC, resulting in a white powder with 
an overall yield of 15% over 4 steps (starting from compound 20). 
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3.3.8. Trifluoroacetyl protection hydrazine (II) 
 
 
The final step in this synthesis was then the replacement of the Boc-group with 
the trifluoroacetyl-group, which was done as discussed above by stirring 25 in TFA 
overnight followed by concentration under vacuum, yielding probe 1 with 
quantitative yield. Whereas this work up did prevent deprotection of the 
hydrazine moiety, LC-MS analysis revealed that the final product was a mixture of 
the desired probe 1, (Figure 3-3, peak C; 85%), NHS-hydrolysed probe 24, (Figure 
3-3, peak A; 8%) and a compound with a mass of -56 m/z units compared to the 
probe (Figure 3-3, peak B; 7%). The mass of this latter compound corresponded to 
the mass of compound 26 (Figure 3-4), a molecule that would be formed if probe 
1 reacted with acetone.  
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Figure 3-3. Purity of probe 1. Probe 1 was analysed by HPLC and LC-MS using a C18 column with 
a 5-95% gradient of MeCN in H2O over 60 min. The UV-trace of the HPLC analysis is depicted and 
reveals the presence of three compounds: the desired probe 1 (peak C; 85%), NHS-hydrolysed 
probe 24 (peak A; 8%) and a molecule with a mass corresponding to the acetone adduct of the probe 
(26; peak B; 7%). 
 
Figure 3-4. Structure of possible acetone adduct of probe 1. 
 
3.3.9. Discussion 
The omission of the biotin moiety from this molecule did simplify the purification 
of intermediates 17, 19, and 20 when compared to their counterparts 8, 9 and 
10 in the Triceps synthesis, as no mixtures of water and organic solvents had to 
be used as eluents for flash chromatography. Nevertheless, purification of 
intermediates 21, 23 and 24 remained troublesome and a revised synthesis route 
had to be developed. In this route compounds 21 and 23 were only purified with 
trituration, after which compound 23 was activated with an NHS-ester, yielding 
compound 25 which was purified using preparative HPLC. To circumvent any 
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further purification steps, Boc-deprotection and TFA-protection of the hydrazine 
moiety in 25 were performed in a single step by stirring 25 in TFA overnight.  
That this deprotection and protection step could be performed as one was quite 
surprising, as Boc-deprotection of amines and hydrazines using TFA is standard 
procedure and does normally not result in the formation of an amide bond between 
the Boc-protected starting material and TFA. Although no mechanism or explanation 
for this surprising reaction was given by Surfraz et al. this group did demonstrate that 
the Boc-protecting group was removed prior to the coupling of the trifluoroactelyl 
group (Surfraz et al., 2007). It is not unlikely that the pyridin nitrogen, present in the 
6-hydrazinonicotinyl group, is somehow involved in the mechanism, however, 
additional experiments will have to be performed to investigate this further.  
Although it was possible to synthesise probe 1, the molecule was very unstable 
and could, therefore, only be purified to 85%. Next to the hydrolysis product 24, 
traces of a possible acetone adduct 26 were found, indicating the reactivity of 
this molecule. How exactly the probe would have come into contact with acetone 
was uncertain, however, as acetone was used to clean the glassware it could not 
be ruled out that it had. No attempt was made to separate probe 1 from these by-
products as they were not expected to interfere with the functioning of probe 1 
in LRC experiments. Whereas compound 26 would still be able to couple to a 
ligand, it would not be able to capture any receptors as the hydrazine moiety had 
already reacted. In contrast, the hydrolysis product 24 would not be able to couple 
any ligands, but would still be able to couple to receptors and would, therefore, 
contribute to the non-specific background-labelling, present in all samples. 
Moreover, to couple probe 1 to a ligand it had to be dissolved in an aqueous buffer 
of pH 8.2 and hydrolysis to 24 would be inevitable under these conditions (Lim et 
al., 2014; Klykov and Weller, 2015).   
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3.4. The orexigenic system  
To test the ability of probe 1 to be used in LRC experiments, a known ligand-
receptor pair was used, the OX1 receptor and a fragment of its endogenous ligand, 
orexin A. Orexin A and the OX1 receptor, together with orexin B and the orexin 
receptor 2 (OX2) form the orexinergic system, which, among other roles, is 
involved in feeding and wakefulness (de Lecea et al., 1998; Sakurai et al., 1998; 
Boss and Roch, 2015). Orexin A is a 33 amino acid peptide that, similar to orexin 
B, is produced in the lateral hypothalamus from prepro-orexin via a series of 
enzymatic reactions (Darker et al., 2001). The orexin receptors are both rhodopsin 
like GPCRs, with the OX1 receptor signalling mainly through Gαq coupling and the 
OX2 receptor through Gαq and Gαi/o coupling (Boss and Roch, 2015). Orexin A 
activates both orexin receptors with similar potency, whereas orexin B is ten times 
more potent towards OX2 (Karhu et al., 2015).  
3.4.1. Expression of orexin 1 
Previously in our lab, a construct for a tagged variant of the human OX1 receptor, 
VSV-OX1-eYFP, had been generated and stably transfected into Flp-InTM T-RExTM 
293 cells, allowing inducible expression upon addition of the antibiotic 
doxycycline (Dox) (Ellis et al., 2006). The fusion of the receptor with enhanced 
yellow fluorescent protein (eYFP) not only allowed for visualisation of receptor 
expression, it also simplified analysis of the OX1 receptor through western blotting 
as eYFP binds robustly to an in-house produced antiserum. Moreover, both eYFP 
and the VSV-tag, an 11-amino acid protein sequence (YTDIEMNRLGK) derived from 
vesicular stomatitis virus (VSV) glycoprotein (Kreis, 1986), could be used as affinity 
tags for purification of the receptor. Both immunoblotting and fluorescence 
measurements confirmed that the expression of VSV-OX1-eYFP was indeed 
induced by Dox and that it was concentration-dependent (Figure 3-5a-b). It was 
also confirmed that the receptor was predominantly located at the plasma 
membrane (Figure 3-5c). To ensure maximum expression for all future 
experiments cells were induced with 100 ng/mL Dox.  
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Figure 3-5. Doxycycline dependent expression of VSV-OX1-eYFP. Flp-InTM T-RExTM 293 cells 
expressed VSV-OX1-eYFP at the plasma membrane once induced with Dox. a. Expression of VSV-
OX1-eYFP following overnight treatment with various concentrations of Dox was visualised by 
immunoblotting with an anti-GFP antiserum after cell membrane preparations were resolved with 
SDS-PAGE. b. Expression of VSV-OX1-eYFP following overnight treatment of cells with various 
concentrations of Dox and treatment with Hoechst nuclear stain (10 μg/mL, 30 min) was quantified 
on a microplate reader by measuring fluorescence of eYFP and the Hoechst stained nuclei. Data are 
means + SEM from an experiment performed in triplicate. c. Cells were treated with Dox (100 ng/mL) 
overnight and imaged under a fluorescent microscope.  
3.4.2. Orexin A synthesis  
It has been shown that an N-terminal truncation of the orexin A peptide (orexin A 
16-33) remains an efficient agonist for OX1 (Xu et al., 2012). Not only was this 
truncated peptide easier to synthesise than full-length orexin A, due to the 
absence of two intramolecular cysteine bonds; it also lacked any lysine residues, 
leaving the N-terminus to be the only coupling site for probe 1. It was, therefore, 
decided to synthesise this truncated version of orexin A (27), from now on 
designated OXA, and use it as the test ligand for the evaluation of probe 1. As well 
as OXA, a second version of the peptide, Ac-OXA (28), in which an N-terminal 
acetyl (Ac) cap was incorporated, resulting in a peptide without free amines, was 
synthesised (Figure 3-6).  
  
  Chapter 3. A clickable, hydrazone forming probe 108 
 
Figure 3-6. Structures of OXA (27) and Ac-OXA (28). 
 
3.4.3. VSV-OX1-eYFP activation by OXA 
To determine whether the OX1 fusion receptors could indeed be activated by the 
synthesised OXA peptide, [Ca2+]i assays were conducted. Cells induced to express 
the VSV-OX1-eYFP receptor responded to OXA and with pEC50 of 6.16 ± 0.08, 
confirming the activation of the fusion receptor by this peptide (Figure 3-7). 
Surprisingly, uninduced cells also responded to the peptide, although with both 
lower potency (pEC50 = 4.87 ± 0.15) and efficiency (Figure 3-7). 
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Figure 3-7. Activation of VSV-OX1-eYFP by OXA. The ability of various concentrations of OXA to 
provoke changes in [Ca2+]i was tested in both Dox induced and uninduced Flp-InTM T-RExTM 293 
cells harbouring VSV-OX1-eYFP. Data are means +/- SEM pooled from n = 3 independent 
experiments performed in triplicate or quadruplicate. 
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To assess whether activation in the uninduced cells was caused by OX1, both 
induced and uninduced cells were exposed to OXA in the presence of SB408124, 
an OX1 specific inhibitor (Langmead et al., 2004). Addition of this antagonist 
reduced the activation of the induced cells to the same level as the uninduced 
cells, while it did not have a major effect on the activation of the uninduced cells 
(Figure 3-8). 
-12 -10 -8 -6 -4
0
20
40
60
80
100
120
- SB408124
- SB408124
+ SB408124
+ SB408124
+ Dox
- Dox
Log [OXA]
%
 M
a
x
im
u
m
 r
e
s
p
o
n
s
e
 
Figure 3-8. Activation of VSV-OX1-eYFP by OXA in the presence of SB408124. The ability of 
various concentrations of OXA to provoke changes in [Ca2+]i in both Dox induced and uninduced Flp-
InTM T-RExTM 293 harbouring VSV-OX1-eYFP was tested in the presence of 10 µM SB408124. Data 
are means +/- SEM pooled from n = 2 independent experiments performed in triplicate or 
quadruplicate.  
3.4.4. Discussion  
Cells that expressed VSV-OX1-eYFP upon induction with Dox were successfully 
generated and could be activated by the synthesised OXA peptide. Unexpectedly, 
uninduced cells were also activated by the OXA peptide, although with a lower 
potency and efficiency. No expression of the VSV-OX1-eYFP fusion receptor was 
observed either by western blotting (Figure 3-5), nor by fluorescent microscopy 
(data not shown), suggesting that this activation was caused by an endogenously 
expressed receptor. Indeed, the activation of the uninduced cells could not be 
abolished by the OX1 specific antagonist SB408124, confirming this idea. It was 
then realised that HEK293 cells produce mRNA coding for the OX2 receptor 
(Atwood et al., 2011). As mentioned, orexin A is also an agonist for OX2, whereas 
SB408124 is a 70 times more potent antagonist towards OX1 than OX2 (Langmead 
et al., 2004). Therefore, endogenously expressed OX2 receptor was very likely to 
be responsible for the activation by OXA.  
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Although the presence of some OX2 receptor in this cell line might result in the 
identification of both the OX1 and OX2 receptors when performing a full LRC 
experiment using OXA as a test ligand, this was not expected to hamper the 
validity of the test system. Therefore, it was decided to proceed with the 
oxergenic system to test probe 1.  
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3.5. Evaluation of probe 1 
The oxergenic test system was used to investigate individual steps of the LRC 
protocol, including ligand-coupling, interference of the probe on the ligand-
receptor interaction, and ability of the probe to covalently couple to the receptor. 
Furthermore, the click reaction between probe 1 and biotin-PEG-azide was 
optimised. 
3.5.1. Ligand coupling 
The first step in a full LRC experiment is the coupling of the probe to a ligand of 
interest, therefore, it was attempted to couple probe 1 to OXA. Following the 
procedure described by Frei et al. probe 1 was added to a solution of OXA in HEPES 
(pH 8.2) and incubated for 1 h at room temperature. To evaluate the coupling, 
the mixture was analysed by LC-MS (Figure 3-9). Two important observations were 
made. Firstly, although OXA contained only one free amine moiety, three distinct 
addition products were observed. The LC-MS spectrum revealed two peaks with 
masses corresponding to the addition of a single probe molecule to the OXA 
peptide (Figure 3-9, peaks C and D) and one peak with a mass suggesting the 
coupling of two equivalents of probe (Figure 3-9, peak E). Secondly, apart from 
these adducts, a significant amount of free peptide was also still present in these 
mixtures (Figure 3-9, peak B). 
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Figure 3-9. Coupling of probe 1 to OXA. OXA was incubated with probe 1 for 1 h at RT in 25 mM 
HEPES (pH 8.2). The mixture was then analysed by LC-MS using a C18 column with a 5-95% 
gradient of MeCN in H2O over 40 min. The UV-trace is depicted. There were 5 main compounds 
present: The NHS-hydrolysed probe 24 (peak A), free OXA (peak B), two compounds with a mass 
corresponding to OXA attached to one molecule of probe (peaks C and D) and one compound with 
a mass corresponding to OXA coupled to 2 molecules of probe 1 (peak E).  
To further investigate the first observation, an attempt was made to couple probe 
1 to Ac-OXA, a peptide without free amines. Although probe 1 was designed to 
specifically couple to free amines, LC-MS analysis revealed that addition of probe 
1 to Ac-OXA did result in the formation of an adduct (Figure 3-10, peak C). This 
demonstrated that probe 1 was not only able to couple to free amines, but also 
to a chemical moiety present in Ac-OXA.  
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Figure 3-10. Coupling of probe 1 to Ac-OXA. Ac-OXA was incubated with probe 1 for 1 h at RT in 
25 mM Hepes (pH 8.2). The mixture was then analysed by LC-MS using a C18 column with a 5-95% 
gradient of MeCN in H2O over 40 min. The UV-trace is depicted. There were 3 main compounds 
present: The NHS-hydrolysed probe 24 (peak A), free OXA (peak B) and a compound with a mass 
corresponding to OXA attached to one molecule of probe 1 (peak C)  
It has been reported before that NHS-esters can undergo undesired side reactions 
with serine (Ser), threonine (Thr) and tyrosine (Tyr) residues (Kalkhof and Sinz, 
2008). Moreover, it has been shown that that NHS-esters are more prone to couple 
to such hydroxyl groups when a histidine (His) residue is in close proximity (Mädler 
et al., 2009). Since these OXA peptides have a His residue at position 21 and a Tyr 
residue at position 17, it was assumed that probe 1 coupled to this latter amino 
acid, giving adducts 29, 30 and 31 as coupling products for OXA and 32 for Ac-
OXA (Figure 3-11). 
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Figure 3-11. Structures of adducts formed between probe 1 and OXA (29,30,31) or Ac-OXA 
(32).  
    
 
Chapter 3. A clickable, hydrazone forming probe 115 
As well as these coupling adducts, the addition of probe 1 to OXA also left a 
significant amount of this peptide uncoupled (Figure 3-9, peak B). This result was 
not unexpected as it is well-known that the coupling reaction of NHS-esters to 
free amines competes with hydrolysis of the NHS-ester (Lim et al., 2014; Klykov 
and Weller, 2015). Indeed, NHS-hydrolysed probe 24 was also formed during the 
coupling reactions (Figure 3-9, peak A). The amount of probe (0.6 mM) and ligand 
(1 mg/mL) used in these coupling experiments was based on the protocol 
described by Frei et al. and corresponded to 1.1 equivalents of probe per peptide 
molecule. Clearly, this small excess was not enough to couple all of the OXA 
peptide to probe 1. Therefore, for some experiments described in this chapter, 
five times more probe 1 (3 mM, 5.5 eq) was added to OXA, as it was hoped that 
this would result in less free peptide. Unfortunately, due to insufficient amounts 
of probe 1, no LC-MS analysis of this mixture could be performed. When 
experiments were performed using OXA that had been coupled to 3mM probe 1, 
this will be clearly stated.  
The coupling of probe 1 to OXA thus led to a mixture of NHS-hydrolysed probe 24, 
free peptide 27, and the adducts 29, 30 and 31. In this thesis, the term OXA-
probe-1 will be used to denote this mixture. 
3.5.2. Interference with ligand-receptor interaction 
To test whether coupling of probe 1 to the OXA peptide interfered with its binding 
to the VSV-OX1-eYFP receptor, [Ca2+]i assays were conducted. These showed there 
was no significant reduction in the potency of OXA-probe-1 compared to the free 
OXA peptide (Figure 3-12). It was thus concluded that OXA-probe-1 still bound to 
VSV-OX1-eYFP. 
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Figure 3-12. Activation of VSV-OX1-eYFP by OXA and OXA-probe 1. The ability of various 
concentrations of OXA and OXA-probe-1 to provoke changes in [Ca2+]i. was tested in Flp-InTM T-
RExTM 293 cells induced to express VSV-OX1-eYFP. Data are means +/- SEM pooled from n = 3 
independent experiments performed in triplicate or quadruplicate. 
3.5.3. Biotin coupling 
To test and optimise the click reaction, probe 1 was coupled to a ligand and 
subsequently it was tried to click Biotin-PEG-azide to it using various reaction 
conditions. To minimise the amount of probe used during these test reactions, 
rather than analysing the results via LC-MS, successful coupling of biotin was 
visualised via immunoblotting with streptavidin. Since the OXA peptide is only 1.9 
kDa, its analysis by western blot would be almost impossible, therefore, a larger 
ligand, albumin, was used. After coupling of probe 1 to albumin several ‘click 
mixtures’, containing biotin-PEG-azide, CuSO4, TBTA and variable concentrations 
of either TCEP or sodium ascorbate (NaAsc), were tested. It was revealed that, of 
the click mixtures tested, the one containing 1 mM TCEP resulted in the best 
coupling (Figure 3-13a). To prove that biotin-PEG-azide was actually clicked to 
probe 1 and not randomly binding to albumin, the amount of probe 1 added to 
albumin was varied. As expected, as more probe 1 was added more biotin was 
detected on the blot (Figure 3-13b).  
    
 
Chapter 3. A clickable, hydrazone forming probe 117 
 
Figure 3-13. Biotin click on albumin-probe-1. Albumin-probe-1 was treated with various click 
conditions after which covalently coupled biotin was visualised via immunoblotting with streptavidin. 
a. Albumin (1 mg/mL), and probe 1 (0.6 mM) were incubated for 1 h at RT after which biotin-PEG-
azide (1 mM), TBTA (100 μM), CuSO4 (100 μM) and TCEP/NaAsc (variable) were added and the 
mixture was incubated for 1 h at RT. b. Albumin (1 mg/mL) and probe 1 (variable) were incubated 
for 1 h at RT after which biotin-PEG-azide (1 mM), TBTA (100 μM), CuSO4 (100 μM) and TCEP 
(1mM) were added and the mixture was incubated for 1 h at RT.  
3.5.4. Receptor coupling 
Immunoblotting was performed to investigate whether probe 1 could indeed form 
a covalent bond with the VSV-OX1-eYFP receptor. In short, cells expressing VSV-
OX1-eYFP were mildly oxidised and exposed to OXA-probe-1, after which the cells 
were lysed and the click reaction with biotin-PEG-azide was performed on the 
lysates. Agarose beads conjugated to an anti-VSV antibody were then used to 
purify VSV-OX1-eYFP. The total lysate (TL), pulled-down proteins (PD) and the 
flow through (FT) of these beads were resolved with SDS-PAGE, transferred to a 
membrane and probed for eYFP and biotin. If probe 1 did indeed form a covalent 
bond with the VSV-OX1-eYFP receptor, the blots should show an overlapping signal 
for both biotin and eYFP.  
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As expected, probe 1 did not specifically couple to one receptor. High background 
labelling of the probe was observed in both samples treated with OXA-probe-1 
(Figure 3-14, lanes 1-TL and 2-TL), as indicated by the smears on the blots present 
when probed with streptavidin. Nevertheless, it could be observed that a protein 
with the mobility of ~80 KDa, the same mobility as VSV-OX1-eYFP, was indeed 
binding to streptavidin (Figure 3-14, lane 1-TL). Unfortunately, when VSV-OX1-
eYFP was pulled down, no streptavidin-binding could be observed (Figure 3-14, 
lanes 1-PD and 2-PD). Although none of the pulled down VSV-OX1-eYFP receptor 
appeared to be coupled to probe 1, a small fraction of receptor was still present 
in the flow-through (Figure 3-14, lanes 1-FT and 2-FT). It was realised that this 
fraction of the receptor might have coupled to OXA-probe-1, but that this coupling 
might interfere with the binding of VSV-OX1-eYFP to anti-VSV.  
Since the VSV-tag was fused to the N-terminus of OX1 and eYFP to the C-terminus, 
it appeared unlikely that OXA-probe-1 would interfered with the pull-down 
through both tags. Therefore, the experiment was repeated, however, instead of 
a VSV pull-down, a GFP-trap (agarose beads conjugated to the GFP-binding 
domains of alpaca antibodies) was used to purify the receptor via eYFP. 
Unexpectedly, the GFP-trap, which could successfully be used for pull-down of 
the receptor in absence of probe 1 (Figure 3-15, lane PD), hardly captured any 
receptor once cells were treated with OXA-probe-1 (Figure 3-16, lanes 1-PD and 
2-PD). This total lack of binding to the GFP-trap was unlikely to be explained by 
the coupling of OXA-probe-1, as the VSV pull-down had revealed that a large 
fraction of the receptor had not coupled to the probe.  
As it was unclear why the GFP-trap could not pull down any receptor, a final 
attempt was made to pull down the receptor by using streptavidin conjugated 
agarose beads. It was soon realised, however, that, due to the extremely strong 
coupling between biotin and streptavidin (Kd = 10−15 M), the biotinylated proteins 
could not be eluted from the beads and could thus not be analysed using western 
blotting (Rybak et al., 2004; Fukuyama et al., 2012; Chang et al., 2016). 
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Figure 3-14. Western blotting analysis of OXA-probe-1 capture of VSV-OX1-eYFP after VSV pull-down. Dox induced Flp-InTM T-RExTM 293 cells harbouring VSV-
OX1-eYFP were mildly oxidised and treated with OXA-probe 1 (either created with 0.6 mM probe 1, or 3 mM probe 1). Following cells lysis, VSV-OX1-eYGP was purified 
using agarose beads conjugated to an anti-VSV antibody. A fraction of the total lysate before purification (TL), the pulled down proteins (PD) and the flow-through (FT) 
were resolved by SDS-PAGE. and immunoblotted with an anti-GFP antiserum (left panel), or streptavidin (centre panel). Merging of these two images and pseudo-colour 
labelling should identify the receptor-probe complex as yellow (right panel). The blue box marks the mobility of VSV-OX1-eYFP. 
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Figure 3-15. Western blotting analysis of VSV-OX1-eYFP after eYFP pull-down. Dox induced Flp-InTM T-RExTM 293 cells harbouring VSV-OX1-eYFP were lysed and 
VSV-OX1-eYGP was purified using a GFP-trap. A fraction of the total lysate before purification (TL), the pulled down proteins (PD) and the flow-through (FT) were 
resolved by SDS-PAGE. These were immunoblotted with an anti-GFP antiserum. The blue box marks the mobility of VSV-OX1-eYFP. 
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Figure 3-16. Western blotting analysis of OXA-probe-1 capture of VSV-OX1-eYFP after eYFP pull-down. Dox induced Flp-InTM T-RExTM 293 cells harbouring VSV-
OX1-eYFP were mildly oxidised and treated with OXA-probe 1 (either created with 0.6 mM probe 1, or 3 mM probe 1). Following cells lysis, VSV-OX1-eYGP was purified 
using a GFP-trap. A fraction of the total lysate before purification (TL), the pulled down proteins (PD) and the flow-through (FT) were resolved by SDS-PAGE. These 
were immunoblotted with an anti-GFP antiserum (left panel), or streptavidin (centre panel). Merging of these two images and pseudo-colour labelling should identify the 
receptor-probe complex as yellow (right panel). The blue box marks the mobility of VSV-OX1-eYFP. 
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3.5.5. Discussion  
Probe 1 was successfully coupled to the OXA peptide, although, as discussed 
above, it coupled in two places and did leave a significant amount of free peptide. 
To reduce the amount of free peptide present after coupling of probe 1 some 
experiments were performed with 5.5 equivalents of probe 1, instead of 1.1 
equivalents. No LC-MS analysis was performed on these mixtures, making it hard 
to conclude that this did indeed result in a higher amount of coupling and thus a 
reduction of free peptide. Nevertheless, it was shown that when larger quantities 
of probe 1 were added to albumin this did result in more efficient coupling of 
biotin-PEG-azide through the click reaction. This would suggest that the addition 
of more probe did indeed result in more probe being coupling to a ligand.  
That the interaction of OXA with VSV-OX1-eYFP was not hindered by the coupling 
of probe 1 was clear from the [Ca2+]i assays. Nevertheless, although much time 
was invested in trying to pull down any VSV-OX1-eYFP coupled to OXA-probe-1, it 
remained unclear whether probe 1 could also form a covalent bond with the VSV-
OX1-eYFP receptor. As mentioned, no biotin could be detected on the pulled-down 
receptor. There were three possible explanations for this observation.  
Firstly, the click reaction between probe 1 and biotin-PEG-azide might not have 
worked, which would mean that even if OXA-probe-1 coupled covalently to VSV-
OX1-eYFP, this could not be detected using streptavidin. It has to be noted, 
however, that the click reaction was successful on alumbin-probe-1. Moreover, 
full lysates treated with probe 1 and clicked to biotin-PEG-azide showed an 
increase in biotinylated proteins when more probe 1 was used (Figure 3-14 lanes 
1 vs 2; Figure 3-16, lanes 1 vs 2), suggesting that the click reaction between probe 
1 and biotin was successful.  
A second explanation for the absence of any biotin in the pull-down fractions was 
that coupling of OXA-probe-1 to VSV-OX1-eYFP rendered the receptor impossible 
to be captured via the pull down-experiments. The results obtained for the VSV-
pull down support this theory. The small fraction of VSV-OX1-eYFP that was not 
pulled down with the anti-VSV antibody would then represent the fraction of the 
receptor that had coupled to probe 1. As pull-down experiments with a GFP-trap 
were not successful, however, it was hard to verify this hypothesis. Although this 
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was not realised at this point in time, the reason that the eYFP pull-down was 
unsuccessful might be because the reagents of the click reaction rendered eYFP 
unable to bind to the GFP-trap. The effect of the click reagents on the enhanced 
green fluorescent protein (eGFP), which is probably very similar to the effect on 
eYFP, will be discussed in Section 4.6.3.2.  
The third and final explanation for the absence of any biotin on the pulled-down 
VSV-OX1-eYFP was that no covalent bond had formed between probe 1 and the 
receptor. To form a covalent bond the hydrazine moiety of probe 1 has to be in 
close proximity to an aldehyde present on the receptor of interest after mild 
oxidation. Although, as mentioned by Frei et al, it is true that most 
transmembrane receptors are glycosylated, not all of them have the same number 
of glycosylated residues. The OX1 receptor has only one putative N-glycosylation 
site, Asn 194 (The UniProt Consortium, 2017). Whether this residue was close 
enough to the OXA-binding site to enable covalent capture of the receptor by OXA-
probe-1 upon binding of this adduct to VSV-OX1-eYFP was unknown, as the exact 
binding mode of both full-length and truncated orexin A peptides remains a topic 
of debate (Tran et al., 2011; Karhu et al., 2015; Yin et al., 2016). Therefore, it 
might be impossible for OXA-probe 1 to capture VSV-OX1-eYFP once the ligand is 
bound to the receptor.  
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3.6. Conclusion  
Probe 1, a variant of Triceps in which the biotin moiety was replaced with an 
alkyne moiety was designed and successfully synthesised in 10 steps with an 
overall yield of 5.7%, an average of 75% per step. Whereas probe 1 was unstable 
and the final product was not fully purified, the by-products were not expected 
to interfere with the functioning of probe 1 in LRC experiments. Probe 1 was then 
tested in the individual steps of the LRC protocol using VSV-OX1-eYFP and OXA as 
a test system. Probe 1 was successfully coupled to the peptidic ligand OXA. 
Unexpectedly, however, the probe did not only couple to this peptide’s free amine 
but also to another moiety, suggested to be the hydroxyl group of its Tyr residue. 
It was then demonstrated that OXA-probe-1 activated VSV-OX1-eYFP with the 
same potency as the free peptide indicating that the probe-adduct did bind to the 
receptor. Using a mixture of CuSO4, TBTA and TCEP, biotin-PEG-azide could 
effectively be coupled to probe 1. Finally, it was attempted to show that a 
covalent bond could be formed between probe 1 and VSV-OX1-eYFP, however, the 
existence of such a bond was never proven. It was realised that probe 1 was not 
as universal with respect to receptor coupling as was initially envisioned, since N-
glycosylation on the receptor had to be present in close proximity to the ligand-
binding site. Therefore, it was decided to stop investing time in this particular 
molecular probe and instead search for a better method to covalently capture 
receptors.  
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4. Two clickable photoaffinity probes  
4.1. Introduction  
Following the unsatisfactory results obtained with probe 1, mentioned in Chapter 
3, it was decided to move away from receptor coupling through hydrazone 
formation via a hydrazine-aldehyde coupling. This linkage might be hard to 
establish for many receptors as it relies on the proximity of N-linked sugar tails to 
the ligand-binding pocket. Therefore, another method to couple the probe to 
receptors was sought. As has been discussed in Section 1.7.5, a well-known 
method to create covalent bonds between biomolecules is via photoreactive 
moieties. Photoreactive moieties form the basis of AfBPs, which have successfully 
been used to identify various intracellular receptors starting from ligands of 
interest (Lenz et al., 2011).  
4.1.1. Photoreactive groups 
Once activated by a specific wavelength, photoreactive moieties form covalent 
bonds with molecules in close proximity, a process that is also referred to as 
photoaffinity labelling. There are three main photoreactive groups that are 
regularly used: benzophenones, aryl azides and diazirines. 
4.1.1.1. Benzophenones 
Benzophenones are popular photoreactive groups and various building blocks 
bearing this moiety, including amino acids, are commercially available. This 
moiety is fairly stable in most solvents and its activation wavelength, 350-360 nm, 
is compatible with living cells. Irradiation results in the formation of an active 
diradical that can either react with a nearby C-H bond via a sequential abstraction 
and recombination mechanism, or can deactivate to reform the original 
benzophenone moiety that can then be activated again. Drawbacks of the 
benzophenone moiety are its bulkiness and long irradiation times, which might 
lead to non-specific labelling (Sumranjit and Chung, 2013; Dormán et al., 2016).  
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Scheme 4-1. Activation of benzophenone. 
 
4.1.1.2. Aryl azides 
Aryl azides are smaller molecules that are relatively easily synthesised. They have 
high stability in the dark while they need only short irradiation times to become 
activated. Unfortunately, the maximum activation wavelength is 300 nm, which 
means that irradiation can cause severe damage to biological systems. Irradiation 
results in the formation of a nitrene which can either insert into nearby C-H bonds 
or heteroatom-H bonds, or it can undergo undesired side reactions to form bicyclic 
benzazirine and 1,2-azacycloheptatetraene. These by-products can both react 
with nucleophiles which leads to non-specific labelling and decreased photo-
labelling yields (Sumranjit and Chung, 2013; Murale et al., 2016).  
 
Scheme 4-2. Activation of aryl azide. 
 
4.1.1.3. Diazirines 
The final class of photoreactive moieties is the diazirines. As the aryl azides, these 
are smaller molecules, however, their synthesis is often long and more 
complicated. Irradiation happens at 350-380 nm, making probes bearing these 
moieties suitable for use on living cells. Irradiation results in the formation of a 
highly reactive carbene which can be inserted into nearby C–H or heteroatom-H 
bonds. Due to intramolecular rearrangements, diazo compounds can be formed, 
which, via nucleophilic attack, might lead to unspecific labelling (Sumranjit and 
Chung, 2013; Hill and Robertson, 2018). The newest and nowadays most used 
diazirines, 3-aryl-3-(trifluoromethyl)diazirines, significantly reduce this unspecific 
labelling, as their diazo derivatives are less reactive (Dubinsky et al., 2012; 
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Hatanaka, 2015). Moreover, these 3-aryl-3-(trifluoromethyl)diazirines are more 
stable than other compounds in this class.  
 
Scheme 4-3. Activation of diazirine.  
 
 
Scheme 4-4. Activation of 3-aryl-3-(trifluoromethyl)diazirine.  
 
4.1.2. Aim 
Combining the idea to develop a universal probe for various ligands with the idea 
of incorporating a photoreactive group for receptor capture led to the design and 
synthesis of two new clickable photoaffinity probes. To test the ability of these 
probes to be used in LRC experiments, the known interaction between the 
neurokinin 1 (NK1) receptor and its peptidic ligand substance P (SP) was employed.  
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4.2. Design of probes 2 and 3 
As both ligand binding and the click reaction were effective for probe 1, it was 
decided that the NHS-ester, for ligand coupling, and the alkyne moiety, for the 
click reaction to biotin, would be incorporated into the new probe. For the 
photoreactive group, the choice was made to test two distinct groups with 
different crosslinking mechanisms: the benzophenone and the 3-aryl-3-
(trifluoromethyl)diazirine moieties. The first was chosen as it could be obtained 
commercially, the second was chosen for its superior features (Section 4.1.1.3). 
The molecular frame keeping these three groups together was simplified 
compared to probe 1. Whereas probe 1 was designed to closely resemble Triceps, 
for the new probes a smaller and synthetically more accessible framework was 
chosen. These considerations led to the design of probe 2 and probe 3 (Figure 
4-1).  
 
Figure 4-1. Structures of probes 2 and 3.  
 
With these new probes, the LRC protocol had to be adapted slightly. Scheme 4-5 
depicts the newly proposed LRC protocol including some potential variations. Most 
importantly, after the cells are incubated with the ligand-probe adduct they have 
to be exposed to UV-light to activate the photoreactive group. This two-step 
coupling to the receptor creates the option to include a wash step prior to UV-
activation of the probe, which might minimise non-specific coupling of the 
photoreactive group to other membrane proteins.  
Moreover, since, in contrast to Triceps and probe 1, probes 2 and 3 do not bind 
to receptors through oxidised sugar moieties, proteins captured on streptavidin 
beads cannot be released using PNGase F. Because the biotin-streptavidin 
interaction is extremely strong (Kd = 10−15 M), eluting biotin from streptavidin 
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beads remains a challenge (Rybak et al., 2004; Fukuyama et al., 2012; Chang et 
al., 2016). An alternative to eluting the biotinylated proteins from the streptavidin 
beads is to trypsin digest these proteins while they are still attached the beads. 
This approach, when followed by MS, has before led to higher numbers of target 
proteins being identified than digestion of eluted proteins (Fukuyama et al., 2012; 
Tremblay and Hill, 2017), and it was, therefore, decided to incorporate it into the 
LRC protocol for probes 2 and 3.  
Having decided to perform an ‘on-bead’ trypsin digest, it was realised that instead 
of clicking the probe to biotin, the probe could also be clicked directly to azide-
coupled agarose beads (Punna et al., 2005). This method would improve various 
steps in the protocol. Firstly, it would shorten the protocol since the biotin-
coupling step could be omitted. Secondly, it would simplify the removal of copper 
after the click reaction as these beads could easily be washed. Finally, on-bead 
digestion on streptavidin conjugated beads would result in the presence of 
streptavidin peptides in the MS sample (Fukuyama et al., 2012), while the use of 
azide-beads would remove this problem.  
Both options, clicking the probes to biotin and clicking them directly to beads, 
were explored and will be discussed in this chapter. The wash step before UV-
activation was omitted in initial experiments, as it was first intended to show that 
the probes could indeed couple to the receptor of interest and so background 
coupling was considered to be a potential concern to be addressed later. 
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Scheme 4-5. Possible ligand-based receptor capture protocols using probes 2 and 3. The probe is first coupled to the ligand of interest (top of scheme) and a 
control ligand (glycine – bottom of scheme), after which the adduct is added to cells. After an appropriate incubation during which the ligand binds the receptor, cells can 
be washed to rinse away unbound probe. Next, cells are exposed to UV-light to activate the photoreactive moiety which captures the receptor. Cells are lysed and the 
probe is either clicked to biotin, followed by streptavidin purification, or the probe is clicked directly to agarose beads. Captured proteins are digested on the beads with 
trypsin and released peptides are analysed using mass spectrometry. Comparison between the proteins identified for ligand-treated and glycine-treated cells should 
reveal the ligand-binding receptor 
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4.3. Synthesis of probes 2 and 3  
4.3.1. Coupling propargylamine 
 
 
Similarly to probe 1, the synthesis of both probes 2 and 3 started with the coupling 
of propargylamine to Fmoc-N-ε-Boc-L-lysine (6) (Hartwig and Hecht, 2010), which, 
as mentioned before (Section 3.3.1), proceeded without any complications and 
resulted in a 95% yield of alkyne 17. 
4.3.2. Coupling photoreactive group 
 
 
After Fmoc-deprotection, the acid derivative of benzophenone (commercially 
available) or 3-aryl-3-(trifluoromethyl)diazirine (synthesised by Dominik Herkt 
according to the procedure described by Geurink et al. 2010) was attached via a 
standard amide-coupling. For both photoreactive groups this reaction worked 
excellently, with quantitative and 91% yield, for 32 and 33, respectively.  
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4.3.3. Coupling succinic anhydride  
 
 
After Boc-deprotection, succinic anhydride was used to incorporate a carboxylic 
acid that could then be used to create the NHS-ester. Compounds 34 and 35 were 
purified with moderate to good yields of 51% and 75%, respectively.   
4.3.4. NHS-esterification 
 
 
The final step in the synthesis of these probes was the coupling of the NHS-ester. 
As for probe 1, the purification of the final NHS-coupled probes was not trivial, 
since these NHS-esters were very reactive. For probe 2, small quantities of final 
product were synthesised and purified using flash chromatography, during test 
reactions. Due to problems with the UV-activation of the benzophenone moiety in 
compound 34 (Section 4.4), it was decided not to optimise the NHS-coupling for 
probe 2 and to focus on probe 3 instead. For probe 3, a first attempt to purify the 
final product was made using flash chromatography, however, the MeOH needed 
to elute the product reacted with the NHS-ester and the Me-ester was formed. It 
was, therefore, decided to triturate the final compound with water and dry the 
resulting white powder on a lyophiliser. Whereas this trituration did prevent the 
Me-ester formation, LC-MS analysis revealed that the final product was still a 
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mixture of the desired probe 3 (Figure 4-2, peak B; 74%), hydrolysed probe 35 
(Figure 4-2, peak A; 19%), as well as a probe product 36 which had undergone 
intramolecular cyclic imide formation (Figure 4-2, peak C; 7%; Figure 4-3). 
 
Figure 4-2. Purity of probe 3. Probe 3 was analysed by LC-MS using a C18 column with a 5-95% 
gradient of MeCN in H2O over 40 min. The UV-trace of the analysis is depicted. This revealed the 
presence of three compounds: the desired probe 3 (peak B; 74%), hydrolysed probe 35 (peak A; 
19%) and cyclised probe 36 (peak C; 7%). 
 
Figure 4-3. Structure of the intramolecular cyclic imide by-product of probe 3. 
 
4.3.5. Discussion  
Probe 3 was at least 74% pure, however, it has to be noted that the actual purity 
of probe 3 might be higher since the probe underwent hydrolysis once dissolved 
in 1:1 buffer A and buffer B, as was done for LC-MS analysis (see Appendix 5). 
Although the probe was not pure, no attempt was made to separate probe 3 from 
its by-products since, for its final application, the probe was to be dissolved in an 
aqueous buffer of pH 8.2 and hydrolysis and cyclisation to 35 and 36, respectively, 
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were inevitable under these conditions (Lim et al., 2014; Klykov and Weller, 
2015). Moreover, these probe variants were not expected to interfere with the 
functioning of probe 3 in LRC experiments, as they would either be washed away 
before UV-activation or, when no washing was performed, contribute to the non-
specific background-labelling present in all samples.  
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4.4. UV-activation of probes 2 and 3  
Before proceeding to biological assays, the UV-activation of the probes was 
tested. As mentioned above, due to the presence of the NHS-ester, probes 2 and 
3 were not stable compounds. Moreover, as can be seen in Figure 4-2, the LC-MS 
trace of probe 3 consisted of multiple peaks. Therefore, to test UV-activation, the 
free acids 34 and 35 were used. These compounds were dissolved in MeOH and 
either exposed to UV-light of 365 nm for 15 minutes, or kept in the dark. The 
resulting mixtures were then analysed by LC-MS and analytical HPLC. UV exposure 
of compound 34 did not result in any activation of the benzophenone group, as no 
differences were observed between the two samples (Figure 4-4a-b). Longer UV-
exposure (30 or 60 min) did not improve this result (data not shown). For 
compound 35, however, a 15-minutes exposure to 365 nm was sufficient for 
complete activation of the diazirine group, resulting in insertion of compound 35 
Figure 4-4c, peak C) into H2O (37; Figure 4-4d, peak D; Figure 4-5) or MeOH (38; 
Figure 4-4d, peak E; Figure 4-5).  
 
Figure 4-4. UV-activation of probes 2 and 3. The free acid derivatives of probes 2 and 3 
(compounds 34 and 35) were dissolved in MeOH and either kept in the dark (a, c) or exposed to UV-
light of 365 nm for 15 min (b, d). Samples were then analysed by LC-MS and analytical HPLC using 
a C18 column with a 5-95% gradient of MeCN in H2O over 40 min. The UV-traces of the analytical 
HPLC runs are depicted. Upon activation with UV, the free acid derivative of probe 2 (34; peaks A 
and B) did not react, whereas the free acid derivative of probe 3 (35; peak C) formed adducts with 
H2O (37; peak D) and MeOH (38; peak E). 
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Figure 4-5. Structures of the insertion products of compound 35 into H2O (37) and MeOH (38). 
 
4.4.1. Discussion  
That probe 2 did not insert into MeOH was surprising, as identical conditions have 
been used by others to successfully activate benzophenone moieties (Suva et al., 
1997; Li et al., 2012). Benzophenone activation occurs through the formation of a 
diradical that can either react with a nearby CH-group or relax back to its original 
state (Tanaka et al., 2008). Whereas it could not be ruled out that probe 2 did 
active and relax without inserting into MeOH. As the probe was dissolved in, and 
thus surrounded by, the solvent it seemed unlikely that activation of the probe 
would not result in insertion. Due to this lack of activation is was decided to stop 
working with probe 2 and instead focus solely on probe 3. 
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4.5. The tachykinin system 
As was the case for probe 1, to test the ability of probe 3 to be used in LRC 
experiments, a known ligand-receptor pair was used. Since coupling of probe 1 to 
OXA led to mixtures of unidentified coupling products (Section 3.4.5), it was 
decided to move away from the orexin system and instead use a new system: the 
neurokinin 1 (NK1) receptor and its agonist ligand substance P (SP). The 
unadecapeptide SP is a tachykinin and, like other tachykinin peptides, binds to 
the three neurokinin receptors (NK1, NK2 and NK3). All three receptors can bind 
SP and the other two major mammalian tachykinins, neurokinin A (NKA) and 
neurokinin B (NKB), however, SP is most potent towards NK1, NKA towards NK2, 
and NKB towards NK3 (Regoli et al., 1994; Pennefather et al., 2004). NK1 and SP 
are associated with various processes, including mitogenesis, wound healing, 
emesis, and  neuronal transmission related to pain, depression, stress and anxiety 
(Garcia-Recio and Gascón, 2015).The NK receptors are rhodopsin-like GPCRs and 
predominantly signal through Gαq-coupling, although they have also been reported 
to couple to Gαs (Nakajima et al., 1992; Satake and Kawada, 2006) 
4.5.1. Expression of neurokinin 1 
A cDNA fragment corresponding to HA-NK1-eGFP was generated using subcloning 
(Section 2.2.3.11). eGFP was included for three reasons: it allowed for 
visualisation of expression; it could be used in immunoblotting; and it could be 
used for affinity purification. Moreover, a nonapeptide, corresponding to amino 
acids 98-106 (YPYDVPDYA) of the human influenza hemagglutinin sequence, more 
commonly known as an HA-tag, was included as a second option for 
immunoblotting and affinity purification (Green et al., 1982; Wilson et al., 1984; 
Field et al., 1988). The Flp-InTM T-RExTM system was then used to create a cell line 
with the ability to inducibly express HA-NK1-eGFP upon addition of the antibiotic 
Dox (Ward et al., 2011). Both immunoblotting and fluorescence measurements 
confirmed that the expression of HA-NK1-eGFP was induced by Dox and was 
concentration-dependent (Figure 4-6a-b). It was also confirmed that the receptor 
was predominantly located at the plasma membrane (Figure 4-6c). To ensure 
maximum expression for all future experiments cells were induced with 100 ng/mL 
Dox.  
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Figure 4-6. Doxycycline dependent expression of HA-NK1-eGFP. Flp-InTM T-RExTM 293 cells 
expressed HA-NK1-eGFP at the plasma membrane once induced with Dox. a. Expression of HA-
NK1-eGFP following overnight treatment with various concentration of Dox was visualised by 
immunoblotting with an anti-GFP antiserum after cell lysates were resolved with SDS-PAGE and 
transferred to blotting membrane. As a loading control, tubulin was also visualised using anti-tubulin. 
b. Expression of HA-NK1-eGFP following overnight treatment of cells with various concentrations of 
Dox and treatment with Hoechst nuclear stain (10 μg/mL, 30 min) was quantified with a microplate 
reader by measuring fluorescence of eGFP and the Hoechst stained nuclei. Data are means + SEM 
from an experiment performed in triplicate. c. Cells were treated with Dox (100 ng/mL) overnight and 
images using a confocal microscope. 
Whilst analysing the expression of the HA-NK1-eGFP receptor, it was realised that 
Flp-InTM T-RExTM 293 cells endogenously expressed some proteins that bound to 
streptavidin. Three distinct streptavidin-binding bands were present in lysates of 
Flp-InTM T-RExTM 293 cells, two at ~80 kDa and one at ~125 kDa (Figure 4-7). 
Unfortunately, the two bands at ~80 kDa had approximately the same mobility as 
the HA-NK1-eGFP fusion receptor. The presence of these proteins was very 
inconvenient, as these cells were designed to explore the binding of probe 3 to 
HA-NK1-eGFP through immunoblotting with streptavidin, which should bind to the 
biotin that is clicked to the probe. A streptavidin-binding protein of roughly the 
same size as HA-NK1-eGFP would make it harder to interpret these future blots.  
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Figure 4-7. Streptavidin binding bands overlapping with HA-NK1-eGFP Cell lysates of Dox 
induced and uninduced Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP were resolved on 
SDS-PAGE, transferred to a blotting membrane and probed with an anti-GFP antiserum and 
streptavidin. Three distinct streptavidin-binding bands were observed, two of them overlapping with 
the HA-NK1-eGFP signal. The blue box marks the position of HA-NK1-eGFP. 
To overcome the problem of overlapping streptavidin signals on western blots, a 
smaller fusion protein, with a 6xHis-tag instead of eGFP (HA-NK1-6xHis), was 
expressed in Flp-InTM T-RExTM 293 cells. The 6xHis-tag is a polyhistidine 
hexapeptide, invented by Roche, that through its nickel-chelating properties, is 
often used for affinity purification (Hochuli et al., 1988). Immunoblotting 
confirmed that the expression of HA-NK1-6xHis was Dox induced and 
concentration-dependent (Figure 4-8a). Furthermore, it was shown that no 
streptavidin-binding protein was present with the same mobility as the tagged 
receptor (Figure 4-8b).  
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Figure 4-8. Expression of HA-NK1-6xHis. Flp-InTM T-RExTM 293 cells expressed HA-NK-6xHis 
once induced with Dox. a. Expression of HA-NK1-6xHis following overnight treatment with various 
concentrations of Dox was visualised by immunoblotting with an anti-6xHis antiserum after cell 
lysates were resolved with SDS-PAGE and transferred to a blotting membrane. As a loading control, 
tubulin was also visualised using anti-tubulin. b. Lysates of induced and cells harbouring HA-NK1-
6xHis were resolved on SDS-PAGE, transferred to a blotting membrane and probed with an anti-
6xHis antiserum and streptavidin. This showed that HA-NK1-6xHis did not run at the same mobility 
as any endogenously expressed streptavidin-binding proteins.  
4.5.2. Substance P synthesis  
A slightly modified version of SP, Ac-Nle-SP (39), was synthesised using solid phase 
peptide synthesis (Figure 4-9). The N-terminal Ac-cap was incorporated to leave 
only one free amine available for probe-binding. Moreover, the C-terminal 
methionine residue was replaced with a norleucine (Nle) residue, an isosteric 
amino acid residue that lacks the sulphur atom and is, therefore, less prone to 
oxidation (Thomson et al., 1994). This replacement was reported to not have a 
major effect on the SP-NK1 interaction (Fournier et al., 1982). In this thesis Ac-
Nle-SP will be denoted as SP.  
 
Figure 4-9. Structure of Ac-Nle-SP. 
 
4.5.3. HA-NK1-eGFP activation by SP 
To determine whether the NK1 fusion receptors could indeed be activated by the 
synthesised SP peptide, inositol monophosphate (IP1) accumulation assays were 
    
 
Chapter 4. Two clickable photoaffinity probes 141 
conducted. Cells expressing the HA-NK1-eGFP receptor or the HA-NK1-6xHis 
receptor responded to SP with pEC50’s of 7.60 ± 0.06 and 7.67 ± 0.05, respectively 
(Figure 4-10). Uninduced cells had only a minor response to SP, indicating that the 
peptide was successfully activating the receptors.  
 
Figure 4-10. Activation of HA-NK1-eGFP and HA-NK1-6xHis by SP. IP1 accumulation was 
assessed via homogeneous time resolved fluorescence in both Dox induced and uninduced Flp-InTM 
T-RExTM 293 cells harbouring the HA-NK1-eGFP (a) or HA-NK1-6xHis (b) construct upon activation 
with various concentrations of SP. Data are means +/- SEM pooled from n = 6 independent 
experiments performed in triplicate  
4.5.4. Discussion 
Cells that expressed HA-NK1-eGFP upon induction with Dox were successfully 
generated. Immunoblotting, however, did reveal that these cells endogenously 
expressed three proteins, two of ~80 kDa and one of ~125 kDa, that bound to 
streptavidin. Others have seen similar seized streptavidin-binding bands before, 
although in different organisms (Kim et al., 2010; Tytgat et al., 2015). These 
bands might indicate the presence of biotinylated carboxylases, as biotin is an 
important cofactor of carboxylase enzymes, which are found in most organisms 
(Tong, 2013; Tytgat et al., 2015).  
To allow easier interpretation of future western blots a second cell line, 
expressing HA-NK1-6xHis was generated. Initially all experiments preformed to 
evaluate probe 3 were done on HA-NK1-6xHis expressing cells, however, many 
immunoblots using this cell line showed inexplicable results. After lengthy 
investigations it was discovered that the 6xHis antibody used was not only binding 
to His-tagged proteins, but also to keratin (Lee and McNellis, 2008). Since keratin 
had the same mobility on the SDS-page gel as HA-NK1-6xHis it was almost 
impossible to tell when blots showed the receptor or when they showed a keratin 
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contamination. The problem was most pronounced when the samples had been 
purified on agarose beads, as addition of Laemmli buffer to agarose beads resulted 
in the presence of more keratin on the western blot than addition to of Laemmli 
buffer to H2O or RIPA buffer (Appendix 6). It was, therefore, decided to return to 
the HA-NK1-eGFP cell line. Experiments shown and discussed in the rest of this 
chapter were conducted with the eGFP variant of the receptor unless it is clearly 
stated otherwise. 
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4.6. Evaluation of probe 3  
Before advancing to a full LRC experiment, the interaction between NK1 and SP 
was used to investigate individual steps in the LRC protocol, including ligand-
coupling, interference of the probe on the ligand-receptor interaction and ability 
of the probe to covalently couple to the receptor. Furthermore, the click reaction 
between probe 3 and biotin was optimised, and the option of clicking probe 3 to 
azide-conjugated agarose beads was also explored.  
4.6.1. Ligand coupling 
The first step in an LRC experiment is the coupling of the probe to a ligand of 
interest. To evaluate the coupling of probe 3 to SP, 5 equivalents of the probe 
were added to a solution of SP (1 mM) in PBS (pH 8.2). After an hour of incubation 
at room temperature, the mixture was diluted with DMSO (1:1) to redissolve the 
precipitated peptide adduct, before it was analysed by LC-MS (Figure 4-11b). After 
addition of probe 3, no free SP peptide (Figure 4-11a, peak A) was present, 
indicating that all the peptide had successfully coupled to the probe. Apart from 
the desired SP-probe-3 adduct 40 (Figure 4-11b, peak C; Figure 4-12), the 
previously mentioned hydrolysed probe 35 (Figure 4-11b, peak B) and the 
intramolecularly cyclised probe 36 (Figure 4-11b, peak D) were present in the final 
reaction mixture. Probe 3 was also coupled to glycine (Gly) in a similar fashion to 
give the Gly-probe-3 adduct 41 (Figure 4-12) in a mixture with 35 and 36; this 
was done on smaller scale and no analytics were performed afterwards.  
In this thesis, the term SP-probe-3 will be used to denote the mixture of 35, 36, 
and 40, while Gly-probe-3 will denote the mixture of 35, 36, and 41. 
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Figure 4-11. Coupling of probe 3 to SP. SP was incubated with probe 3 for 1 h at RT in PBS (pH 
8.2), the mixture was then diluted with DMSO (1:1, v/v). Free SP (a) and the mixture resulting of 
coupling to probe 3 (b) were analysed with LC-MS using a C18 column with a 5-95% gradient of 
MeCN in H2O over 40 min. The UV-traces are depicted. There were three main compounds present 
in the mixture: the desired SP-probe adduct 40 (Peak C), the hydrolysed probe 35 (Peak B) and the 
intramolecularly cyclised probe 36 (Peak D). There was no free SP (Peak A) left in the mixture.  
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Figure 4-12. Structures of adducts formed between probe 3 and SP (40) or Gly (41).  
 
4.6.2. Interference with ligand-receptor interaction 
SP-probe-3 was tested for its capability to activate HA-NK1-eGFP and HA-NK1-
6xHis using IP1 accumulation assays (Figure 4-13). With a pEC50’s of 6.81 ±0.04 and 
7.01 ±0.06, the potencies of the probe-bound peptide were 5-6-times lower than 
that of the free peptide. Despite these lower potencies, the peptide-probe adduct 
was still able to activate, and thus bind, the receptors. Gly-probe-3 was also 
tested and, as expected, was unable to activate either receptor. 
 
Figure 4-13. Activation of HA-NK1-eGFP and HA-NK1-6xHis by SP-probe-3. IP1 accumulation 
was assessed via homogeneous time resolved fluorescence in both induced and uninduced Flp-InTM 
T-RExTM 293 cells harbouring the HA-NK1-eGFP (a) or HA-NK1-6xHis (b) construct upon activation 
with various concentrations of SP-probe-3. Data are means +/- SEM pooled from n = 3 or more 
independent experiments performed in triplicate. 
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4.6.3. Biotin coupling 
In the first instance, it was thought that no optimisation was needed for the click 
reaction to attach the biotin moiety to probe 3 and that click reagents could be 
kept similar to those used on probe 1. Some preliminary experiments, however, 
showed that no addition of biotin had taken place to any of cell lysates treated 
with SP-probe-3, indicating that optimisation was required after all.  
4.6.3.1. Buffers 
A possible explanation for the absence of any click reaction was the change in lysis 
buffer. To keep in line with the Triceps protocol, when using probe 1, cells were 
lysed with 0.1% Rapigest in Ambic (Frei et al., 2012). For probe 3, however, cells 
were lysed using our lab’s usual, and much cheaper, lysis buffer, 
Radioimmunoprecipitation assay (RIPA) buffer. Whereas successful click reactions 
in RIPA buffer have been reported (Fu et al., 2014), it is also known that the lysis 
buffer might have a negative effect on click efficiency (Yang et al., 2013).  
To test this hypothesis, probe 3 was coupled to albumin and it was attempted to 
click this adduct to biotin both in PBS and in RIPA buffer. Immunoblotting the 
resulting reaction mixture with streptavidin revealed that the click reaction with 
biotin was successful in PBS, but not in RIPA buffer (Figure 4-14, lanes 1 vs 2). 
Therefore, it was decided to lyse the cells with a tissue grinder in PBS and make 
membrane preparations through high speed centrifugation (Cisar and Cravatt, 
2012). To ensure that the click reaction was indeed working under these 
conditions, the adduct of albumin and probe 3 was added to membrane 
preparations of Flp-InTM T-RExTM 293 cells in PBS and the click reaction was 
performed on the mixture. The reaction mixture was then analysed by 
immunoblotting with streptavidin which revealed that the click reaction with 
biotin was indeed successful (Figure 4-14, lane 3). 
    
 
Chapter 4. Two clickable photoaffinity probes 147 
 
Figure 4-14. buffer dependency of the click reaction efficiency. Albumin and probe 3 were 
incubated for 1 h at RT in PBS (pH 8.2), the mixture was then diluted with DMSO (1:1, v/v). Click mix 
(10X) was either added directly (lane 1) or after buffer exchange to RIPA buffer (lane 2) or after 
dilution of the albumin-probe 3 mixture in membrane preparations of Flp-InTM T-RExTM 293 cells 
(1:99) (lane 3). The final concentration of the click components was: 100 μM biotin-PEG-azide, 
100 μM TBTA, 1 mM CuSO4 and 1 mM TCEP. Click reactions were incubated for 1 h at RT. Proteins 
were resolved with SDS-PAGE and biotin was visualised via immunoblotting with streptavidin. This 
showed that the albumin-probe 3 adduct could be clicked to biotin in PBS but not in RIPA buffer. The 
blue box marks the mobility of albumin. 
4.6.3.2. Receptor stability  
At this stage of the project, experiments were mostly performed on the HA-NK1-
6xHis receptor variant. During initial experiments, it was realised that HA-NK1-
6xHis was not stable in presence of the click reagents used. Incubation of HA-NK1-
6xHis containing membrane preparations with click reagents resulted in the 
complete loss of anti-6xHis binding to the receptor on western blot (Figure 4-15). 
Whereas this could indicate that the receptor was fully degraded in the presence 
of click reagents, a more plausible explanation was that Cu+ catalysed the 
formation of reactive oxygen species (ROS), which modified the histidine residues 
in the 6xHis-tag, making its impossible for the anti-6xHis antibody to recognise it 
(S. Li et al., 2016). 
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Figure 4-15. Stability of HA-NK1-6xHis during click reaction. Membrane preparations of Flp-InTM 
T-RExTM 293 cells expressing HA-NK1-6xHis were incubated with click reagents (100 μM TBTA, 
1 mM CuSO4 and 1 mM TCEP) at RT for 1 h or overnight. Proteins were resolved with SDS-PAGE 
and HA-NK1-6xHis was visualised via immunoblotting with an anti-6xHis antiserum. The blue box 
marks the mobility of HA-NK1-6xHis.  
Since, after this experiment, it was decided to stop working with the HA-NK1-
6xHis receptor, no optimisation of the click reaction for this receptor was 
performed. Nevertheless, it was recognised that ROS might also negatively affect 
the eGFP tag of the HA-NK1-eGFP receptor (Löschberger et al., 2014). Therefore, 
western blots and fluorescence measurements were used to analyse the stability 
of HA-NK1-eGFP in the presence of the click reagents.  
Membrane preparations containing HA-NK1-eGFP were incubated with different 
variants of click reagents. Immunoblotting these samples with anti-GFP showed 
that there was no clear band visible for HA-NK1-eGFP in the presence of 0.5 mM 
or 1 mM CuSO4 (Figure 4-16a). In contrast to HA-NK1-6xHis, the eGFP-tagged 
receptor did not seem to lose its ability to bind the antibody used for detection, 
instead the receptor seemed to aggregate and got stuck at the top of the gel. It 
should be noted that the presence of copper in SDS-page samples can lead to the 
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aggregation of membrane proteins once they are dissolved in Laemmli buffer, thus 
the receptor might still have been intact during the click reaction (Mackinnon and 
Taunton, 2009). 
Fluorescence measurements over time on the same samples showed that high 
CuSO4 concentrations in combination with TCEP and TBTA abolished fluorescence 
of the eGFP-tag (Figure 4-16b). Whether ROS were responsible for this loss of 
fluorescence was unclear. Absence of the reducing agent TCEP, resulted in 
protection of fluorescence and this could be explained by the lack of Cu+, and thus 
ROS, formed. However, absence of TBTA had the same effect which was 
unexpected, since TBTA is a ligand that should stabilise Cu+ and thus reduce the 
amount of ROS formed (Chan et al., 2004). Another possibility was that, instead 
of ROS, Cu+ itself was responsible for the loss of fluorescence, which would explain 
why both TBTA and TCEP were needed to abolish fluorescence. Again, it should 
be noted that the absence of fluorescence did not necessarily mean that the full 
receptor had aggregated or degraded during the click reaction, as only specific 
amino acids required for the fluorescence might be affected. 
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Figure 4-16. Stability of HA-NK1-eGFP during the click reaction (I). Membrane preparations of 
Flp-InTM T-RExTM 293 cells expressing HA-NK1-eGFP were incubated with click reagents (100 μM 
TBTA, 1 mM TCEP and variable concentrations of CuSO4) at RT overnight. a. Proteins were resolved 
with SDS-PAGE and HA-NK1-eGFP was visualised by immunoblotting with an anti-GFP antiserum. 
The blue box marks the mobility of HA-NK1-eGFP. b. Fluorescence of eGFP samples was monitored 
during the reaction with a microplate reader. High concentrations of copper in the presence of TBTA 
and TCEP led to aggregation of HA-NK1-eGFP on a SDS-page gel and abolished fluoresce of the 
eGFP-tag  
To optimise the stability of the receptor, a literature search on other click 
reagents and conditions was carried out. A large body of literature has been 
generated about click reactions and their optimisation. However, there is no 
standardised mixture of click reagents; it appears that what works in one example 
does not work in another. Nevertheless, there were two key facts which stood 
out. Firstly, whereas TCEP is often used in click chemistry, it is known to reduce 
azides and it was, therefore, suggested that NaAsc should be used instead 
(Presolski et al., 2011). Secondly, when working in aqueous solutions, it was 
recommended to use water-soluble Cu+-stabilizing ligands, like THPTA, since these 
can be used at higher concentrations than hydrophobic ligands, thereby reducing 
the formation of ROS (Hong et al., 2009; Presolski et al., 2011). 
Keeping these considerations in mind two new combinations of click reagents were 
tested (Uttamapinant et al., 2012; Joiner et al., 2017). Since the above mentioned 
experiments only considered the stability of the receptor and not the actual 
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success of the click reaction, these new conditions were tested in a different way. 
The experiment used will be discussed in more detail in Section 4.6.4.1. In short, 
cells expressing HA-NK1-eGFP were incubated with SP-probe-3, UV-light was 
shone on them to covalently bind the probe to membrane proteins and the cells 
were subsequently lysed to obtain membrane preparations in PBS. These 
membrane preparations were then treated with click reagents and biotin-PEG-
azide, and analysed by immunoblotting with streptavidin and anti-GFP.  
Using a combination of NaAsc and THPTA clearly improved the stability of the 
receptor, since at both 0.5 mM and 1 mM of CuSO4 no aggregation of the receptor 
was observed (Figure 4-17). Moreover, a clear difference in the amount of 
streptavidin binding to the blot could be observed between the two combinations 
of click reagents (Figure 4-17, lanes 2 vs 3), indicating that conditions A (0.5 mM 
CuSO4, 2 mM THPTA, 2 mM NaAsc) resulted in more biotin-clicked to SP-probe-3.  
4.6.3.3. Final click conditions 
For further experiments, cells treated with SP-probe-3 were lysed with a tissue 
grinder in PBS and membrane proteins were separated through high speed 
centrifugation. Click reactions were carried out using 0.5 mM CuSO4, 2 mM THPTA 
and 2 mM NaAsc. Some data discussed later in this chapter were obtained before 
the optimisation of the click conditions was finalised, consequently when different 
click reagents were used this will be indicated. 
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Figure 4-17. Stability of HA-NK1-eGFP during the click reaction (II). Flp-InTM T-RExTM 293 cells expressing HA-NK1-eGFP were incubated with SP-probe-3 and 
exposed to UV-light. Membrane preparations in PBS were obtained and incubated with click reagents and biotin-PEG-azide (100 μM) for 1 h at RT. Proteins were 
resolved with SDS-PAGE and immunoblotted with an anti-GFP antiserum (left panel), or streptavidin (centre panel). The images were labelled with pseudo-colour and 
merged (right panel). The blue box marks the mobility of HA-NK1-eGFP. 
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4.6.4. Receptor coupling 
Before moving to the full LRC experiments an investigation was carried out as to 
whether SP-probe-3 could indeed form a covalent bond with the HA-NK1-eGFP 
receptor. This was done in two independent ways. Firstly, as for probe 1, cell 
lysates treated with SP-probe-3 were clicked to biotin-PEG-azide and analysed 
using western blotting. Secondly, cell lysates treated with the ligand-probe adduct 
were clicked to (cleavable) azide-beads in an attempt to show that the receptor 
was indeed attached to the beads.  
4.6.4.1. Biotin click  
In the first experiment, the formation of a covalent bond between SP-probe-3 and 
HA-NK1-eGFP was assessed through a click reaction with biotin-PEG-azide, 
followed by western blotting analysis. In short, cells expressing HA-NK1-eGFP were 
grown and incubated with SP-probe-3. The cells were placed under UV-light for 
15 minutes, washed, scraped off the plates, and membrane preparations were 
made in PBS. The click reaction with biotin-PEG-azide was performed on these 
membranes before they were resolved with SDS-PAGE. The proteins were 
transferred to a membrane and probed for eGFP and biotin. If probe 3 did indeed 
form a covalent bond with the HA-NK1-eGFP receptor, the blots should show an 
overlapping signal for both biotin and eGFP. In contrast to the experiments 
performed on probe 1, blots were run with total lysates; no prior purification step 
for HA-NK1-eGFP was carried out.  
For the first experiments, only Dox induced cells were used. Although it was hard 
to see due the presence of the endogenously expressed streptavidin-binding 
proteins of ~80 kDa mass in the cells used, in the sample treated with both probe 
and click reagents, a protein of the same mobility as HA-NK1-eGFP (~90 kDa mass) 
was indeed binding to streptavidin (Figure 4-18, lane 5), whereas this protein was 
not present in any of the other control samples (Figure 4-18, lanes 1-4). The non-
appearance of this band in the absence of probe or click reagents suggested that 
this protein was indeed covalently attached to probe 3 and subsequently clicked 
to biotin.  
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To confirm that this probe-coupled protein was indeed the HA-NK1-eGFP receptor, 
the same experiment was repeated with uninduced cells, not expressing the 
receptor. Unexpectedly, the uninduced cells treated with SP-probe-3 and click 
reagents also showed the presence of this probe-bound protein (Figure 4-19, lane 
6). There were two possible explanations for presence of this band in uninduced 
cells. It may be that the uninduced cells produced a small amount of HA-NK1-eGFP 
even without being induced with Dox, that is the expression was slightly leaky. 
Looking at the blot stained with anti-GFP a small amount of receptor could indeed 
be discerned in the uninduced cells (Figure 4-19, lanes 5, 6). Alternatively, the 
probe could also have bound to another protein of the same size as the receptor, 
which was constitutively present in Flp-InTM T-RExTM 293 cells.  
In order to distinguish between these options, Flp-InTM T-RExTM 293 cells that were 
not transfected with HA-NK1-eGFP were used as a control. If, as was hoped, the 
probe was binding solely to HA-NK1-eGFP, then the band indicated before should 
disappear in the empty FLP-In cell samples. As can be seen in Figure 4-20, the 
streptavidin-binding band of ~90 kDa was present in all three samples treated with 
probe and click reagents (Figure 4-20, lanes 2, 4, 6), however, more streptavidin 
was bound to the induced, NK1 containing, cells than to the other two samples. 
Whereas this experiment confirmed that probe 3 bound to another protein of 
roughly the same size as HA-NK1-eGFP, it did not rule out that probe 3 also bound 
to HA-NK1-eGFP. On the contrary, the larger amount of streptavidin binding to 
the blot at ~90 kDa in lane 6, which contained HA-NK1-eGFP, as compared to the 
other lanes, which did not contain the receptor, supported the notion of probe-
binding to HA-NK1-eGFP.  
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Figure 4-18. Probe 3 coupling to HA-NK1-eGFP . Flp-InTM T-RExTM 293 cells expressing HA-NK1-eGFP were incubated with SP-probe-3 and exposed to UV-light. 
Membrane preparations in PBS were made and incubated with click reagents (0.5 mM CuSO4, 2 mM THPTA, 2 mM NaAsc) and biotin-PEG-azide (100 μM) for 1 h at 
RT. Proteins were resolved with SDS-PAGE and HA-NK1-eGFP and biotin were visualised via immunoblotting with an anti-GFP antiserum (left panel) and streptavidin 
(centre panel), respectively. The images were labelled with pseudo-colour and merged (right panel). The band that could correspond to HA-NK1-eGFP coupled to probe 
3 is marked with blue. 
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Figure 4-19. Probe 3 coupling to HA-NK1-eGFP – Uninduced cells. Flp-InTM T-RExTM 293 cells, induced or uninduced to express HA-NK1-eGFP, were incubated with 
SP-probe-3 and exposed to UV-light. Membrane preparations in PBS were made and incubated with click reagents (0.5 mM CuSO4, 2 mM THPTA, 2 mM NaAsc) and 
biotin-PEG-azide (100 μM) for 1 h at RT. Proteins were resolved with SDS-PAGE and HA-NK1-eGFP and biotin were visualised via immunoblotting with an anti-GFP 
antiserum (left panel) and streptavidin (centre panel), respectively. The images were labelled with pseudo-colour and merged (right panel). The band that could 
correspond to HA-NK1-eGFP coupled to probe 3 is marked with blue. 
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Figure 4-20. Probe 3 coupling to HA-NK1-eGFP – Empty FLP-In cells. Empty Flp-InTM T-RExTM 293 cells or similar cells expressing HA-NK1-eGFP (induced and 
uninduced) were incubated with SP-probe-3 and exposed to UV-light. Membrane preparations in PBS were made and incubated with click reagents (0.5 mM CuSO4, 
2 mM THPTA, 2 mM NaAsc) and biotin-PEG-azide (100 μM) for 1 h at RT. Proteins were resolved with SDS-PAGE and HA-NK1-eGFP and biotin were visualised via 
immunoblotting with an anti-GFP antiserum (left panel) and streptavidin (centre panel), respectively. The images were labelled with pseudo-colour and merged (right 
panel). The band that could correspond to HA-NK1-eGFP coupled to probe 3 is marked with blue.
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4.6.4.2. Click to beads  
Another method to determine whether probe 3 had indeed bound HA-NK1-eGFP 
was also exploited. This included clicking the probe-receptor adduct to azide-
conjugated beads, which, as stated before, might have some advantages over 
clicking to biotin. For the full LRC experiment, beads with covalently attached 
azide groups would be used, as this would create the opportunity to wash the 
beads, after the probe-receptor adduct had been clicked on, very harshly and 
perform an on-bead trypsin digest. To test the formation of the total complex, 
however, beads containing a cleavable linker between the azide-group and the 
agarose bead were used. This cleavable linker was based on the 1-(4,4-dimethyl-
2,6-dioxocyclohex-1-ylidene)ethyl (Dde) protecting group (Figure 4-21) and could 
be cleaved using 0.05% SDS in Tris (Yang and Verhelst, 2013). 
 
Figure 4-21. Structure of Dde-azide.  
  
Identically to the biotin-click experiments, cells expressing HA-NK1-eGFP were 
grown, followed by incubation with SP-probe-3, and exposure to UV-light. After 
washing, membrane preparation in PBS were obtained and added to azide-Dde-
agarose beads, together with the click reagents. After incubation and washing 
with PBS, the linker was cleaved with 0.05% SDS in Tris buffer to release the 
clicked proteins. Afterwards beads were incubated with Laemmli buffer at 70°C 
to release any proteins that did not come off during the first cleavage. The total 
lysate (TL), the flow through (FT), SDS cleaved protein (CL) and the Laemmli 
buffer fractions (LB) were resolved with SDS-PAGE, transferred to a membrane 
and probed for GFP. It should be noted that some of the experiments described in 
this section were performed before the optimisation of the click reaction was 
completed.  
The first time this experiment was performed the results looked very promising. 
Although there was still receptor present in the flow through, indicating that not 
all receptor had clicked to the beads, there was clearly less HA-NK1-eGFP present 
in the flow through of the probe-treated sample compared to the untreated 
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sample (Figure 4-22, lanes 2 vs 3). Moreover, despite some aggregation of the 
receptor on the gel, it appeared as if there was more HA-NK1-eGFP present in 
both the cleaved and the Laemmli buffer fractions of the probe-treated sample 
than then untreated sample (Figure 4-22, lanes 4 vs 5 and lanes 6 vs 7).  
 
Figure 4-22. Probe 3 coupling to HA-NK1-eGFP – Click to agarose beads (I). Flp-InTM T-RExTM 
293 cells expressing HA-NK1-eGFP were incubated with SP-probe-3 and exposed to UV-light. 
Membrane preparations in PBS were made and added to azide-Dde-agrose beads together with 
click reagents (1 mM CuSO4, 1.5 mM TBTA, 5 mM NaAsc) for 1 h at RT. The flow through (FT) was 
taken of beads and they were washed with PBS before they were incubated for 2 h at RT with 0.05% 
SDS in Tris buffer (200 mM pH 8.5) to give the cleaved (CL) fraction. Beads were then incubated 
with Laemmli buffer for 10 min at 70°C to give the LB fraction. Total lysate (TL), FT, CL, and LB were 
resolved with SDS-PAGE and HA-NK1-eGFP was visualised via immunoblotting with an anti-GFP 
antiserum. The position of HA-NK1-eGFP on the gel is marked with blue.  
Unfortunately, this outcome could never be replicated. In all the attempted 
repeats of this experiment, the amount of receptor cleaved off the beads was 
equal between the probe-treated and untreated samples (Figure 4-23, lanes 6 vs 
8). Also, no change in the amount of receptor coupled to the beads was observed 
when Gly-probe-3 was used instead of SP-probe-3 (Figure 4-23, lanes 7 vs 8). 
Moreover, it was discovered that HA-NK1-eGFP was also sticking to the beads in 
the absence of CuSO4 (Figure 4-23, lane 9). This last observation indicated that 
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some of the receptor binding to the beads was unspecific and was not caused by 
a successful click reaction.  
 
Figure 4-23. Probe 3 coupling to HA-NK1-eGFP – Click to agarose beads (II). Flp-InTM T-RExTM 
293 cells expressing HA-NK1-eGFP were incubated with SP-probe-3 or Gly-probe-3 and exposed to 
UV-light. Membrane preparations in PBS were made and added to azide-Dde-agrose beads together 
with click reagents (1 mM CuSO4, 1.5 mM TBTA, 5 mM NaAsc) for 1 h at RT. The flow through (FT) 
was taken of beads and they were washed with PBS before they were incubated for 2 h at RT with 
0.05% SDS in Tris buffer (200 mM pH 8.5) to give the cleaved (CL) fraction. Total lysate (TL), FT, 
and CL were resolved with SDS-PAGE and HA-NK1-eGFP was visualised via immunoblotting with 
an anti-GFP antiserum. The position of HA-NK1-eGFP on the gel is marked with blue.  
A potential way to remove this unspecific binding would be through more stringent 
washes. Unfortunately, whereas these washes might be performed on non-
cleavable azide-beads, the Dde-linker would not stay intact under harsher 
conditions, for example in the presence of a high concentrations of SDS (Yang and 
Verhelst, 2013). As mentioned before, when clicking molecules to azide-agarose 
there was no way to get the intact proteins off the beads again and it was 
impossible to analyse the coupled proteins with SDS-PAGE. Attempts were made 
to click probe 3-treated lysates to non-cleavable beads and quantify the amount 
of HA-NK1-eGFP through different techniques (fluorescent measurements of the 
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beads and addition of αGFP antibody to the beads), but this did not result in any 
reliable data. 
4.6.5. Discussion 
Probe 3 was successfully coupled to the SP peptide through its only free amine 
group, while leaving no free peptide. Although the potency of SP towards the NK1 
fusion receptors was reduced upon the coupling of probe 3, it was clear that SP-
probe-3 did still bind to the receptors. Regrettably, neither the click reaction to 
biotin, nor the click reaction directly to agarose beads resulted in proof of the 
formation of a covalent bond between SP-probe-3 and the HA-NK1-eGFP receptor. 
Nevertheless, it could also not be ruled out that a covalent bond had formed 
between the probe and the receptor. Due to the complicated nature of the full 
LRC protocol it was very hard to pinpoint where exactly the experiment failed. 
Apart from the actual failure of probe 3 to couple to the receptor, the absence of 
a clear biotin-coupled band on the western blots and the absence of specific 
binding of the probe to the beads could also have been caused by a low efficiency 
of the click reaction. As has been discussed extensively above, a successful click 
reaction in not always trivial. Even though the click reaction seemed to be 
successful for certain probe-bound proteins, it might not be successful on all.   
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4.7. Conclusion 
Two clickable photoaffinity probes incorporating two different photoreactive 
groups were designed. As the synthesis of probe 2 was never completed no final 
yield could be determined. Probe 3 was synthesised in 6 steps with an overall yield 
of 37%, an average of 84% per step. Whereas the addition of the NHS-ester led to 
a mixture of compounds, as was demonstrated for probe 3, this was not regarded 
as a problem, since these by-products would be formed insurmountably upon 
addition of the probe to the ligand. Probe 3, but not probe 2, was activated and 
inserted upon irradiation by UV-light. Probe 3 was then tested in the individual 
steps of the LRC protocol using NK1 and SP as a test system. Probe 3 was 
successfully coupled to SP through the peptide’s only free amine. When SP-probe-
3 was then used to activate HA-NK1-eGFP and HA-NK1-6xHis a shift in the 
potencies was observed, with the probe-coupled peptide being 5-6 times less 
potent than the free peptide. Nevertheless, observation of a response indicated 
that SP-probe-3 was still binding to HA-NK1-eGFP. It was realised that the click 
reaction did not take place in all buffers and, therefore, it was decided to make 
membrane preparations of probe-treated cells in PBS instead of full lysates in 
RIPA. Moreover, it became clear that the copper needed to catalyse the 
cycloaddition might have led to oxidation and aggregation of the NK1 fusion 
receptors. Click conditions that seemed to be compatible with the HA-NK1-eGFP 
receptor were found and used to investigate the formation of a covalent bond 
between probe 3 and the receptor. Unfortunately, the formation of such a bond 
was not undoubtedly demonstrated; as discussed above, however, this did not 
indicate that the bond was not formed. Instead, it might be that the click reaction 
was not successful or that it damaged the NK1 fusion receptors. It was realised 
that the possible advantages of the absence of a biotin moiety on the probe might 
not outweigh the problems related to its incorporation by the click reaction. 
Therefore, a derivative of probe 3 containing a biotin moiety was created. Results 
obtained with this probe will be discussed in Chapter 5. 
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5. A biotinylated photoaffinity probe  
5.1. Introduction  
As discussed in Chapter 4, various experiments trying to verify the covalent 
coupling of a ligand-probe-3 adduct to a target receptor were conducted, 
nevertheless it remained unclear whether coupling had indeed occurred. Proof of 
the coupling between probe 3 and the target receptor could only be given after 
clicking the probe to either biotin or agarose beads. If this click reaction did not 
work, or if the click reagents damaged the target receptor, it would be impossible 
to tell whether ligand-bound probe 3 was coupling to its target receptor or not. 
Therefore, it was decided to develop a probe with a biotin moiety already 
incorporated into the structure.  
5.1.1. Aim  
A modified version of probe 3, with the biotin moiety incorporated into the 
structure of the probe, was designed and synthesised. This biotinylated 
photoaffinty probe was then tested for its ability to be used in LRC experiments 
using NK1 and SP as a test system. 
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5.2. Design of probe 4 
The easiest and quickest way to incorporate the biotin moiety into probe 3, 
without starting the synthesis from scratch, was by performing a click reaction on 
the alkyne moiety of probe 3 with biotin-PEG-azide, resulting in probe 4 (Figure 
5-1). 
 
Figure 5-1. Structure of probe 4. 
 
The only difference in the total LRC protocol for probe 4 compared to that of 
probe 3 was the lack of the click reaction (Scheme 5-1). 
 
Scheme 5-1. Ligand-based receptor capture protocol using probe 4. The probe is first coupled 
to the ligand of interest (top of scheme) and a control ligand (glycine – bottom of scheme), after which 
the adduct is added to cells. After an appropriate incubation time during which the ligand binds the 
receptor, cells can be washed to rinse away unbound probe. Next, cells are exposed to UV-light to 
activate the photoreactive moiety which captures the receptor. Cells are lysed and added to 
streptavidin beads. Captured proteins are digested on the beads with trypsin and released peptides 
are analysed using mass spectrometry. Comparison between ligand-bound probe and glycine-bound 
probe should reveal the ligand-binding receptor. 
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5.3.  Synthesis of probe 4 
To prevent hydrolysis of the NHS-ester the free acid variant of probe 3, compound 
35, was used for the click reaction and the NHS-ester was incorporated in a later 
step. 
5.3.1. Click reaction  
 
 
Previously described click reactions on compounds containing a 3-aryl-3-
(trifluoromethyl)diazirine moiety were performed in the absence of any copper-
stabilizing ligand (Gu et al., 2010; Xu et al., 2014; Cassell et al., 2015). Following 
the procedure described by Gu et al., compound 35 and biotin-PEG-azide were 
dissolved in MeOH and aqueous solutions of both CuSO4 and NaAsc were added to 
this mixture. The reaction was stirred at room temperature and its progress was 
followed by LC-MS, which revealed completion after as little as two hours. After 
purification by flash chromatography, compound 42 was obtained with a 
reasonable yield of 65%.  
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5.3.2. NHS-esterification 
 
 
Coupling of the NHS-ester was performed using the same procedure as for probe 
3. After coupling, probe 4 was triturated in H2O and to remove the final traces of 
H2O it was dried on a lyophiliser giving a 45% yield. As for probe 3, this resulted 
in a mixture of the desired probe 4 (Figure 5-2, peak B; 68%), hydrolysed probe 
42 (Figure 5-2, peak A; 20%) and the intramolecularly cyclised probe 43 (Figure 
5-2, peak C; 12%; Figure 5-3). 
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Figure 5-2. Purity of probe 4. Probe 4 was analysed by LC-MS using a C18 column with a 5-95% 
gradient of MeCN in H2O over 40 min. The UV-trace of the analysis is depicted and reveals the 
presence of three main compounds: the desired probe 4 (Peak B; 68%), hydrolysed probe 42 (Peak 
A; 20%) and cyclised probe 43 (Peak C; 12%). 
 
Figure 5-3. Structure of the intramolecular cyclic imide by-product of probe 4.  
 
5.3.3. Discussion 
Probe 4 was synthesised in 7 steps from Fmoc-N-ε-Boc-lysine with an overall yield 
of 19%. As for probes 1-3 addition of the NHS ester led to a mixture of compounds, 
however, as formation of these by-products would be inevitable upon addition of 
probe 4 to any ligand, and since these products would be washed away before UV-
irradiation, no further purification was performed.  
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5.4. UV-activation of probe 4  
Before proceeding with probe 4, it was tested whether the diazirine moiety could 
indeed be activated by UV-light of 365 nm. As before, the free acid variant of the 
probe, compound 42, was dissolved in MeOH and either kept in the dark or 
exposed to UV-light for 15 minutes. As for probe 3, this exposure was enough to 
activate all diazirine groups, resulting in insertion of compound 42 into either H2O 
(44; Figure 5-4b, peak B; Figure 5-5) or MeOH (45; Figure 5-4b, peak C; Figure 
5-5). 
 
Figure 5-4. UV-activation of probe 4. The free acid derivative of probe 4 (compound 42) was 
dissolved in MeOH and either kept in the dark (a) or exposed to UV-light of 365 nm (b) for 15 min. 
Samples were then analysed by LC-MS using a C18 column with a 5-95% gradient of MeCN in H2O 
over 40 min. The UV-traces are depicted. Upon activation with UV, the free acid derivative of probe 
4 (42; peak A) formed adducts with H2O (44; peak B) and MeOH (45; peak C). 
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Figure 5-5. Structures of the insertion products of compound 42 into H2O (44) and MeOH (45). 
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5.5.  Evaluation of probe 4 
Whether probe 4 could be used for LRC was evaluated using the same test system 
as was used for probe 3, namely the HA-NK1-eGFP receptor and the SP peptide. 
More information about this ligand-receptor pair can be found in Section 4.5. 
5.5.1. Ligand coupling 
It was first tested whether probe 4 could indeed be coupled to SP. The probe (2.5 
eq) was added to a solution of SP (1 mM) in PBS (pH 8.2). After an hour of 
incubation at room temperature, the mixture was diluted with DMSO (1:1, v/v) to 
redissolve the precipitated peptide adduct, before it was analysed by LC-MS. As 
for probe 3, three main peaks were observed in the LC-MS spectrum, 
corresponding to the desired SP-probe-4 adduct 46 (Figure 5-6a, peak C; Figure 
5-7), the hydrolysed probe 42 (Figure 5-6a, peak A), and the intramolecularly 
cyclised probe 43 (Figure 5-6a, peak B). Probe 4 was also coupled to Gly in a 
similar fashion to give the Gly-probe-4 adduct 47 (Figure 5-6b, peak D; Figure 5-7) 
in a mixture with 42 and 43 (Figure 5-6b, peaks A and B).  
In this thesis, the term SP-probe-4 will be used to denote the mixture of 42, 43, 
and 46, while Gly-probe-4 will denote the mixture of 42, 43, and 47. 
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Figure 5-6. Coupling of probe 4 to SP and Gly. SP (a) or Gly (b) were incubated with probe 4 for 
1 h at RT in PBS (pH 8.2), the mixtures were then diluted with DMSO (1:1, v/v). The mixtures were 
analysed with LC-MS using a C18 column with a 5-95% gradient of MeCN in H2O over 40 min. The 
UV-traces are depicted. There were three main compounds present in both mixtures: the desired 
SP-probe and Gly-probe adducts 46 and 47 (peaks C and D), the hydrolysed probe 42 (peak A) and 
the intramolecularly cyclised probe 43 (peak B). There was no free SP or Gly left in the mixtures.  
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Figure 5-7. Structures of adducts formed between probe 4 and SP (46) or Gly (47). 
 
5.5.2. Interference with ligand-receptor interaction 
SP-probe-4 was tested for its capability to activate HA-NK1-eGFP and HA-NK1-
6xHis using IP1 accumulation assays (Figure 5-8). SP-probe-4 activated HA-NK1-
eGFP with pEC50 of 6.52 ± 0.07, and HA-NK1-6xHis with pEC50 of 7.01 ± 0.06, 
making it approximately 5-12 times less potent than the free peptide. Despite 
these lower potencies, SP-probe-4 was still able to bind and activate the 
receptors. 
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Figure 5-8. Activation of HA-NK1-eGFP and HA-NK1-6xHis by SP-probe-3. IP1 accumulation was 
assessed via homogeneous time resolved fluorescence in both induced and uninduced Flp-InTM T-
RExTM 293 cells harbouring the HA-NK1-eGFP (a) or HA-NK1-6xHis (b) constructs upon activation 
with various concentrations of SP-probe-4. Data are means +/- SEM pooled from n = 3 or more 
independent experiments performed in triplicate. 
5.5.3. Receptor coupling 
Successful coupling of probe 4 to SP and the capability of this complex to activate 
HA-NK1-eGFP meant that the SP-probe-4 could now be used to investigate the 
formation of a covalent bond between the probe and the receptor. This was done 
via an experiment comparable to the biotin-click experiment performed with SP-
probe-3 (Section 4.6.4.1). In short, cells expressing HA-NK1-eGFP were grown, 
incubated with SP-probe-4, and placed under UV-light for 15 minutes. After 
washing of the cells, lysates were made in RIPA buffer. Samples were resolved 
with SDS-PAGE and transferred to a membrane, which was probed for GFP and 
biotin. For certain experiments the receptor was purified using a GFP-trap before 
analysing the samples through immunoblotting. 
Apart from the omission of the biotin-click step, four other changes were made to 
the protocol for probe 4 compared to that for probe 3. Firstly, for the experiments 
with SP-probe-3, cells were grown on 6-well plates and treated with the ligand-
probe complex while still adhered to the plates; for these experiments the cells 
were first harvested and incubated with SP-probe-4 in suspension. This change 
was made as it was realised that, when this probe was to be used for MS-
experiments, a large scale up would have to take place and larger numbers of 
suspended cells could be exposed to UV-light at once. Secondly, where before the 
incubation with the ligand-probe adduct took place at 37°C for 10 minutes, from 
here on incubation took place at 4°C for an hour. This was done to prevent 
internalisation of the receptor (Garland et al., 1994). Thirdly, for cell lysis our 
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lab’s usual buffer, RIPA buffer, was used, as, in contrast to lysates of SP-probe-3 
treated cells, no click reaction had to be performed on these lysates. Finally, 
when cells were incubated with SP-probe-3, this was done in the presence of 0.1% 
BSA, as it was thought that this might reduce non-specific binding of the probe. It 
was realised, however, that this, instead, led to the coupling of the probe to BSA 
and, therefore, it was omitted in these experiments (Appendix 7).  
In a first experiment both induced and uninduced Flp-InTM T-RExTM 293 cells 
harbouring HA-NK1-eGFP were tested. Where previous experiments with probe 3 
were always performed with 1 μM SP-probe-3, for SP-probe-4, which has a lower 
potency on HA-NK1-eGFP, it was decided to also include a higher concentration of 
10 μM. Similar to the results obtained with probe 3, incubation of Dox-induced 
cells with 1 μM SP-probe-4 resulted in the presence of a probe-coupled protein of 
the right mobility to correspond to HA-NK1-eGFP (Figure 5-9, lane 2). In contrast 
to observations made for probe 3 (Section 4.6.4.1), this band was not only absent 
in the Dox-induced probe-untreated cells (Figure 5-9, lane 6), but also in the 
uninduced, probe-treated cells (Figure 5-9, lane 1), suggesting that the band 
might indeed represent probe 4-coupled HA-NK1-eGFP. Treating cells with 10 μM 
SP-probe-4 resulted in very high background labelling (Figure 5-9, lanes 3-4), 
making it impossible to distinguish any distinct bands.  
To further investigate the covalent bond between HA-NK1-eGFP and probe 4, it 
was decided to purify the receptor from the lysates using a GFP-trap and analyse 
the pulled-down fractions by western blotting. As can be seen in Figure 5-10, there 
was an overlapping streptavidin and eGFP signal at the predicted mobility of the 
HA-NK1-eGFP receptor for the samples treated with SP-probe-4, but not for 
untreated cells (lanes 1-2 vs 3). This indicated that probe 4 had indeed 
successfully coupled to the HA-NK1-eGFP receptor. As coupling between the probe 
and the receptor was successful both when 1 μM and 10 μM SP-probe-4 were used, 
to reduce the amount of probe that had to be used, subsequent experiments were 
only performed using 1 μM of SP-probe-4. 
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Figure 5-9. Probe 4 coupling to HA-NK1-eGFP. Flp-InTM T-RExTM 293 cells, induced or uninduced to express HA-NK1-eGFP, were incubated with SP-probe-4 and 
exposed to UV-light. Lysates were made in RIPA buffer. Proteins were resolved with SDS-PAGE and immunoblotted with an anti-GFP antiserum (left panel), or 
streptavidin (centre panel). The images were labelled with pseudo-colour and merged (right panel). The band that could correspond to HA-NK1-eGFP coupled to probe 
4 is marked with blue.  
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Figure 5-10. Probe 4 coupling to HA-NK1-eGFP – GFP-trap. Flp-InTM T-RExTM 293 cells, induced or uninduced to express HA-NK1-eGFP, were incubated with SP-
probe-4 and exposed to UV-light. Lysates were made in RIPA buffer and were incubated with GFP-trap. Proteins were released form the beads with Laemmli buffer, 
resolved with SDS-PAGE and immunoblotted with an anti-GFP antiserum (left panel), or streptavidin (centre panel). The images were labelled with pseudo-colour and 
merged (right panel). 
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5.5.3.1. Control experiments  
Although the results discussed above indicated the presence of a covalent bond 
between SP-probe-4 and HA-NK1-eGFP, it was realised that some control 
experiments had to be performed to demonstrate the nature of this probe-
receptor coupling. Several variations of the protocol were tested in a single 
experiment: (1) the use of Gly-probe-4 (Figure 5-11, lane 2); (2) the addition of 
washes before UV-activation (Figure 5-11, lane 4); (3) cell lysis in PBS (Figure 5-11, 
lane 5); (4) the use of probe-3 (Figure 5-11, lane 6); and (5) performing the 
experiment on uninduced cells (Figure 5-11, lane 7). All results will be discussed 
below and, if follow up experiments had been performed, these will be discussed 
in separate sections of this chapter.  
Firstly, to see whether the receptor-coupling was specific for the ligand, cells 
were treated with Gly-probe-4. Unexpectedly, this resulted in a similar amount 
of biotin coupled to the probe as treatment with SP-probe-4 (Figure 5-11, lanes 1 
vs 2). This indicated that coupling of the probe to the HA-NK1-eGFP receptor might 
not be due to the specific binding of SP. This will be further discussed in Section 
5.5.3.2. 
Secondly, cells were treated with SP-probe-4, but a washing step was introduced 
before UV-activation. Although this still resulted in coupling of the probe to the 
receptor, it did reduce the amount of probe coupled (Figure 5-11, lanes 1 vs 4). 
This will be further discussed in Section 5.5.3.2. 
Thirdly, to see whether the lysis conditions influenced the result, instead of lysing 
cells in RIPA buffer, membrane preparations of SP-probe-4-treated cells were 
made in PBS. These lysis conditions resulted in a lower amount of total receptor 
(Figure 5-11, lanes 1 vs 5). Therefore, for further experiments cells were lysed 
using RIPA buffer.  
Fourthly, to get an idea about the difference between probe 3 and 4, cells were 
treated with SP-probe-3, lysed in PBS and clicked to biotin-PEG-azide. Although 
there seemed to be a small amount of biotin coupled to the receptor, the 
increased amount of handling of these samples resulted in such a low amount of 
total receptor that no useful conclusion could be made (Figure 5-11, lane 6). Since 
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lengthy investigations into probe 3 had already been performed without leading 
to any successes (Chapter 4), it was decided not to pursue this any further at this 
point in time.  
Finally, a GFP-trap pull down was performed on uninduced cells treated with SP-
probe-4, which, as expected, resulted in the total absence of receptor and probe 
(Figure 5-11, lane 7).
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Figure 5-11. Probe 4 coupling to HA-NK1-eGFP – Control experiments. Flp-InTM T-RExTM 293 cells, induced or uninduced to express HA-NK1-eGFP, were incubated 
with SP-probe-4, Gly-probe-4 or SP-probe-3 and exposed to UV-light after an optional wash. Lysates were made in RIPA buffer or membrane preparations were prepared 
in PBS and sample 6 was incubated with click reagents (0.5 mM CuSO4, 2 mM THPTA, 2 mM NaAsc) and biotin-PEG-azide (100 μM) for 1 h at RT. Lysates and 
membrane preparations were then incubated with GFP-trap. Proteins were released from the beads with Laemmli buffer, resolved with SDS-PAGE and immunoblotted 
with an anti-GFP antiserum (left panel), or streptavidin (centre panel). The images were labelled with pseudo-colour and merged (right panel). 
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5.5.3.2. Ligand specificity 
The observation that not only SP-probe-4, but also Gly-probe-4 coupled to the HA-
NK1-eGFP receptor (Figure 5-11, lane 2) was of concern, as this indicated that 
coupling of the probe to HA-NK1-eGFP might not be due to the specific binding of 
SP. To further investigate this issue, an experiment was performed in which cells, 
treated with either SP-probe-4 or Gly-probe-4, were exposed to UV-light either 
without prior washing, or after one or two washes with HBSS. As can be seen in 
Figure 5-12, washing the unbound probe away before exposing cells to UV-light 
reduced the total amount of probe that coupled to the receptor (lanes 2 vs 4 and 
6), however, it also totally eliminated the coupling of Gly-probe-4 to HA-NK1-
eGFP (lanes 1 vs 3 and 5). Thus, although some of the binding of probe 4 HA-NK1-
eGFP was non-specific, this fraction of the probe could be removed by washing 
the cells before UV-activation, leaving the specifically bound SP-probe-4 behind.
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Figure 5-12. Probe 4 coupling to HA-NK1-eGFP – Washes. Flp-InTM T-RExTM 293 cells, induced to express HA-NK1-eGFP, were incubated with SP-probe-4 or Gly-
probe-4 and exposed to UV-light after optional washes. Lysates were made in RIPA buffer and these were incubated with GFP-trap. Proteins were released from the 
beads with Laemmli buffer, resolved with SDS-PAGE and immunoblotted with an anti-GFP antiserum (left panel), or streptavidin (centre panel). The images were labelled 
with pseudo-colour and merged (right panel).  
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5.5.4. Ligand-based receptor capture (I) 
Having shown that, after washing, SP-probe-4 covalently coupled to HA-NK1-
eGFP, while Gly-probe-4 did not, gave enough confidence to allow a first attempt 
to identify the covalently captured receptor in a non-biased manner via LRC 
followed by LC-MS/MS. This was done according to the procedure depicted in 
Scheme 5-1. In short, after treatment of cells expressing HA-NK1-eGFP with either 
SP-probe-4 or Gly-probe-4, cells were washed followed by exposure to UV. Cells 
were then lysed with RIPA buffer and added to streptavidin coated beads. An on-
bead trypsin digest was performed and the resulting peptides were analysed using 
LC-MS/MS. This resulted in a total list of 12 identified human proteins, 11 of which 
were identified in both Gly-probe-4 and SP-probe-4 treated samples and one that 
was only identified in the Gly-probe-4 treated sample (Appendix 8). These 
proteins were mostly endogenously biotinylated proteins, like carboxylases, and 
common contaminants such as keratin (Tong, 2005; Hodge et al., 2013). None of 
the samples contained any NK1 derived peptides. 
5.5.5. Receptor coupling - Live cell imaging 
Western blots had shown that SP-probe-4 was able to covalently couple to HA-
NK1-eGFP, however, when performing the full LRC protocol no HA-NK1-eGFP 
receptor was identified. Therefore, it was decided to exploit a different technique 
to investigate the nature of the coupling between SP-probe-4 and the NK1 
receptor. Confocal microscopy was considered as a good parallel technique that 
could easily be applied to our test system. HA-NK1-eGFP already had a fluorescent 
tag and because streptavidin-conjugated fluorophores were commercially 
available, it would be possible to visualise co-localisation of the receptor and the 
probe. Cells expressing HA-NK1-eGFP were incubated with SP-probe-4, washed 
and exposed to UV-light to activate the probe and capture the receptor. Cells 
were then washed again before they were incubated with Dylight-594-
Streptavidin, which interacts with the biotin component of the probe. After some 
final washes, the eGFP-tagged receptor and the fluorophore-conjugated 
streptavidin were visualised using a confocal microscope. 
As expected, plasma membrane localisation of HA-NK1-eGFP was clearly observed 
in Dox-induced cells but not in uninduced cells (Figure 5-13, upper panels).  
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Moreover, when cells expressing the NK1 receptor were treated with SP-probe-4 
the probe bound to the plasma-membrane (Figure 5-13, middle panels). This 
observation was not replicated when Gly-probe-4 was used, or when SP-probe-4 
was added to cells not expressing the NK1 receptor (Figure 5-13, middle panels). 
Merging of the images showed co-localisation at the level of light microscopy of 
the eGFP-containing receptor and the DyLight™ 594 labelled probe (Figure 5-13, 
lower panels). 
 
Figure 5-13. Live cell imaging of SP-probe-4 binding to HA-NK1-eGFP. Dox induced or 
uninduced Flp-InTM T-RExTM 293 cells harbouring HA-NK1-eGFP were treated with SP-probe-4 or 
Gly-probe-4 before they were activated with UV-light and treated with DyLight™ 594-conjugated 
streptavidin. A laser scanning confocal microscope was used to acquire high resolution images, while 
HA-NK1-eGFP and the DyLight™ 594 labelled probe were excited simultaneously at 488 nm (top 
panels) and 561 nm (middle panels), respectively. Co-localisation between the receptor and the 
probe was visualised (yellow colour, bottom panels). The bright field image demonstrates that cells 
were present in the uninduced -Dox panels. 
Although this showed that SP-probe-4 was binding to HA-NK1-eGFP, while Gly-
probe-4 did not, it did not prove that a covalent bond was formed between the 
probe and the receptor. Therefore, competition experiments were performed. 
After treatment with SP-probe-4, cells were either exposed to UV-light or kept in 
the dark, then an excess (10 µM) of free SP was added to the cells to compete off 
any non-covalently bound probe. For cells exposed to UV-light, treatment with 
free ligand did not result in reduction of co-localisation between the probe and 
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the receptor (Figure 5-14, samples 1 vs 3). By contrast, for cells maintained in the 
dark, there was a significant reduction in co-localisation (Figure 5-14, samples 2 
vs 4), indicating that the SP-probe partially dissociated from the receptor. This 
suggested that UV-activation did indeed induce a covalent linkage between probe 
4 and the NK1 receptor, since, although dissociation of SP-probe from the receptor 
in the absence of cross-linking was slow, it did occur. 
 
Figure 5-14. Live cell imaging of SP-probe-4 coupling to HA-NK1-eGFP. a. Induced Flp-InTM T-
RExTM 293 cells expressing HA-NK1-eGFP were treated with SP-probe-4 or Gly-probe-4 before they 
were activated with UV-light (samples 1 and 3) or kept in the dark (samples 2 and 4). Cells were then 
either treated immediately with DyLight™ 594-conjugated streptavidin (samples 1-2) or were first 
exposed to SP (10 μM at 4°C for 3 h) (samples 3-4). A laser scanning confocal microscope was used 
to acquire high resolution images, while HA-NK1-eGFP and the DyLight™ 594 labelled probe were 
excited simultaneously at 488 nm (top panels) and 561 nm (middle panels), respectively. Co-
localisation between the receptor and the probe was visualised (yellow colour bottom panels). b. Co-
localisation was quantified by generating green-red pixel intensity scatterplots for each pixel and 
determining the Pearson correlation coefficient for 4 representative images for each condition. Data 
are means + SEM. Significant statistical difference was determined using ANOVA with Tukey’s 
multiple comparison test (*** p ≤ 0.001). 
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When combining the results of both these experiments the conclusion could be 
reached that SP-probe-4 was coupling covalently to HA-NK1-eGFP upon activation 
with UV-light, while Gly-probe-4 did not bind the receptor. Furthermore, in the 
absence of HA-NK1-eGFP there was almost no coupling of SP-probe-4 to the cell 
membrane. 
5.5.6. Receptor coupling – Background reduction 
For the western blotting experiments discussed in Section 5.5.3.2, only the pulled-
down fractions of the GFP-trap were shown, as the full lysates of cells treated 
with SP-probe-4 or Gly-probe-4, even when cells were washed before UV-
activation, resulted in ‘smearing’ when blots were probed with streptavidin 
(Appendix 9). This indicated that both SP-probe-4 and Gly-probe-4 coupled to 
various proteins. It was first thought that these labelled proteins were membrane 
proteins, as it was assumed that probe 4 could not pass the plasma membrane due 
to the presence of the PEG-linker and the biotin moiety (Smith and Collins, 2015). 
Live cell imaging, however, indicated that treatment of cells with Gly-probe-4 did 
not result in any significant background labelling on the plasma membrane, nor 
was any obvious labelling by SP-probe-4 visible on cells that did not express HA-
NK1-eGFP (Figure 5-13). One possible explanation for the difference in background 
labelling observed between the western blotting experiments and the live-cell 
imaging experiments could be that the probe was binding to intracellular proteins. 
Since the streptavidin dye could not enter the cells, these intracellular 
biotinylated proteins would be invisible by live cell imaging, however, they would 
be obvious when full lysates were used for western blotting.  
It was thus hypothesised that membrane preparations of cells treated with SP-
probe-4 would have much lower background than full lysates and that, if the 
background was reduced enough, it might be possible to visualise the SP-probe-4 
coupling to the NK1 receptor without using any purification of the receptor. Since, 
the HA-NK1-eGFP receptor had the same mobility on SDS-PAGE gels as some 
endogenously biotinylated proteins (Section 4.5.4; Figure 5-9, lanes 5-6) it was 
decided to return to cells expressing the HA-NK1-6xHis receptor. 
Experiments were performed as described before in Section 5.5.3.2, with the 
following adaptations: cells were expressing HA-NK1-6xHis instead of HA-NK1-
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eGFP; membrane preparations were made in PBS instead of full lysates in RIPA 
buffer; and no purification of the receptor was performed.  
As hoped, the use of membrane preparations instead of full lysates did indeed 
significantly reduce the presence of other biotinylated proteins, and a distinct 
streptavidin-binding band of the same mobility as the HA-NK1-6xHis receptor was 
present in UV-irradiated samples treated with SP-probe-4 (Figure 5-15, lane 2), 
but not in samples treated with Gly-probe-4 (Figure 5-15, lane 3), nor in samples 
that were not exposed to UV-light (Figure 5-15, lane 4), or in samples not 
expressing the NK1-receptor (Figure 5-15, lane 5). 
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Figure 5-15. Probe 4 coupling to HA-NK1-6xHis. Flp-InTM T-RExTM 293 cells, induced to express HA-NK1-6xHis, were incubated with SP-probe-4 or Gly-probe-4 and 
washed after which they were exposed to UV-light or kept in the dark. Membrane preparations were made in PBS and proteins were resolved with SDS-PAGE and 
immunoblotted with an anti-6xHis antiserum (left panel), or streptavidin (centre panel). The images were labelled with pseudo-colour and merged (right panel).  
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5.5.7. Ligand-based receptor capture (II) 
This significant reduction of the background in the samples was encouraging 
enough to believe that it might now be possible to identify the NK1 receptor in a 
full LRC experiment followed by LC-MS/MS. Therefore, as before for the HA-NK1-
eGFP receptor, the procedure of Scheme 5-1 was followed (Section 5.5.4). The 
two differences were that cells expressing HA-NK1-6xHis were used and that 
membrane preparations were made instead of full lysates. The membrane 
preparations were detergent solubilised and added to streptavidin-coated beads, 
followed by an on-bead trypsin digest and LC-MS/MS analysis. Three biological 
repeats of this experiment were performed and the results were combined to 
reveal a total of 49 identified human proteins, 48 of which were identified in both 
Gly-probe-4 and SP-probe-4 treated samples (Appendix 10). Again, this group 
mostly consisted of endogenously biotinylated proteins and common 
contaminants. This time, however, there was one protein that was identified in 
SP-probe-4 treated samples, but not in Gly-probe-4 treated samples. This protein, 
which was recovered as five distinct peptide fragments (Table 5-1; Figure 5-16), 
was the NK1 receptor (Uniprot ID P25103). Not only was the NK1 receptor the only 
protein solely found in the SP-probe-4 treated samples, it was also the only protein 
that showed significant differences (p ≤ 0.05) in either total spectrum count or 
total ion current (TIC) between the SP-probe-4 treated or Gly-probe-4 treated 
samples (Appendix 11).  
Table 5-1. Peptides identified for NK1 in a full LRC experiment. Colours correspond to Figure 
5-16. 
Peptide sequence Total 
spectra (#) 
Found in 
# samples 
Modifications 
(R)LETTISTVVGAHEEEPEDGPK(A) 2 2  
(R)YLQTQGSVYKVSR(L) 1 1  
(K)ATPSSLDLTSNcSSR(S) 2 2 Carbamidomethyl  
(R)YMAIIHPLQPR(L) 1 1  
(R)YLQTQGSVYK(V) 1 1  
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Figure 5-16. Peptides identified for NK1 in a full LRC experiment. Amino acid sequence of the 
human NK1 receptor. Peptides that were identified using LC-MS/MS after a full LRC experiment are 
depicted in colours corresponding to those in Table 5-1.    
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5.5.8. Discussion 
Probe 4 was successfully used to identify the NK1 receptor as the only SP-binding 
protein present in our test system, illustrating the specificity of the probe. To 
reach this result, however, a lot of optimisation had to be performed.  
One of the important changes that was made was lowering the temperature at 
which the ligand-receptor binding took place to 4°C. For LRC experiments to be 
successful it is important that the ligand-probe adduct binds to the receptor of 
interest, moreover, it is vital that the ligand remains associated with the receptor 
until the probe has been activated by UV-light. Whereas incubation of cells with 
SP-probe-3 was performed at 37°C, it was realised that the NK1 receptor rapidly 
(3 minutes) internalises upon activation by its agonist SP.(Garland et al., 1994) 
Internalisation of the NK1-SP complex is known to be associated with dissociation 
and degradation of SP, therefore, it was important to perform receptor-capture 
experiments at lower temperatures, preventing internalisation of the receptor 
(Garland et al., 1994). Binding of the SP-probe-4 adduct to the NK1 receptor at 
4°C, without any significant internalisation of the receptor, was apparent from 
the microscopy results discussed above (Section 5.5.5). These lower 
temperatures, however, also slowed down the dissociation of the ligand from the 
receptor, which explained why the dissociation rate of the non-cross-linked SP-
probe-4 from the HA-NK1-eGFP receptor in the presence of an excess of free SP 
was slow (Figure 5-14, sample 4). This slower off-rate, however, might potentially 
have been beneficial for receptor capture, as it kept the probe in close proximity 
to the receptor. 
Another important optimisation made was the change from full lysates to 
membrane preparations. As discussed in Section 5.5.6, full lysates contained many 
more non-specifically biotinylated proteins than membrane preparations. This 
suggested that SP-probe-4 and Gly-probe-4 crossed the plasma membrane and 
coupled to intracellular proteins upon irradiation with UV-light. This was a 
surprising discovery, as it was assumed that probe 4, due to the presence of the 
biotin moiety and PEG linker, could not pass the membrane (Smith and Collins, 
2015). Whether the probe passed the membrane through diffusion, through active 
transport by biotin-transporters (Azhar et al., 2015), or via another mechanism 
remained unclear. Moreover, it was unknown whether all compounds present in 
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the SP-probe-4 and Gly-probe 4 mixtures (42, 43, 46 and 47) entered the cells, 
or only some of them. Notwithstanding the manner by which probe 4 coupled to 
intracellular proteins, changing from full lysates to membrane preparations 
significantly reduced the background in western blotting experiments and also 
resulted in the successful identification of NK1 by LC-MS/MS.  
As well as the SP-specific receptor NK1, the full LRC experiment followed by LC-
MS/MS also identified 48 proteins that were captured by streptavidin beads in 
samples treated with both SP-probe-4 and Gly-probe-4. It is worth mentioning 
that three of these proteins are biotin-coupled carboxylases that have molecular 
masses corresponding to the three non-specific streptavidin binding bands 
observed before on western blots of HA-NK1-eGFP and HA-NK1-6xHis expressing 
cells (Section 4.5.4.; Figure 4-7). Propionyl- coenzyme A carboxylase alpha chain 
and methylcrotonoyl-coenzyme A carboxylase subunit alpha both have molecular 
masses of some 80 kDa, while pyruvate carboxylase has a molecular mass of 130 
kDa. This suggested that these proteins may correspond to the three streptavidin-
binding bands visualised by western blotting.  
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5.6. Conclusion  
Probe 4, a trifunctional photoaffinity probe containing an NHS-ester for ligand 
coupling, a diazirine moiety for receptor capture, and a biotin group to allow 
affinity purification, was designed and successfully synthesised in 7 steps from 
Fmoc-N-ε-Boc-lysine with an overall yield of 19%, an average yield of 79% per step. 
Although probe 4 was unstable and the final product was not fully purified, the 
by-products did not interfere with the functioning of SP-probe 4 in LRC 
experiments. The diazirine moiety in probe 4 was activated and inserted upon 
irradiation by UV-light. Probe 4 was then tested in the individual steps of the LRC 
protocol using the HA-NK1-eGFP and HA-NK1-6xHis receptors together with their 
peptidic ligand SP as a test system. Probe 4 was successfully coupled to SP through 
the peptide’s only free amine. When SP-probe-4 was then used to activate HA-
NK1-eGFP and HA-NK1-6xHis a shift in potency was observed, with the probe-
coupled peptide being roughly 5-12 times less potent than the free peptide. 
Nevertheless, observation of a functional response indicated that SP-probe-4 was 
still able to bind to the fusion receptors. This observation was later confirmed 
with live cell imaging. In contrast to the other probes discussed in this thesis, for 
probe 4 it was possible to proof that a covalent bond formed between SP-probe-
4 and the NK1 receptor. This was first demonstrated through western blotting of 
the purified HA-NK1-eGFP receptor. Whereas this was a very promising result, it 
was also obvious that SP-probe-4 and Gly-probe-4 coupled to many other proteins 
as well and this might have been part of the reason why, when a full LRC 
experiment followed by LC-MS/MS was performed on full lysates of cells treated 
with SP-probe-4, the NK1 receptor could not be identified. Live cell imaging 
experiments revealed that many of the non-specifically biotinylated proteins were 
intracellular proteins that could potentially be removed from the final LC-MS/MS 
analysis by generating membrane preparations instead of full lysates. Indeed, 
when a full LRC experiment followed by LC-MS/MS was performed on membrane 
preparations, the NK1 receptor was successfully identified as the only protein that 
had specifically bound to SP. 
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6. Final discussion 
Transmembrane proteins, which do not only provide a way to transport molecules 
across membranes, but can also transfer signals, are vital to both unicellular and 
multicellular organisms. The importance of these proteins is further illustrated by 
the fact that they are targeted by 60% of the drugs currently on the market (Santos 
et al., 2017). Nevertheless, the range of drugged transmembrane proteins is 
limited, with just over a quarter of all non-olfactory GPCRs being targeted (Hauser 
et al., 2017). Phenotypic drug discovery allows for the development of first-in-
class drugs acting on previously untargeted proteins, however, separate 
experiments to identify these proteins are often needed. Whereas, over the years, 
various methods for target identification have been developed, the identification 
of transmembrane proteins remains a challenge. This thesis has described the 
development of a universal probe that can be used to identify transmembrane 
receptors employing a known ligand in a process referred to as LRC. In this 
chapter, after a short summary, this work will be compared to that of others in 
the field from the last four years and future directions will also be suggested. 
This project started out with the idea of synthesising Triceps, a probe specifically 
designed for the identification of transmembrane receptors (Frei et al., 2012), 
however, as has been discussed in Chapter 3, probe 1, a clickable probe with a 
more convenient synthesis route was developed instead. Probe 1 was evaluated 
using OXA and OX1 as a test system. Although this probe could be coupled to OXA 
and this did not interfere with the OXA-OX1 interaction, in our hands it was 
impossible to prove that probe 1 could covalently capture OX1. It was realised 
that probe 1 and Triceps, which both act through the formation of hydrazones 
with aldehydes present on oxidised sugar moieties, would never be able to capture 
receptors that do not contain an N-glycan in close proximity to the ligand-binding 
site. Therefore, an alternative method to covalently capture receptors was 
sought. Probes containing photoreactive groups had been successfully used by 
others to identify intracellular receptors (Hatanaka, 2015; Smith and Collins, 
2015; Murale et al., 2016). Hence, as has been discussed in Chapter 4, two 
universal, clickable, photoaffinity probes were created: probe 2, which contained 
a benzophenone moiety; and probe 3, which contained a 3-aryl-3-
(trifluoromethyl)diazirine moiety. As probe 2 did not show any activation by UV-
light it was decided to focus on probe 3. This probe was successfully coupled to 
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the peptidic ligand SP and this coupling did not interfere with the interaction 
between SP and its receptor, the GPCR NK1. Unfortunately, it was impossible to 
show that a covalent bond could be formed between probe 3 and NK1. Whether 
this was due to the absence of such a bond or due to the various problems 
encountered with the click reaction between probe 3 and biotin-PEG-azide was 
unclear. To proceed, probe 4, a derivative of probe 3 with biotin-PEG-azide 
already clicked to the probe, was designed and synthesised (Chapter 5). As for 
probe 3, probe 4 was coupled to SP and this coupling did not interfere with the 
NK1-interaction. Fluorescent confocal microscopy was used to show that SP-
probe-4 coupled covalently to cells expressing HA-NK1-eGFP, while no, or 
significantly less, coupling was observed for cells lacking the receptor, when Gly-
probe-4 was used or when experiments were performed in the absence of UV-
light. Probe 4 was then successfully used in a full LRC experiment to identify NK1 
as the only SP-binding receptor. 
Notwithstanding our difficulties with probe 1, over the last four years Triceps has 
been used by others to successfully capture and identify target proteins in LRC 
experiments (Table 6-1). Out of the seven proteins that have been identified, 
however, only two were integral plasma membrane proteins, while four of the 
others were extracellular secreted proteins and one was a mitochondrial outer-
membrane protein. Lysosomal-associated membrane protein 1 (LAMP-1) and 
lysosome membrane protein 2 (LIMP II), the two plasma membrane proteins that 
were identified, both have many N-glycosylation sites (18 and 10, respectively), 
thus forming perfect targets for Triceps (The UniProt Consortium, 2017).Whereas 
LAMP-1 and LIMP II were both identified as binding partners for C1q TNF related 
protein 3 (CTRP3), the interaction between this ligand and LIMP II was not 
confirmed by any other experiments (Y. Li et al., 2016). That CTPR3 did indeed 
bind LAMP-1 was confirmed by their co-immunoprecipitation, indicating that this 
interaction was not weak and transient, as is often the case for other 
transmembrane protein-binding ligands (Y. Li et al., 2016). Consequently, 
although Triceps has successfully been used in LRC experiments, only one 
confirmed plasma membrane receptor has been identified in the last four years. 
Not only does this protein have 18 N-glycosylation sites, thereby providing many 
interaction points for the probe, it also forms such a strong interaction with its 
ligand that it could be identified through co-immunoprecipitation.  
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Table 6-1. Successful examples of LRC using Triceps.
Ligand Type of ligand Target identified Type of Target # N-Glycans Target confirmation Ref. 
CTRP3-
FLAG  
Flag tagged 
variant of the 
secreted mouse 
C1q TNF related 
protein 3  
Lysosomal-
associated 
membrane 
protein 1  
(LAMP-1) 
A single helix 
transmembrane protein, 
which is mostly found on 
lysosomal membranes, 
however ~5% is located at 
the plasma membrane. 
18 - Co-immunoprecipitation 
- An polyclonal α-LAMP-1 
antibody blocked CTRP3 
binding to cells  
 
(Y. Li et al., 
2016) 
Lysosome 
membrane 
protein 2  
(LIMP II) 
A double helix 
transmembrane protein 
found on lysosomal 
membranes. Expression at 
the plasma membrane has 
not been examined but 
this protein is known to be 
essential for cell-to-cell 
adhesion of the plasma 
membrane for cardiac 
myocytes. 
10 - 
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Ligand Type of ligand Target identified Type of Target # N-Glycans Target confirmation Ref. 
HK-D5-
H497–K520 
24 amino acid 
peptide derived 
from the 
secreted high-
molecular 
weight 
kininogen 
domain 5 
Thrombospondin-
4 (TSP4)  
A secreted extracellular 
matrix protein. 
2 An α-TSP4 antibody 
decreased HK-D5-H497–K520 
induced migration 
 
(Ponda and 
Breslow, 
2016) 
Voltage-
dependent anion 
channel 2 
(VDAC2) 
A β-barrel forming protein 
located on the 
mitochondrial outer 
membrane. 
? An α-VDAC2 antibody did 
not decrease HK-D5-H497–
K520 induced migration, so 
target was not confirmed 
 
PRP-1 Antitumorigenic 
cytostatic 
proline rich 
polypeptide 1 
Mucin 5B 
(MUC5B) 
Secreted protein 31 ELISA (Galoian et 
al., 2018) 
SEE Staphylococcal 
superantigen 
enterotoxin E 
Laminin subunit 
α2 (LAMA2) 
A secreted extracellular 
matrix protein. 
28 - ELISA 
- Co-immunoprecipitation 
- Surface plasmon 
resonance 
(Li et al., 
2018) 
HRG The mouse 
secreted 
histidine-rich 
glycoprotein 
Stanniocalcin-2 
(STC2) 
Secreted protein 1 Co-immunoprecipitation (Roche et 
al., 2018) 
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That Triceps is not the ideal probe to capture transmembrane receptors was also 
realised by others and two variants of this probe have been designed. The first 
contained an aldehyde-reactive aminooxy group, a sulfhydryl, and a biotin moiety 
(ASB; 48) (Tremblay and Hill, 2017), while the second, Hatric (49), which was 
designed by the group that also designed Triceps, contained a NHS-ester, an 
acetone-protected hydrazine moiety and an alkyne group (Figure 6-1) (Sobotzki et 
al., 2018).  
 
Figure 6-1. Structures of ASB (48) and Hatric (49). 
 
The LRC protocol for ASB differs from that of Triceps in four important ways. (1) 
Coupling of ASB to the ligand of interest is achieved via a two-step process where 
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free amine-containing ligands are first treated with long chain succinimidyl 3-(2-
pyridyldithio)propionate (LC-SPDP; 50) or PEG4-SPDP (51) (Figure 6-2). These SPDP 
variants couple to free amines through their NHS-ester and introduce a disulphide 
bond that can interact with the sulfhydryl moiety of ASB. (2) The capturing of 
glycosylated receptors happens through the formation of an oxime bond instead 
of a hydrazone bond. The oxime bond is formed at pH 8.0 and this reaction is 
catalysed by p-phenylenediamine (52; Figure 6-2) through formation of a Schiff 
base intermediate. (3) Cells are lysed under reducing conditions, which results in 
the reduction of the disulphide bond between ASB and the ligand, thus 
‘transferring’ biotin to the target receptor. (4) Finally, whereas the LRC protocol 
for Triceps involves a trypsin digest on the streptavidin beads and after which 
labelled peptides are released using PNGaseF, for ASB an on-bead trypsin digest 
is performed and all trypsinised peptides are analysed using LC-MS/MS, a method 
that was also used for probes 3 and 4. 
 
Figure 6-2. Structures of LC-SPDP (50), PEG4-SPDP (51) and p-phenylenediamine (52). 
 
Hatric resembles Triceps more closely than ASB. Not only is their molecular frame 
identical, it contains an NHS-ester for ligand-coupling and a protected hydrazine 
for receptor capture. There are, however, three important differences between 
Triceps and Hatric. (1) Instead of a biotin moiety, Hatric contains an azide group 
that is used to click the probe to alkyne-conjugated agarose beads, a strategy 
comparable to the approach that was investigated by us for probe 3. (2) 
Furthermore, similar to ASB and our probes 3 and 4, the LRC protocol for Hatric 
includes an on-bead trypsin digest. (3) Finally, the hydrazine moiety present in 
Hatric is not protected with a trifluoroacetyl group but with an acetone moiety. 
Whereas hydrazone formation for Triceps took place at pH 6.4 in the absence of 
any catalyst, for Hatric this reaction takes place at physiological pH and is 
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catalysed by 5-methoxyanthranilic acid (5-MA; 53) (Figure 6-3). As is the case for 
ASB, this catalyst acts through the formation of a Schiff base. The authors 
demonstrated that hydrazone formation is more efficient in the presence of 5-MA 
and they claimed (but did not show) that the acetone protection group allows for 
better coupling than the trifluoroacetyl group. 
 
Figure 6-3. Structure of 5-methoxyanthranilic acid. 
 
Both ASB and Hatric have some advantages over Triceps. Most importantly, the 
on-bead trypsin digest ensures that not only receptors captured through N-linked 
glycans, but also ones that are captured through O-linked sugars, can be 
identified. Furthermore, the addition of the catalyst to the oxime or hydrazone 
formation seems to improve capture yields and for Hatric even allows capturing 
at physiological pH. ASB uses a biotin-transfer technique, which, especially when 
working with large protein ligands, will simplify the MS analysis as the ligand will 
not be co-purified with the receptor. For Hatric the background is also reduced as 
it does not rely on biotin for its purification and endogenously biotinylated 
proteins will, therefore, not be contaminating the samples. 
Although not commented on by the authors, not all the LRC protocols used the 
same conditions for the glycan oxidation. Whereas for Triceps, probe 1 and Hatric 
the NaIO4 concentration was 1.5 mM, for ASB oxidation took place at a 
concentration of 2-10 mM NaIO4. It has been demonstrated before that the 
outcome of glycan oxidation is dependent on the concentration of NaIO4; when 
cells are oxidised using 1 mM NaIO4 at 4 °C, aldehydes will only be formed on 
terminal sialic acid residues, while oxidation with 10 mM NaIO4 at room 
temperature results in the cleavage of hydroxyl containing carbon-carbon bonds 
and the formation of aldehydes on other sugar residues as well (Scheme 6-1) 
(Hermanson, 2013). A higher concentration of NaIO4 consequently results in the 
presence of more aldehyde moieties that can be captured by the probe. Whereas 
this might lead to more efficient capturing of the target receptor(s) it could also 
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result in more non-specific receptors being captured. Investigating the optimal 
concentration of NaIO4 should be part of future research towards these probes. 
 
Scheme 6-1. Oxidation of sugar residues. a. Oxidation of terminal sialic acid residues at 1 mM 
NaIO4. b. Oxidation of sugar residues within a polysaccharide chain at 10 mM NaIO4. 
Notwithstanding the improvements that ASB and Hatric have over Triceps, all four 
probes, Triceps, probe 1, ASB and Hatric, have two important limitations. Firstly, 
they are all unstable compounds. Although for Triceps and Hatric this instability 
was not commented upon, for ASB it has been mentioned that problems were 
encountered of this probe interacting with contaminating aldehydes and ketones, 
including acetone (Tremblay and Hill, 2017), a problem that was also observed 
during the synthesis of probe 1. Secondly, and most importantly, for these four 
probes to be effectively used in LRC experiments, the presence of a glycan, be it 
N- or O-conjugated, near the ligand-binding site of the receptor of interest is 
required.  
To broaden the scope of our probes, photoreactive groups were incorporated into 
probes 2, 3, and 4. Whilst we were working on the development of these probes, 
two papers describing photoaffinity probes specifically targeting GPCRs were 
published. Neither of these probes were universal; instead they were structurally 
based on a ligand of interest. Blex et al. created a probe, CPT-00031 (54), based 
on sertindole, a well-known dopamine D2 receptor (DRD2) antagonist (Blex et al., 
2017), while Thomas et al. created a probe based on an active parent compound 
known to bind G-protein coupled receptor 39 (GPR39) (Figure 6-4) (Thomas et al., 
2017). This latter probe was called probe 1 but will for clarity be called Thom1 
(55). Similar to probe 4, both these probes contained a 3-aryl-3-
(trifluoromethyl)diazirine moiety and a biotin group.  
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Figure 6-4. Structure of CP-00031 (54) and Thom1 (55). 
 
To evaluate whether CPT-00031 and Thom1 could be used in LRC experiments the 
authors performed experiments similar to the ones described in this thesis. First 
it was verified that the probe, or in our case the ligand-probe adduct, bound to 
the receptor. CPT-00031 had a pKi = 7.3 for DRD2 and Thom1 had a pEC50 = 7.4 for 
GPR39 (Blex et al., 2017; Thomas et al., 2017). The affinities of these probes seem 
to be comparable to that of SP-probe-4 which had a pEC50 = 6.5-7.0 for NK1 
(Section 5.5.2). The next step was verification of a covalent bond between the 
probe and the receptor. For probe 4 the formation of this bond was demonstrated 
by fluorescent microscopy and western blotting. For CPT-00031 western blotting 
was also employed to confirm that the probe had covalently coupled to DRD2 (Blex 
et al., 2017). For Thom1, however, no experimental set up to verify capture of 
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the receptor was mentioned. Finally, for all three probes a full LRC experiment 
was performed to show that these probes could be used to identify their target 
receptor in an unbiased manner through LC-MS/MS. Similar to our probe 4, for 
which the full LRC experiment was performed on Flp-InTM T-RExTM 293 cells 
overexpressing NK1, both these probes were also tested on HEK293 cells 
overexpressing the receptor of interest (Blex et al., 2017; Thomas et al., 2017).  
The full LRC protocols for these two probes were very similar to that of our probe 
4. Cells were first incubated with 1-2 µM of the probe (or ligand-probe) followed 
by activation with UV-light. Cells were then lysed and the lysates were added to 
streptavidin beads (probe 4, CPT-00031) or neutravidin (deglycosylated avidin) 
beads (Thom1). Cells were trypsinised, either on the beads (probe 4, CPT-00031), 
or after being released from the beads by boiling in sample buffer (Thom1). 
Peptides were then analysed by LC-MS/MS. As a negative control for SP-probe-4 a 
parallel experiment was performed with Gly-probe-4. As a negative control for 
CPT-00031 and Thom1 parallel experiments were performed with the probe and 
an excess of the free ligand (Blex et al., 2017; Thomas et al., 2017).  
When LRC was performed with CPT-00031 on DRD2 transfected HEK293 cells, there 
were over 150 proteins enriched in the non-competition over the competition 
samples (Blex et al., 2017). The authors then mixed transfected cells with 
untransfected cells and performed LRC on these mixtures. Even when as little as 
5% of the total cells was transfected it was still possible to identify DRD2, however, 
there were always other proteins identified as well (Blex et al., 2017). Moreover, 
whereas DRD2 was not significantly enriched when only 1% transfected cells were 
used, 18 other membrane proteins were enriched (Blex et al., 2017). Whether 
these 18 proteins truly bound to sertindole was not further investigated.  
Thomas et al. did not include the full data set obtained with the LC-MS/MS 
experiments and it is, therefore, hard to tell how many proteins were identified 
using the LRC setup. It is clear, however, that there were at least seven 
transmembrane receptors, including GPR39, enriched in the non-competition 
samples (Thomas et al., 2017). To determine which of these seven receptors were 
truly binding the ligand, the ‘normal’ LRC experiment was combined with a 
‘titration’ LRC experiment. For this titration LRC cells were treated with various 
concentrations of Thom1 (0, 0.01, 0.05, 0.1, 0.5, 1, 5, 10 µM) in the absence of 
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any competitor (Thomas et al., 2017). For each of the seven receptors the ion 
signal intensity was quantified for all Thom1 concentrations. Only receptors for 
which the intensities plateaued at higher concentrations of Thom1 were 
considered real hits, as this indicated that the receptor became saturated. This 
eliminated four of the seven initial hits (Thomas et al., 2017).  
That the ‘normal’ LRC experiments for CPT-0031 and Thom1 resulted in the 
identification of multiple proteins, while for SP-probe-4 the NK1 receptor was 
identified as the only SP-binding protein, might have to do with some small 
differences in the LRC protocols. For probe 4 it was important to wash the cells 
after incubation with the probe but before UV-activation (Section 5.5.3.2). 
Moreover, LRC was only successful when membrane preparations were used, not 
when full cell lysates were created (Section 5.5.6). For both CPT-0031 and Thom1, 
however, no washes were performed before UV-irradiation and full cell lysates 
were added to the streptavidin and neutravidin beads (Blex et al., 2017; Thomas 
et al., 2017). Although the ingenious titration LRC set up did provide Thomas et 
al. with a way to narrow down the ‘real’ hits, it might be worth to repeat these 
experiments while performing washes and creating membrane preparations to see 
if this does reduce the background.  
The probes described in this chapter can be classified on three important features: 
receptor coupling method, universality, and affinity tag (Table 6-2). Each of these 
features and their advantages and disadvantages will shortly be discussed. 
Table 6-2. Probe classification.
Name Coupling  Universality  Affinity tag 
Probe 1 Glycan Universal Click 
Probe 3 Photoreactive Universal Click 
Probe 4 Photoreactive Universal Biotin 
Triceps Glycan Universal Biotin 
ASB Glycan Universal Biotin 
Hatric Glycan Universal Click 
CPT-00031 Photoreactive Specific Biotin 
Thom1 Photoreactive Specific Biotin 
 
The advantages of photoaffinity probes over glycan-binding probes have been 
discussed thoroughly throughout this thesis, the former are more stable and can 
bind to all receptors, not just receptors that contain a glycan in close proximity 
to the ligand-binding site. Nevertheless, Triceps has successfully been used to 
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identify unknown receptors, while these photoaffinity probes have only been used 
to identify receptors of known ligand-receptor interactions on systems that 
overexpressed these receptors. It will be an important next step to see whether 
photoaffinity probes can also be used for LRC experiments on cells endogenously 
expressing target receptors. Only when this is shown can the next step, 
identification of unknown receptors, be considered. 
While the universal probes discussed in this chapter can bind to almost all peptide 
and protein ligands, binding to a small molecule can only happen if this molecule 
contains a free amine. Neither sertindole nor the GPR39 binding compound, which 
were the basis of CPT-00031 and Thom1, contain a free amine and these ligands 
could thus not be coupled to any of these universal probes. Slight modifications 
could be made to such ligands to introduce a free amine and allow coupling of 
these probes, however, once a ligand has to be chemically modified it might be 
easier to create a specific probe. In the future, whether it more advantageous to 
couple a universal probe or to create a specific probe for ligands that do not 
contain free amines is something that has to be decided on a case by case basis.  
There are clear advantages of an alkyne moiety over a biotin moiety. Firstly, as 
the alkyne moiety is smaller than biotin it might interfere less with ligand-receptor 
interactions. Secondly, the alkyne moiety can be clicked to azide-conjugated 
beads which eliminates the use of streptavidin beads and thus results in the 
purification of less endogenously biotinylated proteins. Lastly, an alkyne moiety 
creates the possibility of clicking the probe to another reporter tag such as a 
fluorescent tag. Although, in our hands, it was never possible to prove that probe 
3 formed a covalent bond with the NK1 receptor, now it is known that probe 4 
does form such a bond. Moreover, it has been shown that Hatric could be clicked 
to beads (Sobotzki et al., 2018). Therefore, it might be worth revisiting probe 3. 
Similarly, for the other biotin-containing probes, CPT-00031 and Thom1, an alkyne 
or azide bearing variant could be investigated. Interestingly, Thomas et al. 
indicated that, next to Thom1, a probe with an alkyne moiety instead of a biotin 
group was already created (Thomas et al., 2017). It was mentioned that this probe 
could be clicked to biotin-PEG-azide, however, whether they have tried this and 
whether this was successful was not discussed.  
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To conclude, to my knowledge, probe 4 is the first and only universal photoaffinity 
probe that has specifically been designed to capture transmembrane receptors. 
This probe has successfully been used to identify NK1 as the only SP-binding 
receptor in a test system overexpressing this protein. The most important next 
step will be to verify that this probe can also be used to identify endogenously 
expressed receptors, after which this probe could be used to identify unknown 
receptors binding to ligands of interest. 
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Appendices 
Appendix 1. Purity of synthesised peptides 
 
Purity of synthesised peptides. UV-trace of HPLC analysis of OXA (a), Ac-OXA (b) and SP (c) 
using a C18 column with a 5-95% gradient of MeCN in H2O over 40 or 60 min.    
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Appendix 2. Purity of compound 21 
 
Purity of compound 21. UV-trace of the LC-MS analysis of compound 21 using a C18 column with 
a 5-95% gradient of MeCN in H2O over 40 min.  
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Appendix 3. Purity of compound 23 
 
Purity of compound 23. UV-trace of the LC-MS analysis of compound 23 using a C18 column with 
a 5-95% gradient of MeCN in H2O over 40 min. 
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Appendix 4. Purity of compound 25 
 
 
Purity of compound 25. UV-trace of the HPLC analysis of compound 25 using a C18 column with 
a 5-95% gradient of MeCN in H2O over 60 min. 
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Appendix 5. Stability of probe 3  
 
Stability of probe 3 in LC-MS buffer. Probe 3 was dissolved in 1:1 (v/v) buffer A and buffer B and 
analysed by LC-MS after 3 h (a), 4 h (b) and 16 h (c) using a C18 column with a 5-95% gradient of 
MeCN in H2O over 40 or 60 min. The UV-trace of the analysis is depicted and reveals the presence 
of four compounds: the desired probe 3 (Peak C), hydrolysed probe 35 (Peak A) cyclised probe 36 
(Peak D) and the Me-ester of the probe 54 (Peak B). This last compound was present as this analysis 
was performed on a batch of the probe that had been purified using MeOH (Section 4.3.4). Over time 
probe 3 clearly hydrolysed to 35.   
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Appendix 6. Keratin detection on agarose beads  
  
 
Keratin detection on agarose beads using anti-6xHis antiserum. Agarose beads (50 µL) were 
washed twice with H2O, then 40 µL H2O and 10 µL 5X Laemmli buffer were added and the samples 
were heated for 10 min at 70 °C. 40 µL H2O or RIPA buffer were also mixed with Laemmli buffer and 
heated for 10 min at 70 °C. Samples were resolved with SDS-PAGE and probed with anti-6xHis 
antiserum, which is likely probing for keratin as well. 
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Appendix 7. Probe 4 coupling to BSA  
  
Probe 4 coupling to BSA when this is present in the binding-buffer. Flp-InTM T-RExTM 293 cells, 
induced to express HA-NK1-eGFP, were incubated with SP-probe-4 or Gly-probe-4 in HBSS 
supplemented with or without 0.1% BSA and exposed to UV-light. Lysates were made in RIPA buffer. 
Proteins were resolved with SDS-PAGE and immunoblotted with streptavidin. The position of BSA 
on the blot marked with blue. This showed that the probe is coupling to BSA when this is present in 
the binding buffer.  
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 Appendix 8. Ligand-based receptor capture - HA-NK1-eGFP  
Proteins identified through LC-MS/MS analysis after full LRC on HA-NK1-eGFP expressing cells. 
  
# 
 
Identified Proteins  
Accession 
Number 
Molecular 
Weight 
1  Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 Q13085 266 kDa 
2  Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 P04264 66 kDa 
3  Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 Q96RQ3 80 kDa 
4  Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 P13645 59 kDa 
5  Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1 P68363 50 kDa 
6  Histone H4 OS=Homo sapiens GN=HIST1H4A PE=1 SV=2 P62805 11 kDa 
7  Propionyl-CoA carboxylase alpha chain, mitochondrial (Fragment) OS=Homo sapiens GN=PCCA PE=1 SV=1 A0A1B0GU58 (+1) 67 kDa 
8  Pyruvate carboxylase, mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 P11498 130 kDa 
9  Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 P35908 65 kDa 
10  Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 P35527 62 kDa 
11  Protein-L-isoaspartate O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=1 A0A0A0MRJ6 (+2) 30 kDa 
12  Propionyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=1 C9JQS9 (+6) 61 kDa 
 
The next page gives more detailed information about these identified proteins. 
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# Gly SP Gly SP Gly SP Gly SP Gly SP Gly SP Gly SP Gly SP Gly SP
1 100% 100% 13.3% 7.5% 0.36% 0.19% 21 12 21 12 22 13 22 13 29 17 29 17
2 100% 100% 23.8% 17.1% 0.21% 0.13% 9 7 11 7 9 7 11 7 15 11 17 11
3 100% 100% 13.7% 16.1% 0.16% 0.11% 7 8 7 8 7 8 7 8 13 10 13 10
4 100% 100% 20.7% 14.0% 0.11% 0.10% 8 5 8 5 8 5 8 5 9 9 9 9
5 100% 100% 14.0% 11.1% 0.12% 0.09% 4 3 4 3 4 3 4 3 10 8 10 8
6 100% 0% 42.7% 0.0% 0.10% 0.00% 4 0 4 0 4 0 4 0 8 0 8 0
7 100% 100% 15.0% 10.2% 0.10% 0.05% 7 4 7 4 7 4 7 4 8 4 8 4
8 100% 100% 4.0% 3.1% 0.05% 0.05% 3 3 3 3 4 3 4 3 4 4 4 4
9 100% 100% 9.7% 5.8% 0.09% 0.05% 3 3 5 3 4 3 6 3 5 4 7 4
10 100% 100% 5.8% 14.9% 0.04% 0.08% 3 6 3 6 3 6 3 6 3 7 3 7
11 100% 100% 11.9% 14.7% 0.05% 0.05% 3 3 3 3 4 3 4 3 4 4 4 4
12 100% 100% 8.1% 10.7% 0.04% 0.06% 3 4 3 4 3 4 3 4 3 5 3 5
Protein 
Identifcation 
Probability
Percentage 
Coverage
Percentage 
Total Spectra
Exclusive 
Unique 
Peptide 
Count
Total Unique 
Peptide 
Count
Exclusive 
Unique 
Spectrum 
Count
Total Unique 
Spectrum 
Count
Exclusive 
Spectrum 
Count
Total 
Spectrum 
Count
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Appendix 9. Streptavidin binding full lysates 
 
Streptavidin binding to full lysates of cells treated with SP-probe-4 or Gly-probe-4. A western 
blot of the full lysates of the experiment described in Figure 5-12 probed with streptavidin showed 
that Gly-probe-4 and SP-probe-4 couple to various proteins. See Section 5.5.3.2 for more 
information. 
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Appendix 10. Ligand-based receptor capture - HA-NK1-6xHis 
Proteins identified through LC-MS/MS analysis after full LRC on HA-NK1-6xHis expressing cells. 
1 Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 Q13085 266 kDa 
2 Pyruvate carboxylase, mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 P11498 130 kDa 
3 Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 P05165 80 kDa 
4 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 Q9HCC0 61 kDa 
5 Propionyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=1 C9JQS9 (+3) 61 kDa 
6 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 P04264 66 kDa 
7 Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 P35527 62 kDa 
8 Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 P13645 59 kDa 
9 Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 Q96RQ3 80 kDa 
10 Elongation factor Tu, mitochondrial OS=Homo sapiens GN=TUFM PE=1 SV=2 P49411 50 kDa 
11 60S ribosomal protein L4 OS=Homo sapiens GN=RPL4 PE=1 SV=5 P36578 48 kDa 
12 Stress-70 protein, mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 P38646 74 kDa 
13 60S ribosomal protein L15 OS=Homo sapiens GN=RPL15 PE=1 SV=2 P61313 24 kDa 
14 Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 P35908 65 kDa 
15 ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1 SV=1 P25705 60 kDa 
16 60S ribosomal protein L3 OS=Homo sapiens GN=RPL3 PE=1 SV=2 P39023 46 kDa 
17 Tubulin alpha chain OS=Homo sapiens GN=TUBA1C PE=1 SV=1 F5H5D3 (+3) 58 kDa 
18 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 P60709 (+1) 42 kDa 
19 60S ribosomal protein L8 OS=Homo sapiens GN=RPL8 PE=1 SV=2 P62917 28 kDa 
20 60S ribosomal protein L10a OS=Homo sapiens GN=RPL10A PE=1 SV=2 P62906 25 kDa 
21 60S ribosomal protein L7a OS=Homo sapiens GN=RPL7A PE=1 SV=2 P62424 30 kDa 
22 Cytochrome b-c1 complex subunit 2, mitochondrial OS=Homo sapiens GN=UQCRC2 PE=1 SV=1 H3BRG4 (+2) 45 kDa 
23 40S ribosomal protein S23 OS=Homo sapiens GN=RPS23 PE=1 SV=3 P62266 16 kDa 
24 60 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPD1 PE=1 SV=2 P10809 61 kDa 
25 60S ribosomal protein L12 OS=Homo sapiens GN=RPL12 PE=1 SV=1 P30050 18 kDa 
26 Keratin, type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 P02538 60 kDa 
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27 60S ribosomal protein L18 OS=Homo sapiens GN=RPL18 PE=1 SV=1 F8VYV2 (+1) 16 kDa 
28 Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 P13647 62 kDa 
29 60S ribosomal protein L28 OS=Homo sapiens GN=RPL28 PE=1 SV=3 P46779 16 kDa 
30 Elongation factor 1-alpha 1 OS=Homo sapiens GN=EEF1A1 PE=1 SV=1 A0A087WVQ9 (+2) 48 kDa 
31 Heat shock 70 kDa protein 1B OS=Homo sapiens GN=HSPA1B PE=1 SV=1 A0A0G2JIW1 (+1) 70 kDa 
32 60S ribosomal protein L10 OS=Homo sapiens GN=RPL10 PE=1 SV=1 A0A087WV22 (+3) 20 kDa 
33 60S ribosomal protein L23 (Fragment) OS=Homo sapiens GN=RPL23 PE=1 SV=1 C9JD32 (+2) 10 kDa 
34 Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 Q86YZ3 282 kDa 
35 Protein S100-A8 OS=Homo sapiens GN=S100A8 PE=1 SV=1 P05109 11 kDa 
36 ADP/ATP translocase 2 OS=Homo sapiens GN=SLC25A5 PE=1 SV=7 P05141 33 kDa 
37 60S ribosomal protein L7 OS=Homo sapiens GN=RPL7 PE=1 SV=1 A8MUD9 (+1) 24 kDa 
38 60S ribosomal protein L6 OS=Homo sapiens GN=RPL6 PE=1 SV=3 Q02878 33 kDa 
39 40S ribosomal protein S8 OS=Homo sapiens GN=RPS8 PE=1 SV=2 P62241 (+1) 24 kDa 
40 Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1 E9PKE3 (+1) 69 kDa 
41 Neurokinin 1 receptor OS=Homo sapiens GN=TACR1 PE=1 SV=1 P25103 46 kDa 
42 Protein S100-A9 OS=Homo sapiens GN=S100A9 PE=1 SV=1 P06702 13 kDa 
43 Tubulin beta-2A chain OS=Homo sapiens GN=TUBB2A PE=1 SV=1 Q13885 (+1) 50 kDa 
44 Keratin, type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 P02533 52 kDa 
45 Keratin, type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 Q04695 48 kDa 
46 ADP/ATP translocase 3 OS=Homo sapiens GN=SLC25A6 PE=1 SV=4 P12236 33 kDa 
47 Acetyl-CoA carboxylase 2 OS=Homo sapiens GN=ACACB PE=1 SV=3 O00763 277 kDa 
48 Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=2 F5GYT8 64 kDa 
49 Keratin, type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 P08779 51 kDa 
 
The next pages give more detailed information about these identified proteins. 
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Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3 Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3 Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3
1 40 93 103 27 92 101 43 103 118 30 102 115 42 124 128 28 130 126
2 34 72 59 31 89 59 34 72 59 31 89 59 42 106 81 37 138 81
3 22 38 31 23 47 31 23 39 32 24 47 32 24 53 40 23 73 42
4 12 33 27 11 30 32 12 33 27 11 30 32 14 43 37 14 40 41
5 11 21 20 12 22 24 11 21 20 12 22 24 14 25 24 16 25 28
6 15 6 24 17 9 11 19 8 29 24 11 14 17 6 28 17 9 12
7 11 0 15 9 7 4 11 0 15 9 7 4 11 0 16 9 7 4
8 5 3 8 14 3 2 7 4 13 17 4 3 5 4 10 15 4 2
9 4 5 4 4 4 4 20 35 28 22 48 28 5 6 5 4 5 4
10 0 7 9 0 9 9 0 7 9 0 9 9 0 9 10 0 11 10
11 0 6 3 0 13 2 0 6 3 0 13 2 0 6 3 0 19 2
12 0 7 5 0 8 5 0 7 5 0 8 5 0 7 5 0 10 5
13 0 3 5 0 4 4 0 3 5 0 4 4 0 6 6 0 7 5
14 2 2 6 6 2 2 6 4 12 15 5 4 2 2 7 7 2 2
15 1 5 6 1 5 6 1 5 6 1 5 6 1 5 6 1 5 6
16 0 4 2 0 6 3 0 4 2 0 6 3 0 6 3 0 8 5
17 0 3 7 1 3 4 0 3 7 1 3 4 0 3 7 1 4 4
18 0 3 3 3 2 2 1 4 6 7 4 3 0 3 3 4 2 2
19 0 4 3 0 6 3 0 4 3 0 6 3 0 5 3 0 8 3
20 0 3 3 0 8 2 0 3 3 0 8 2 0 3 3 0 9 2
21 0 2 2 0 7 3 0 2 2 0 7 3 0 2 2 0 7 3
22 0 2 3 2 2 2 0 2 3 2 2 2 0 3 4 3 3 3
23 0 5 3 0 5 3 0 5 3 0 5 3 0 6 3 0 5 3
24 0 2 3 0 5 2 0 2 3 0 5 2 0 2 3 0 5 2
25 0 3 4 0 3 3 0 3 4 0 3 3 0 3 4 0 3 3
26 1 0 0 6 0 0 4 2 5 18 2 0 1 0 0 6 0 0
27 0 3 1 0 3 2 0 3 1 0 3 2 0 4 2 0 4 3
28 1 0 2 5 0 0 3 2 7 15 2 0 1 0 2 5 0 0
29 0 1 3 0 4 1 0 1 3 0 4 1 0 1 3 0 4 1
30 0 1 3 1 2 3 0 1 3 1 2 3 0 1 3 1 2 3
31 0 2 2 0 2 2 0 4 3 0 3 4 0 2 3 0 2 3
32 0 3 0 0 5 0 0 3 0 0 5 0 0 4 0 0 7 0
33 0 3 0 0 3 2 0 3 0 0 3 2 0 3 0 0 4 2
34 0 0 3 3 0 0 0 0 3 3 0 0 0 0 3 5 0 0
35 0 0 4 2 0 0 0 0 4 2 0 0 0 0 4 2 0 0
36 0 1 2 0 2 3 1 5 7 1 9 5 0 1 2 0 2 3
37 0 1 1 0 4 1 0 1 1 0 4 1 0 1 1 0 4 1
38 0 0 2 0 3 2 0 0 2 0 3 2 0 0 2 0 4 2
39 0 3 0 0 4 1 0 3 0 0 4 1 0 3 0 0 4 1
40 0 1 1 1 2 1 0 2 2 1 3 2 0 1 1 1 2 1
41 0 0 0 1 2 4 0 0 0 1 2 4 0 0 0 1 2 4
42 0 0 2 4 0 0 0 0 2 4 0 0 0 0 2 5 0 0
43 0 0 1 0 1 2 0 2 3 1 3 4 0 0 1 0 1 2
44 0 0 0 3 0 0 0 0 4 10 0 0 0 0 0 4 0 0
45 0 0 0 3 0 0 0 0 3 9 0 0 0 0 0 3 0 0
46 0 0 1 0 1 0 1 4 6 1 8 2 0 0 1 0 1 0
47 0 0 2 0 0 1 0 0 17 0 0 14 0 0 2 0 0 1
48 0 0 0 0 0 0 16 29 24 18 44 24 0 0 0 0 0 0
49 1 0 0 0 0 0 3 0 0 4 0 0 1 0 0 0 0 0
Exclusive Unique Peptide Count Total Unique Peptide Count Exclusive Unique Spectrum Count
Gly SP Gly SP Gly SP
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Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3 Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3 Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3
1 45 136 145 31 142 141 54 188 315 41 204 289 59 212 359 46 226 324
2 42 106 81 37 138 81 73 212 182 65 283 171 73 212 182 65 283 171
3 25 54 41 24 73 43 37 103 92 39 153 90 38 105 93 41 153 92
4 14 43 37 14 40 41 26 72 89 29 68 71 26 72 89 29 68 71
5 14 25 24 16 25 28 28 44 64 28 43 54 28 44 64 28 43 54
6 22 8 34 27 11 15 23 7 47 30 11 15 31 9 58 46 13 20
7 11 0 16 9 7 4 14 0 21 12 7 4 14 0 21 12 7 4
8 7 5 18 19 5 3 6 4 11 21 4 2 8 5 24 26 5 4
9 24 46 33 24 63 34 11 7 11 9 7 8 52 105 88 44 143 86
10 0 9 10 0 11 10 0 9 11 0 11 10 0 9 11 0 11 10
11 0 6 3 0 19 2 0 6 3 0 22 2 0 6 3 0 22 2
12 0 7 5 0 10 5 0 7 5 0 10 5 0 7 5 0 10 5
13 0 6 6 0 7 5 0 6 6 0 8 5 0 6 6 0 8 5
14 6 4 13 18 5 4 2 2 7 10 2 2 7 4 18 27 6 6
15 1 5 6 1 5 6 1 5 6 1 5 6 1 5 6 1 5 6
16 0 6 3 0 8 5 0 6 3 0 8 5 0 6 3 0 8 5
17 0 3 7 1 4 4 0 3 8 1 4 5 0 3 8 1 4 5
18 1 4 6 8 5 3 0 3 3 5 2 2 1 4 6 10 5 3
19 0 5 3 0 8 3 0 5 3 0 9 3 0 5 3 0 9 3
20 0 3 3 0 9 2 0 4 3 0 10 2 0 4 3 0 10 2
21 0 2 2 0 7 3 0 2 2 0 7 3 0 2 2 0 7 3
22 0 3 4 3 3 3 0 3 4 4 3 3 0 3 4 4 3 3
23 0 6 3 0 5 3 0 6 3 0 5 3 0 6 3 0 5 3
24 0 2 3 0 5 2 0 2 3 0 5 2 0 2 3 0 5 2
25 0 3 4 0 3 3 0 3 4 0 3 3 0 3 4 0 3 3
26 5 2 6 21 2 0 1 0 0 8 0 0 8 2 6 30 3 0
27 0 4 2 0 4 3 0 4 2 0 4 3 0 4 2 0 4 3
28 4 2 8 18 2 0 1 0 2 9 0 0 7 2 8 29 3 0
29 0 1 3 0 4 1 0 1 3 0 4 1 0 1 3 0 4 1
30 0 1 3 1 2 3 0 1 3 1 2 3 0 1 3 1 2 3
31 0 4 4 0 3 5 0 2 3 0 2 3 0 4 4 0 3 5
32 0 4 0 0 7 0 0 4 0 0 7 0 0 4 0 0 7 0
33 0 3 0 0 4 2 0 3 0 0 5 2 0 3 0 0 5 2
34 0 0 3 5 0 0 0 0 3 6 0 0 0 0 3 6 0 0
35 0 0 4 2 0 0 0 0 5 4 0 0 0 0 5 4 0 0
36 1 5 8 1 10 5 0 1 2 0 2 3 1 7 11 1 12 6
37 0 1 1 0 4 1 0 1 1 0 4 1 0 1 1 0 4 1
38 0 0 2 0 4 2 0 0 2 0 4 2 0 0 2 0 4 2
39 0 3 0 0 4 1 0 3 0 0 4 1 0 3 0 0 4 1
40 0 2 2 1 3 2 0 1 1 2 2 1 0 2 2 2 3 2
41 0 0 0 1 2 4 0 0 0 1 2 4 0 0 0 1 2 4
42 0 0 2 5 0 0 0 0 2 5 0 0 0 0 2 5 0 0
43 0 2 4 1 3 5 0 0 1 0 1 2 0 2 4 1 3 5
44 0 0 6 12 0 0 0 0 0 5 0 0 0 0 9 14 0 0
45 0 0 4 9 0 0 0 0 0 3 0 0 0 0 6 10 0 0
46 1 4 7 1 9 2 0 0 1 0 1 0 1 6 10 1 11 3
47 0 0 19 0 0 15 0 0 2 0 0 1 0 0 44 0 0 35
48 19 38 28 20 58 30 0 0 0 0 0 0 41 94 76 35 134 76
49 3 0 0 5 0 0 1 0 0 0 0 0 3 0 0 6 0 0
Total Unique Spectrum Count Exclusive Spectrum Count Total Spectrum Count
Gly SP Gly SP Gly SP
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Appendix 11. Quantitative analysis LRC 
Quantitative analysis of LC-MS/MS data after full LRC on HA-NK1-6xHis expressing cells.  
 
# T-Test (p-value): (p < 0.05) Quantitative Profile Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3
41 0.023 Gly low, SP high 0 0 0 1.8047 1.4425 3.4812
4 0.11 59.381 66.757 63.848 52.336 49.044 61.791
40 0.15 0 1.8544 1.4348 3.6094 2.1637 1.7406
30 0.26 0 0.92718 2.1522 1.8047 1.4425 2.6109
22 0.32 0 2.7815 2.8696 7.2188 2.1637 2.6109
38 0.33 0 0 1.4348 0 2.8849 1.7406
43 0.36 0 1.8544 2.8696 1.8047 2.1637 4.3515
21 0.4 0 1.8544 1.4348 0 5.0486 2.6109
18 0.41 2.2839 3.7087 4.3043 18.047 3.6062 2.6109
42 0.45 0 0 1.4348 9.0234 0 0
5 0.47 63.949 40.796 45.913 50.531 31.013 46.996
34 0.48 0 0 2.1522 10.828 0 0
37 0.48 0 0.92718 0.71739 0 2.8849 0.87029
45 0.5 0 0 4.3043 18.047 0 0
44 0.51 0 0 6.4565 25.266 0 0
11 0.57 0 5.5631 2.1522 0 15.867 1.7406
33 0.57 0 2.7815 0 0 3.6062 1.7406
26 0.59 18.271 1.8544 4.3043 54.141 2.1637 0
28 0.59 15.987 1.8544 5.7391 52.336 2.1637 0
14 0.6 15.987 3.7087 12.913 48.727 4.3274 5.2217
7 0.63 31.975 0 15.065 21.656 5.0486 3.4812
35 0.68 0 0 3.587 7.2188 0 0
20 0.69 0 3.7087 2.1522 0 7.2123 1.7406
9 0.71 118.76 97.354 63.13 79.406 103.14 74.845
46 0.73 2.2839 5.5631 7.1739 1.8047 7.9335 2.6109
24 0.74 0 1.8544 2.1522 0 3.6062 1.7406
16 0.75 0 5.5631 2.1522 0 5.7698 4.3515
19 0.76 0 4.6359 2.1522 0 6.4911 2.6109
3 0.77 86.788 97.354 66.717 73.992 110.35 80.067
8 0.77 18.271 4.6359 17.217 46.922 3.6062 3.4812
49 0.77 6.8517 0 0 10.828 0 0
1 0.78 134.75 196.56 257.54 83.016 163 281.97
23 0.81 0 5.5631 2.1522 0 3.6062 2.6109
39 0.81 0 2.7815 0 0 2.8849 0.87029
2 0.82 166.72 196.56 130.57 117.3 204.11 148.82
25 0.83 0 2.7815 2.8696 0 2.1637 2.6109
29 0.84 0 0.92718 2.1522 0 2.8849 0.87029
32 0.84 0 3.7087 0 0 5.0486 0
48 0.86 93.64 87.155 54.522 63.164 96.645 66.142
12 0.87 0 6.4903 3.587 0 7.2123 4.3515
15 0.88 2.2839 4.6359 4.3043 1.8047 3.6062 5.2217
6 0.91 70.801 8.3446 41.609 83.016 9.376 17.406
36 0.91 2.2839 6.4903 7.8913 1.8047 8.6548 5.2217
17 0.93 0 2.7815 5.7391 1.8047 2.8849 4.3515
27 0.94 0 3.7087 1.4348 0 2.8849 2.6109
10 0.97 0 8.3446 7.8913 0 7.9335 8.7029
13 0.97 0 5.5631 4.3043 0 5.7698 4.3515
47 0.98 0 0 31.565 0 0 30.46
31 0.99 0 3.7087 2.8696 0 2.1637 4.3515
Quantitative Value (Normalized Total Spectra)
Gly SP
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# T-Test (p-value): (p < 0.05) Quantitative Profile Gly-probe 1 Gly-probe 2 Gly-probe 3 SP-probe 1 SP-probe 2 SP-probe 3
41 0.047 Gly low, SP high 0 0 0 440040 165890 697890
4 0.16 23061000 21281000 26199000 1.8E+07 1.4E+07 2.3E+07
40 0.23 0 86357 183730 593420 117330 214250
30 0.34 0 105200 171730 781080 103950 124910
22 0.35 57688 738680 608940 4636600 670030 477590
38 0.35 0 140170 83645 0 787460 193350
43 0.4 0 253360 135780 0 369960 474010
21 0.4 0 0 62356 1164300 0 0
18 0.44 2898700 361820 1859800 3.5E+07 150480 0
42 0.45 2668400 361820 2007300 3E+07 150480 0
5 0.45 0 210030 0 0 1092600 37902
34 0.49 0 0 1028100 4765600 0 0
37 0.49 0 0 125110 0 105680 162950
45 0.5 0 641970 467250 0 1445800 672360
44 0.59 13398000 11854000 16027000 2.5E+07 8222400 1.7E+07
11 0.61 0 0 1993000 4955200 0 0
33 0.64 3336900 636060 4765000 1.6E+07 348160 314810
26 0.65 0 615450 150080 0 1173800 189770
28 0.66 0 1032500 190540 0 2038600 205110
14 0.67 0 124340 539030 204240 162650 592990
7 0.68 1849400 0 0 3728600 0 0
35 0.69 0 749610 217850 0 368920 273640
20 0.72 4699300 661890 3911000 1.3E+07 504490 969020
9 0.72 0 0 1807000 3239500 0 0
46 0.72 101270 2489200 1992200 677380 1086900 1892800
24 0.73 0 140540 722510 103380 193920 954400
16 0.75 101270 2695800 2323400 677380 1257300 2219400
19 0.79 0 0 1187300 1801800 0 0
3 0.8 0 0 23382000 0 0 1.6E+07
8 0.83 0 549080 229890 0 803150 179430
49 0.83 0 912210 0 0 657430 0
1 0.83 0 263380 0 0 204720 130190
23 0.84 33470000 81532000 1.12E+08 2.1E+07 5.7E+07 1.2E+08
39 0.84 0 76500 222830 0 344490 35919
2 0.84 0 35068 118360 0 90945 34584
25 0.85 90125000 96770000 60984000 6E+07 1.1E+08 6.6E+07
29 0.85 0 460440 1156900 98034 302940 951960
32 0.87 35186000 1743200 15978000 3.8E+07 1862500 5208300
48 0.88 50978000 41500000 29473000 3.6E+07 5.3E+07 2.9E+07
12 0.89 371780 990250 1242600 157490 637210 1592900
15 0.9 0 382720 515750 0 136030 658090
6 0.92 4746300 0 5343500 9738500 641840 824620
36 0.92 0 299880 324340 0 266920 311790
17 0.93 0 704480 315810 0 593750 500980
27 0.94 58238000 51853000 30001000 3.5E+07 6E+07 4.3E+07
10 0.94 0 961570 421320 0 795010 494850
13 0.96 0 1707600 2056700 0 1705800 1907500
47 0.96 0 894310 912630 0 855120 1028200
31 0.96 38565000 37354000 26149000 2.6E+07 4.9E+07 2.6E+07
Quantitative Value (Normalized Total TIC)
Gly SP
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